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Abstract
Computational mass spectrometry is a fast evolving field that has attracted increased at-
tention over the last couple of years. The performance of software solutions determines the
success of analysis to a great extent. New algorithms are required to reflect new experimental
procedures and deal with new instrument generations.
One essential component of algorithm development is the validation (as well as comparison)
of software on a broad range of data sets. This requires a gold standard (or so-called ground
truth), which is usually obtained by manual annotation of a real data set. Comprehensive
manually annotated public data sets for mass spectrometry data are labor-intensive to produce
and their quality strongly depends on the skill of the human expert. Some parts of the data may
even be impossible to annotate due to high levels of noise or other ambiguities. Furthermore,
manually annotated data is usually not available for all steps in a typical computational analysis
pipeline. We thus developed the most comprehensive simulation software to date, which allows to
generate multiple levels of ground truth and features a plethora of settings to reflect experimental
conditions and instrument settings. The simulator is used to generate several distinct types of
data. The data are subsequently employed to evaluate existing algorithms. Additionally, we
employ simulation to determine the influence of instrument attributes and sample complexity
on the ability of algorithms to recover information. The results give valuable hints on how to
optimize experimental setups.
Furthermore, this thesis introduces two quantitative approaches, namely a decharging al-
gorithm based on integer linear programming and a new workflow for identification of differ-
entially expressed proteins for a large in vitro study on toxic compounds. Decharging infers
the uncharged mass of a peptide (or protein) by clustering all its charge variants. The latter
occur frequently under certain experimental conditions. We employ simulation to show that
decharging is robust against missing values even for high complexity data and that the algo-
rithm outperforms other solutions in terms of mass accuracy and run time on real data. The last
part of this thesis deals with a new state-of-the-art workflow for protein quantification based
on isobaric tags for relative and absolute quantitation (iTRAQ). We devise a new approach
to isotope correction, propose an experimental design, introduce new metrics of iTRAQ data
quality, and confirm putative properties of iTRAQ data using a novel approach.
All tools developed as part of this thesis are implemented in OpenMS, a C++ library for
computational mass spectrometry.

Zusammenfassung
Rechnergestu¨tzte Massenspektrometrie steht seit Jahren im Fokus von Forschungsbestrebun-
gen und erlangt immer mehr Aufmerksamkeit. Die Gu¨te von Software bestimmt zu einem erheb-
lichen Teil den Erfolg oder Misserfolg einer Datenanalyse. Neue experimentelle Mo¨glichkeiten
und Instrumentengenerationen erfordern die Anpassung bzw. Neuentwicklung von Algorithmen.
Ein essentieller Gesichtspunkt der Algorithmenentwicklung ist die Validierung (oder auch
der Vergleich) von Software auf einer mo¨glichst großen Bandbreite an Eingabedaten. Eine Vali-
dierung erfordert einen Goldstandard, der meist durch manuelle Annotation eines Datensatzes
erzeugt wird. Umfassende manuell annotierte, o¨ffentliche Datensa¨tze fu¨r Massenspektrometrie
sind zeitaufwa¨ndig in der Herstellung und ihre Qualita¨t ha¨ngt stark von den Fa¨higkeiten des
Experten ab. Nicht alle Teile des Datensatzes sind annotierbar, da es teilweise hohe Rauschpegel
und andere Sto¨rquellen gibt die eine zuverla¨ssige Annotation verhindern. Weiterhin sind manuell
annotierte Datensa¨tze u¨blicherweise nicht fu¨r alle Ebenen eines Goldstandards verfu¨gbar. Um
dieses Dilemma zu beheben entwickelten wir die zurzeit umfassendste Simulationssoftware, wel-
che viele Ebenen eines Goldstandards unterstu¨tzt, ebenso wie eine Vielzahl von Einstellungen,
die es erlauben, viele experimentelle Bedingungen und Instrumenteneinstellungen nachzubilden.
Der Simulator wird benutzt um mehrere verschiedenartige Datensa¨tze zu erzeugen. Diese wer-
den anschließend eingesetzt um existierende Algorithmen zu bewerten. Zusa¨tzlich benutzen wir
Simulationen um den Einfluss von Instrumenteneigenschaften und Probenkomplexita¨t auf die
Gu¨te und Vollsta¨ndigkeit der von Algorithmen extrahierten Informationen zu bestimmen. Die
Ergebnisse geben wertvolle Hinweise fu¨r die Optimierung von Versuchsaufbauten.
Zusa¨tzlich fu¨hrt diese Arbeit zwei quantitative Ansa¨tze ein: einen Decharging-Algorithmus
basierend auf ganzzahligen linearen Programmen sowie einen neuen Workflow fu¨r die Identifi-
zierung von differentiell exprimierten Proteinen fu¨r eine große In-vitro-Studie zur Systemtoxi-
kologie. Decharing inferiert die ungeladene Masse eines Peptids (oder Proteins) durch Cluste-
ring aller seiner Ladungsvarianten. Letztere entstehen ha¨ufig unter bestimmten experimentellen
Bedingungen. Wir verwenden Simulationen, um zu zeigen, dass Decharging robust gegen Da-
tenlu¨cken sogar auf hochkomplexen Datensa¨tzen ist, und dass der Algorithmus anderen Lo¨sungen
hinsichtlich der Massengenauigkeit und Laufzeit auf realen Daten u¨berlegen ist. Der letzte Teil
der Arbeit widmet sich einem modernen Workflow fu¨r Proteinquantifizierung mit Hilfe von
iTRAQ (isobaric tags for relative and absolute quantitation). Wir stellen einen neuen Ansatz
fu¨r Isotopenkorrektur vor, entwerfen ein experimentelles Design, konzipieren neue Metriken fu¨r
die Datenqualita¨t von iTRAQ-Daten und verifizieren vermutete Eigenschaften dieser Art von
Daten anhand von neuen Verfahren.
Alle Softwarewerkzeuge, die als Teil dieser Arbeit entstanden sind, wurden in OpenMS –
einer C++-Bibliothek fu¨r Massenspektrometrie – implementiert.
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Chapter 1
Introduction
Synopsis: We motivate the topic of this thesis: the development and application of algorithms
for simulation and quantification for mass spectrometry data analysis. Since mass spectrometry
is a fast-moving field, we give an overview of the current state of the art and challenges.
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1.1 Mass Spectrometry-based Proteomics
Proteomics – commonly defined as the study of the ensemble of proteins at a given point in time,
especially their expression pattern, structure and function – is one of the key research areas of
today enabling us to extend our knowledge of regulation and control in living systems. Many
emerging or already established fields dealing with large-scale biological data are designated by
adding the suffix “-omics” to previously used terms, e.g., metabonomics or genomics, where
ongoing efforts are now focusing on personalized and population aspects [1]. The proteome is
thought to capture the cellular processes much closer than, for example, the genome or tran-
scriptome. Regulation on protein level includes post-translational modifications, degradation,
transport and (protein) interaction. These regulation steps cannot be adequately described or
modeled on the genome- or transcriptome level. Recently it was found that RNA-editing, i.e.,
the alteration of RNA sequence, is not a seldom process in humans [2] but occurs rather fre-
quently. This discovery shifts our understanding of the central dogma of molecular biology in
the sense that translation from DNA to protein is not faithful but merely gives the direction of
information transfer, thus implying that one cannot fully explain the protein content of a cell,
given genes and their splice variants alone. Not only does RNA-editing lead to diversification of
the proteome, but it also implies that protein databases derived from DNA alone cannot contain
the complete set of protein sequences.
Mass Spectrometry (MS) coupled to liquid chromatography (LC) is currently the major
workhorse in proteomics, due its unparalleled automation and high throughput capabilities. It
can be used as a “hypothesis-generating engine” [3] and is increasingly replacing techniques like
2D gels and western blotting, especially in exploratory settings, although the latter are still
used for confirmatory experiments. Mass Spectrometry itself is an established technique. The
introduction of soft-ionization methods, i.e., electrospray ionization (ESI) as proposed by Fenn
[4] and matrix-assisted laser desorption/ionization (MALDI) as invented by Tanaka, made MS
applicable to the analysis of biomolecules. Fenn and Tanaka both received the Nobel Prize in
Chemistry in 2002. Soft ionization prevents larger biomolecules to break upon ionization and
thus allows to measure their intact mass.
In clinical proteomics, LC-MS (and especially MALDI-MS) initially triggered a wide range
of exploratory studies but has not found wide applicability yet [5], though some remarkable
breakthroughs like early detection of kidney scarring have been achieved [6]. About 200 protein
biomarkers [7] as approved by the FDA (Food and Drug Administration) are used in clinical
practice, but only a small subset of these were initially discovered using mass spectrometry.
This is in parts due to the high standards required for clinical biomarkers (with 80 replicates
recommended – see [5]) as well as limited reproducibility and robustness of LC-MS. Protein
abundance covers more than nine orders of magnitude in human blood, whereas a mass spec-
trometer covers a linear dynamic range of 2-4 (possibly up to 6) orders of magnitude. Linear
dynamic range is defined as the range over which ion signal is linear with analyte concentration
[8].
Unfortunately, most biomarkers found to date typically occur at concentrations of several
ng/ml, thus evading exploratory mass spectrometry [5]. Also, mass spectrometry currently lacks
the standardization protocols required for wide clinical applicability. This is partly due to the
fact that MS is much more variable than other omics techniques [9], such as microarrays; thus
the effort of finding standard operating procedures (SOPs) is more involved. This does not
only apply to experimental procedures but also very much to subsequent computational data
analysis.
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Advancements and gain of public interest for MS-based proteomics can be attributed to
improvements in targeted proteomics and instrument design by increasing sensitivity, mass res-
olution, but also in analytical terms where new multiplexing methods have been developed,
allowing the concurrent measurement of multiple samples. Finally, computational biology has
made progress, providing better models and software in order to analyze the increasing amounts
of data generated by high-throughput techniques such as LC-MS. The community has realized
the importance of sustainable software solutions, which are accessible to a wide audience. MS
excels in certain areas like annotation of post-translational modifications [10], and remarkable
discoveries were made possible by MS [3].
Mass Spectrometric Imaging (MSI) [11], which was developed in the late nineties, is becoming
more popular as spatial resolution, sample preparation methods and sensitivity are improving.
An alternative technique to LC (or LC-MS), namely conventional 2D gels with staining,
has advantages in costs and when it comes to the detection of protein isoforms with diverging
modifications but is labor-intensive, has low dynamic range and lacks gel-to-gel reproducibility
[12]. Formerly it was thought that LC(-MS) will replace 2D gels. However, it becomes more and
more clear that they complement each other [13, 14]. Immuno-assays like the enzyme-linked
immunosorbent assay (ELISA) are still in wide use in the clinical setting and during validation
phase, where MS is still only beginning to become the method of choice [15].
The role of computational proteomics is becoming more and more important, as data gen-
eration is currently vastly outpacing data analysis [16]. For example, several hundred patient
samples (i.e., human serum) can be screened by a single MALDI platform in one day [5], a
single LC-MS run on a modern Orbitrap mass analyzer yields many gigabytes of data per day
and public data repositories like PRIDE [17] contain hundreds of millions of spectra1.
Recently, the field has shifted toward high-throughput analysis of (so far unsequenced) or-
ganisms/cells trying to achieve maximum proteome coverage while also attempting to increase
knowledge about modification states and sites of proteins. New techniques like concurrent pep-
tide fragmentation (MSE) [18], fragmenting all peptides, or sequential windowed acquisition of
all theoretical fragment ion mass spectra (SWATH-MS) [19], are emerging, aiming to push the
limits of identification. This also poses a challenge to algorithm development as for each new
technique, new solutions are required to make optimal use of the data and avoid time-consuming
and error-prone manual analysis.
Many publications have called for a set of credible benchmark data providing a gold standard
[20, 21, 22, 23, 24, 25] which allows to compare and evaluate algorithmic approaches. The
premise of the exact nature of this data is not necessarily unified though. Some require a gold
standard (so-called ground truth) for lower-level signal processing of raw LC-MS data [20, 22, 23,
24], others require pre-processed data with protein expression values from different conditions
[25]. One common solution is the use of small protein mixtures (so-called standard mixtures),
which are commercially available and can be used to generate data sets with known protein
content. However, these mixtures often lack the complexity inherent to real biological samples,
and the data quality (e.g., in terms of contaminants from sample handling) strongly depends on
the expertise of the laboratory. Inevitably, such controlled experiments cannot provide the lower
levels of a gold standard, e.g., for peak picking (a low-level data reduction step), whereas they are
useful for peptide identification and quantification problems. Of course, manual annotation can
be employed for many levels of ground truth. However, manual annotation is labor-intensive
and the quality of the annotation strongly depends on the skill of the human expert. Some
1as of PRIDE Basis Statistics at http://www.ebi.ac.uk/pride on 04/22/2012.
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parts of the data may even be impossible to annotate due to high levels of noise or other
ambiguities. Public data sets with comprehensive manual annotation are usually not available
for many levels of ground truth. An orthogonal solution to the problem of a benchmark data
set is the use of extensive simulation of mass spectrometry data. This area of research is usually
neglected or is given only marginal attention when used to validate an algorithm [20, 23, 24]. The
software employed is usually written for this purpose alone and neither published nor extensively
described. One exception is the publication of LC-MSsim [26], a simulation software for LC-MS
data, which unfortunately is not maintained anymore and lacks some desirable functionality, e.g.,
simulation of fragment spectra (so called MS/MS, MS2 or tandem mass spectra) and simulation
of labeled LC-MS data. Fragment spectra allow to identify the peptide (or protein) by sequence
and/or its quantification. Fragments are created by introducing the peptide (or protein) of
interest into a collision cell. A labeling procedure allows to discern identical peptides (in terms
of sequence and post-translational modifications) from different samples within a single LC-
MS experiment (a process called multiplexing) by using chemical or metabolic labeling of some
kind to introduce a systematic mass shift. Therefore, peptides from different samples can be
identified and quantified concurrently. In order to make simulation available to a wider audience
we developed the most comprehensive and convenient simulation software to date, allowing for
many levels of ground truth. The simulator features a plethora of settings to reflect experimental
conditions and instrument configurations. We show how simulation can be used for algorithm
benchmarking and validation. Additionally, we employ simulation to determine the influence
of instrument configurations and sample complexity on the ability of algorithms to recover
information. The results give valuable hints on how to optimize experimental setups.
Labeling can also be used for higher levels of MS, e.g., MS2, where different chemical la-
bels can only be discerned upon fragmentation. One example of an MS2-based multiplexing
technique is isobaric tags for relative and absolute quantitation (iTRAQ) [27]. Like all mul-
tiplexing approaches, iTRAQ allows to save time for sample acquisition as multiple samples
are measured concurrently, and has the added benefit of easy assignment of individual peptide
abundances to samples; thus, differences in expression between peptides can easily be computed
without the need for complex algorithms which try to determine peptide content for each sam-
ple. Quantification is more challenging in label-free experiments, where each sample is measured
separately, and is even more difficult for most MS1-based labeling techniques. However, iTRAQ
suffers from other disadvantages, such as ratio underestimation and isotope impurities, which
are caused by impurities in chemical labeling reagents and give rise to artifactual intensity values
when corrected for with the conventional method of inverse matrix multiplication as proposed
in Shadforth et al. [28]. The second contribution of this thesis is the introduction of a new
procedure for isotope correction of iTRAQ-based quantification values, which is more robust
for low-intensity quantification values. Additionally we present new metrics of iTRAQ data
quality, and confirm putative properties of iTRAQ data using a novel approach. The computa-
tional analysis is made readily available as highly automated workflow and was implemented into
OpenMS [29] – a C++ library for computational mass spectrometry. In large-scale studies using
labeling techniques there is often the problem of finding a suitable experimental design, i.e. the
allocation of samples to the limited set of available labels. The set of samples usually includes
technical or biological replicates. We propose an experimental design, specifically adapted to
the requirements of a large-scale project using iTRAQ-based LC-MS.
A common problem, especially in ESI-MS, is the presence of multiple charge variants, i.e., a
peptide or protein occurs in multiple charge states and possibly with different adducts. This gives
rise to so-called charge ladders. This signal partitioning unfortunately leads to dense spectra,
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but it also allows for multiple measurement points for a single species, which can be used for a
more precise mass estimation. An algorithm which can find charge variants can thus not only
be applied to find the overall signal contribution originating from a single peptide or protein,
thus finding a more clear representation of sample content, but also to determine peptide or
protein mass more precisely. Decharging infers the uncharged mass of a peptide (or protein) by
clustering all its charge variants. The latter occur frequently during ESI, but can also be observed
in MALDI-based experiments under certain conditions [30]. One of the first algorithms by Mann,
Meng, and Fenn [31] is able to decharge spectra from whole protein samples, but is prone to
dense spectra and likely to create artifact signals. Later algorithms have drawbacks in other
areas, e.g., the heuristic approach by Malyarenko et al. [30] is only applicable to MALDI spectra.
The well known ZScore-Algorithm [32] supports decharging either using charge ladders or local
charge information, but not both simultaneously. An algorithm by Wehofsky and Hoffmann [33]
can use both local charge and charge ladders but does not take into account retention time, only
considers proton adducts, and requires charge ladders without gaps. None of the algorithms
mentioned above is able to model charge ladders with multiple adduct combinations, e.g., a
combination of pure proton adduct species with a proton/sodium species from the same peptide
or protein. Our decharging algorithm based on integer linear programming (ILP) is suitable for
finding pairs of labeled data concurrently with charge variants and supports arbitrary adduct
combinations. We employ simulation to show that the algorithm is robust against missing values
even for high complexity data and that it outperforms other solutions in terms of mass accuracy
and run time on real data. The decharging algorithm constitutes our third contribution.
1.2 Guide to this Thesis
This thesis focuses on the algorithmic aspects of mass spectrometry-based proteomics while also
touching on biomarker identification and statistical evaluation.
The remainder of this thesis is structured as follows: The second chapter gives an overview of
the wide field of computational proteomics, especially covering quantification of peptide signals
from LC-MS samples, while also elucidating our contribution to OpenMS [29] – a widely used
framework for computational mass spectrometry. We also cover current algorithmic problems,
some of which are addressed in the following chapters. Every algorithm described in this thesis
was implemented in OpenMS and is part of the official OpenMS release, readily available as
binary package from the official website.
In the third chapter, we describe our simulation tool MSSimulator; motivate why simulation
of MS1 and MS2 data provides a valuable tool for algorithm prototyping, benchmarking and
experimental setup optimization and describe the capabilities of the simulator as well as the
properties of the underlying instruments. This chapter was, in parts, published in Bielow et al.
[34].
The fourth chapter introduces a deconvolution algorithm designed to cluster charge variants,
differently labeled peptides, and common adducts in MS experiments. We show the theoretical
details and multiple applications of this versatile approach. The algorithm is benchmarked
using the simulator described in Chapter 4. An earlier version of this algorithm was published
in Bielow et al. [35].
The fifth chapter represents our contribution to the analysis of iTRAQ data, including ex-
perimental design, a novel isotope correction procedure, and new metrics of iTRAQ data quality.
Parts of the analysis along with the biological interpretation are currently being prepared for
publication in Wilmes et al. [36].
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In Chapter 6 we conclude this thesis with a summary of our work and point to future
extensions.
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Chapter 2
Computational Mass Spectrometry
Synopsis: This chapter introduces common terms used in proteomics and especially mass
spectrometry with the focus on their algorithmic aspects and serves as a foundation for the
following chapters. We also briefly recapitulate the pros and cons of the major existing software
packages as well as our contribution to the OpenMS software library.
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Computational biology, and computational mass spectrometry as a special case, deals with
providing computational methods to analyze and interpret data from molecular biology. Al-
though the idea is not new, the field has received increasing attention in the last years as data
volumes increase to a point unmanageable for manual analysis.
To familiarize the reader with our terminology and the current state-of-the-art methods, we
describe the most typical LC-MS setups and analysis pipelines while also covering algorithmic
challenges and solutions to quantification and identification scenarios. Our contribution to the
widely used software library OpenMS is also covered in this chapter.
2.1 Separation
A separation step is advisable for high-complex samples like serum or whole cell lysates before
the samples are measured by MS. The former method of choice was two-dimensional gel elec-
trophoresis (2-DE), which nowadays is seldomly used since the method is not automatable, thus
very time-consuming, lagging reproducibility, thus not cost-effective [37]. Furthermore, 2-DE
only offers a very limited dynamic range, preventing identification of low abundance species [38].
On top of that, it has problems with hydrophobic proteins and species of extreme low or high
molecular weight or isoelectric point [39].
An alternative to gels is capillary electrophoresis (CE). It offers robustness against inter-
fering substances and uses inexpensive capillaries, it is compatible with practically all buffers
and analytes, delivering high separation efficiency and speed [40, 41, 42, 43]. Furthermore, it
produces visible trends, which can aid in peptide identification [44]. However, decreased loading
capacity, which highlights the potential problem of sensitive detection [42] and (earlier) poor
reproducibility in migration time [41, 45], are drawbacks of this technology.
The term CE refers to a family of separation techniques that use narrow-bore fused-silica
capillaries to separate a complex mixture of large and small charged molecules. In a high elec-
tric field, molecules are separated based on their physical-chemical properties which determine
their migration time, which is further dependent on the background electrolyte (BGE) and its
properties, e.g., ionic strength, pH, or type of ions [46]. The most commonly used trade of CE
is capillary zone electrophoresis (CZE), for which CE will be used synonymously from now on.
In CZE, the separation mechanism is largely based on differences in the charge-to-mass ratio of
the analytes and requires homogeneity of the buffer solution as well as a constant field strength
throughout the length of the capillary. An acetate buffer is usually employed in CE-MS exper-
iments because it is a volatile buffer and is fully MS compatible. Neutral molecules pass down
the column at the pace of water while positively charged analytes are accelerated and negatively
charged analytes are retarded by the electrical field [47]. More precisely, the time taken for the
analyte to migrate through the column is described as the “migration time” (MT) rather than
the “retention time” (RT) as in high-performance liquid chromatography (HPLC). MT is the
product of the electric field strength times the apparent mobility (electrophoretic mobility +
electroosmotic flow mobility) in the BGE. The electrophoretic mobility of an analyte depends
on charge, size, shape, and hydrophobicity properties [48]. The electroosmotic flow is the bulk
flow of liquid through the capillary. It is influenced by the dielectric constant and viscosity of
the buffer. The electric field strength is a function of applied voltage divided by the capillary
length [46].
A model-oriented discussion on the topic of migration time can be found in Section 3.1.
The most commonly used fractionation technique is high-performance liquid chromatogra-
phy (HPLC), which is highly automatable and easily coupled to a mass spectrometer. The
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term “high performance” hints at its ability to cleanly separate nearby species, i.e., achieve a
high resolution. HPLC instrumentation includes a pump, injector, column, detector and data
system. In brief, the mixture is forced through a stationary phase by the flow of a mobile phase
at high pressure, separating the mixture into its components. The stationary phase is defined
as the immobile packing material in the column, whereas the mobile phase is the solvent added
to promote elution. The solvent’s composition can be changed in time to change the interaction
of the solute with mobile and stationary phase.
HPLC has also received attention from the machine learning community, where multiple ap-
proaches for predicting retention times have been published [49, 50]. This allows to weed out
false positive peptide identifications based on a trained RT model, to predict peptide retention
time for in silico experiments, and to design targeted proteomics experiments, e.g., for multiple
reaction monitoring (MRM).
Both CE and HPLC are highly automatable and can be coupled directly to a mass spec-
trometer (so-called online LC-MS). Here, the stream of analytes eluting from the column over
time is directly introduced into the mass spectrometer. Alternatively, the material eluting from
the column is stored (e.g., on a plate) and data acquisition in the mass spectrometer is deferred
(and might take place in another laboratory). The latter is called oﬄine mass spectrometry.
2.2 Introduction to Mass Spectrometry and Terms
Mass spectrometry is an analytical technique that, as the name suggests, measures masses of
molecular species while offering high mass accuracy and detection sensitivity (down to a single
molecule). In general, a mass spectrometer consists of three components, namely an ionization
source (or ion source), a mass analyzer, and a detector. Mass spectrometers can handle diverse
samples (e.g., (non-)volatile, (non-)polar, solid, liquid, gaseous) and complex mixtures. As we
will see later in more detail, masses of any compound can only be measured when the ions are
in gas-phase and the compound is ionized, thus carries one or multiple charges, which can either
be positive (usually by excess of protons due to protonation) or negative (deprotonation). Only
then can the trajectory of ions be manipulated by applying an electromagnetic field for which
different instrument types use different mechanisms [51]. Thus a mass spectrometer measures
not mass but rather mass over charge also denoted using the unitless m/z, where m is the
molecular/atomic mass in u and z is the number of elementary charges. The unit of the mass-
to-charge ratio is infrequently defined as Thomson (Th), with 1 Th = 1Dae , where Da is the unit
dalton (also called u) and e is the elementary charge.
As any measurement technique, MS also suffers from measurement errors. These can be
defined in terms of accuracy and precision-, also called bias and variance respectively. Accuracy
can be corrected using calibration, as it is the difference between the measured mass of an ion
and its theoretical mass, typically given in parts per million (ppm), which can be computed as
Acc =
mmeasured −mtheoretical
mtheoretical
· 106 ppm.
Precision is an intrinsic property of the instrument and describes the reproducibility of a repeated
mass measurement as determined by its physical limits [52]. See Section 3.1 for details.
Independent of accuracy and precision is resolution, which is defined as R = m/∆m50%,
where m is the mass to be measured and ∆m50% is the minimal distance to the next theoretical
mass which can be resolved. The distance is defined in terms of the full width at half maximum
(FWHM), i.e., the width of a single mass peak at half its maximum height, which needs to be
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resolved given an adjacent peak (of the same height). Instrument resolution is typically specified
at 400m/z. The maximal possible resolution of an instrument is usually fixed by its design,
e.g., an LTQ Orbitrap XL has a maximal resolution of R = 100 0001. Resolution and sensitivity
can have a trade-off, i.e., lowering resolution can improve sensitivity or reduce the time required
to acquire the spectrum (as is the case for an Orbitrap). In limited scenarios accuracy follows
resolution, e.g., when resolution is not sufficient to resolve a peak, accuracy will suffer, but once
the peak can be clearly resolved, there is no gain in increasing resolution to increase accuracy.
The dynamic range, defined as the difference between the most and least abundant peptide,
can vary considerably in biological samples. In highly complex samples like serum it spans over
nine orders of magnitude. If the instrument has only low resolving power, peptide signals will
overlap, thus preventing the detection of low abundant peptides [53]. The observable dynamic
range is also influenced by the ionization efficiency and trapping capacity of the instrument.
Ionization efficiency is the ratio of the number of ions formed to the number of molecules
consumed in the ion source and is strongly dependent on the ion species, mostly on its pKa and
molecular volume [54]. Trapping capacity is only relevant for some types of instruments and
denotes the number of ions that can be analyzed concurrently.
Separation (see Section 2.1) can help in improving results by allowing the instrument to
record only a subset of molecular species, thereby improving the observable dynamic range of
the experiment as a whole.
2.3 MS Instruments
In general, a mass spectrometer consists of three components, namely an ionization source, a
mass analyzer, and a detector. We go briefly over each component and highlight computational
challenges arising for specific instrument types. An overview of the general setup is provided in
Figure 2.1.
2.3.1 Ionization
The two most widely used soft ionization techniques are electrospray ionization (ESI) and matrix-
assisted laser desorption/ionization (MALDI).
In brief, MALDI is an oﬄine technique, where the sample eluting from a column is mixed
with a matrix compound and spotted onto a plate. Each spot represents a certain interval of
eluting compounds. Then, a pulsed laser is used to evaporate and ionize material from a certain
spot. The ions are then introduced into the mass analyzer. As usually not all material on
a single spot is shot exhaustively during one experiment, it is possible to redo an experiment
using optimized instrument parameters or select tandem MS sites oﬄine, which is superior to
the online solution as elution shape maxima can be detected more easily. It is possible to store
MALDI samples for several months, even years, with only minor influence on sample quality [55,
56]. However, sample depletion, i.e., the consumption of sample due to evaporation, has been
reported as a major factor for declining spectra quality [57], leading to inferior identification
results.
Due to matrix contaminations, MALDI is known to yield spectra with a baseline, especially
in low mass regions, which can obstruct peptide signal detection and quantification. Ionization
of peptides by MALDI typically yields ions of charge one, rarely higher.
1see http://sjsupport.thermofinnigan.com/techpubs/manuals/LTQ-Orbitrap-XL Hardware.pdf
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Figure 2.1: Components of a typical LC-MS setup. Common alternatives are shown for each
column. Mass analyzers are aligned to ionization sources such that they reflect a typical setup.
Combinations of several instruments are not shown, e.g., LTQ Orbitrap or quadrupole time-of-
flight hybrid. For low complexity samples the separation step can be omitted.
ESI, on the other hand, is an online technique and can be coupled directly to an LC column.
The analyte is forced through a needle at high voltage, leading to solvent evaporation. The
exact mechanism of evaporation is unclear, the two most prominent theories being the Ion
Evaporation Model and the Charge Residue Model. A good overview can be found in Wilm
[58]. Protonation sites are usually attributed to accessible basic residues (Arg, Lys, His and
N-terminus) [59, 60]. The number of charges that is taken up by a peptide/protein during ESI is
highly complex and depends on a number of factors, e.g., number of basic and acidic residues [61,
62], solution pH, solvent system [63], presence of proton sponges [64, 65], supercharging additives
[66], and instrumental factors. Suggestions have been made to experimentally shift and/or
compress the charge distribution by ESI [62] to facilitate disentanglement of spectra. Recently,
Kaltashov and Abzalimov [67] reviewed the information hidden in charge state distributions
to infer macromolecular structure. A peptide species will usually be observable in multiple
charge states with a charge of two being the most common and abundant. Multiple charge
variants cause signal congestion and denser spectra with redundant signals. This can hamper
quantification as the chance of signal overlap increases. Furthermore, algorithms which identify
isotope patterns need to be able to scan a wider range (typically charges one to six, with charge
two and three being the most common). For proteins, very high charge states (z > 100) can be
observed with ESI.
Some percentage of a given peptide population can have one or more non-proton adducts.
Depending on (column) conditions, this results in potentially many signals belonging to a certain
state of a peptide, that have to be identified to get an accurate assessment of the total ion count.
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2.3.2 Mass Analyzers
All mass analyzers separate ions by their mass-to-charge ratio in an electromagnetic field. There
are many types of mass analyzers; we will describe the most common ones in terms of important
characteristics such as resolution, mass accuracy, cost, and dynamic range. Common to all
instruments is that from this step onwards, ions are kept under high vacuum to avoid collision
(and damage) of analyte ions with other species. Exceptions are tandem MS and variants where
ions are introduced into a collision cell on purpose (see below).
One of the earliest class of mass analyzers used in proteomics was the ion trap, where the
linear ion trap is superior to the 3D ion trap in terms of ion capacity, scan speed, and mass
resolving power. A linear trap quadrupole (LTQ) is an example of a linear ion trap and can
be found in modern hybrid instruments such as the LTQ Orbitrap XL (see below). Increased
resolving power can be attained by time-of-flight (TOF) analyzers with currently R ≈ 50 000.
They are often coupled to quadrupole analyzers, which serve as a mass filter during peptide
fragmentation. Both instruments also have a very high mass range, making them suitable for
large molecules [53]. The analyzers providing the highest resolution R are Fourier transform
ion cyclotron resonance (FTICR) instruments achieving R  100 000 using a superconducting
magnet. A similar principle is used in Orbitrap analyzers where the magnet is replaced by purely
electric fields, offering resolutions up to 100 000. However, due to restricted loading capacity, the
elution profile shape of compounds can become distorted if the amount of overall eluting material
changes, which impedes peptide signal detection on the computational side. Data obtained by
FT instruments can suffer from the presence of noise signals known as shoulder peaks, which are
artifacts of the FT function. Shoulder peaks have an intensity usually below 5% of the main
peak [68].
High resolution naturally eases the task of centroiding, i.e., the conversion of a peak into
a single mass representation, since peaks are separated more clearly and become more narrow.
This aids in the analysis of highly complex samples with many interleaving isotope distributions,
but also allows to determine charge states of highly charged proteins since the distance between
isotopic peaks is 1/z and thus becomes closer the higher the charge. As a result, algorithms for
the basic pre-processing of data (such as peak centroiding) become conceptionally easier and
are usually much faster than their earlier counterparts which required advanced mathematical
modeling, e.g., compare a wavelet algorithm [69] against a simple local maxima spline fit.
Different instrument types can produce different peak shapes, which is important for peak
matching algorithms. The commonly accepted models in the literature are a Gaussian and
Lorentzian shape. A more detailed discussion on peak shapes can be found in Section 3.1.
Another important characteristic is resolution behavior across the m/z range. The most
desirable behavior can be seen in TOF instruments, which have a constant resolution, whereas
resolution in FTICR instruments decays linearly with m/z, which is problematic for high m/z.
Orbitraps show intermediate behavior (square root decay with m/z) [70]. See Figure 3.4 for an
illustration. This may pose a serious problem to a peak picking (i.e., centroiding) algorithm,
which is sensitive to the expected peak width as it changes with increasing m/z. With increas-
ing resolution and improved signal-to-noise behavior, one can argue that even naive algorithms
without knowledge of peak width are sufficient. However, especially for low-resolution instru-
ments, it is desirable to have a more detailed concept for a peak to filter out noise and increase
specificity.
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2.3.3 Detectors
Each instrument type uses its own detection system. For TOF and quadrupole instruments,
the common choice is the electron multiplier where ions are detected on impact. FTICR and
Orbitraps on the other hand use contact-free detection plates which record the ions passing
by, allowing multiple rounds of detection without destroying the ion, thus allowing increased
sensitivity.
2.3.4 Data Terminology
We now create a small nomenclature, which is identical to the one used within our software
library OpenMS and its documentation, in order to simplify the description of data and algo-
rithms.
The rawest type of data, which has not been preprocessed and is by far the most memory con-
suming, is referred to as raw data. Here, individual isotope species still have a Gaussian-like
shape, which we refer to as peak, i.e., one peak represents multiple datapoints.
Using a lossy signal compression process called centroiding or peak picking, one can represent a
peak as a single data point called a stick, which is usually close or identical to the peak’s apex.
This representation usually reduces the amount of data by one order of magnitude. Modern
instruments allow to retrieve the data directly in this format, though it might be advantageous
to request the raw data and perform centroiding using custom solutions as provided by OpenMS.
When the meaning is clear, we sometimes loosely refer to a centroided m/z value as peak even
though stick would be more appropriate.
A spectrum is a set of peaks or sticks covering a certain m/z range. It can have a certain
retention/migration time attached to it when recorded in an LC-MS setup. A spectrum can be
recorded in different MS modes (e.g., MS1 or MS2 – see Section 2.5).
An LC-MS map is a collection of spectra covering a certain RT range; thus, each datapoint can
be described by RT, m/z, and intensity.
A feature represents the average retention time, the monoisotopic m/z, and the integrated in-
tensity of a (peptide) signal in a certain charge state.
For an illustration of an LC-MS map with multiple peptide signals see Figure 2.2. The process
of identifying features in a (centroided) LC-MS map is called feature finding. A feature map is
a collection of features representing all features of a single LC-MS map. As retention time is
usually not 100% reproducible between different experiments, there is a need to superimpose
corresponding entities across maps in a process called map alignment, which is using either raw
LC-MS data or feature data (with or without peptide identifications) to identify landmarks
which are used to compute an RT transformation.
To represent a set of features, we use the consensus feature. The common property which
the features are grouped by is usually clear from the context. Groups may also represent charge
variants with similar RT but different m/z of a single peptide in one map during decharging,
or labeled pairs during feature finding. The most common scenario is groups in feature linking
where features with similar m/z, RT, and charge across multiple feature maps are grouped,
representing the (putatively) same peptide in different experiments. A consensus feature always
has a centroid which stands for all features it represents, e.g., in map alignment the centroid
would be the mean m/z and RT of the features.
Similarly, a consensus map is defined as a collection of consensus features.
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Figure 2.2: Example of an LC-MS map in 3D view with multiple peptide features, each with
an elution profile in retention time (RT) and an isotope pattern in m/z. One arbitrary peptide
feature is highlighted.
2.4 LC-MS for Biomolecules/Proteins/Peptides
2.4.1 Isotope Distribution
As this thesis revolves around algorithms for simulation and quantification of peptides and
proteins, we will explain some of the characteristic particularities of peptides and proteins in
contrast to other compounds.
In order to understand how quantification and, especially, identification work, an under-
standing of the nature of the data is required. For proteins and peptides, mass spectrometers
are usually operated in positive ionization mode, i.e., all compounds carry one or more positive
charges. In mass spectrometry, which measures mass over charge of a molecule, different no-
tions of the mass of a molecule and its isotope distribution are the most vital concepts. Every
chemical element has a number of different variants – so-called isotopes – which only differ by
the number of neutrons and thus by mass. The number of protons is by definition identical
for all isotopes of a chemical element, e.g., hydrogen always has one proton and may have zero
or one neutrons in its stable form. The average atomic mass of an element is the sum of all
its isotope masses weighted by their frequency of occurrence. An average mass of a peptide or
protein is simply the sum of the average atomic masses of all elements of a molecule. Thus, the
average mass needs not coincide with a mass from the isotope distribution, since it is weighted.
Note that, depending on the source, elemental isotope distributions may vary slightly; thus, the
average atomic mass of a certain element, e.g., carbon, might not be the same across different
geographical locations.
The isotope distribution of large molecules (such as proteins) is determined by their ele-
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mental composition. For the more general class of metabolites the number of possible sum
formulas, given an isotope distribution of an unknown molecule, is very high. However, due to
the regular architecture of peptides and proteins featuring a limited number of 20 amino acids as
building blocks, the isotope distribution is much more predictable – notwithstanding chemical
modifications, e.g., post-translational modifications (PTMs). Thus, for proteomics one usually
considers the elements carbon, hydrogen, nitrogen, oxygen and sulfur (short CHNOS). Given
any peptide sequence, one can compute the gross isotope distribution, i.e., the probability to
carry ni additional neutrons (i ∈ {0 . . . n}). By definition, the monoisotopic peak is always one
containing only the most abundant isotope of each element. For CHNOS this also coincides with
the lightest (stable) isotopes, i.e., 1H, 12C, 14N, 16O and 32S. As mass increases, the probability
of a peptide not to contain an extra neutron decreases, i.e., the monoisotopic peak vanishes. For
a heavy protein with 16.9 kDa like equine apomyoglobin, it contributes only 0.4% to the total
abundance.
The regular nature of peptides allows to approximate their atom composition just by knowing
their mass. This can be done by simply looking at a large protein database and count the
number of amino acids. From this, an average amino acid of mass 111.1254 – termed averagine
– can be derived, having an elemental composition (cavg) of C4.9384, H7.7583, N1.3577, O1.4773
and S0.0417 [71]. To estimate the isotope distribution given a mass X, one computes f(X) =
X/111.1254 × cavg to get the fractional sum formula. The latter is then rounded element-wise
to its nearest integer and filled with hydrogen to correct for the rounding error. See Figure 2.3
for an example of averagine isotopic gross distributions, i.e., with nominal masses only.
The fractional averagine model as an extension to the general averagine has also been pro-
posed [23], but its use seems limited as the results are very similar and the large portion of
uncertainty lies not in the truncation of the fractional sum formula but rather in the attempt
to describe the wide distribution of peptides (especially the ones containing sulfur) using one
average amino acid.
Given any sum formula, whether derived from the averagine model or from the actual peptide
sequence, the isotope distribution can be computed in a number of ways (see Valkenborg et al.
[72]). The mass defect is usually not considered as instruments typically do not resolve this
rather tiny mass difference and combinatorial explosion gives rather unfavorable computation
times. Thus, most algorithms only deal with computing the gross isotopic distribution, usually
by convolution of two isotope distributions.
However, not only the number of extra neutrons in a molecule are important but also the
fine isotope structure as different elements have different mass defects, i.e., the binding energy
for the extra neutron will result in subtle mass differences between 13C and 12C compared to
2H and 1H. E.g., consider the molecule CO with the gross structures 28, 29, 30 and 31, where
each number gives the summed nucleon number. The gross structure of 12C16O has only one
fine structure whereas within the gross structure of 29 are two fine structures, 13C16O and
12C17O [73]. With today’s instruments, fine structures can usually not be discerned, thus for
most practical applications the fine structure is not relevant yet. This will change, however,
when instrument resolution improves. See Figure 2.4 for an example. A very memory-efficient
algorithm for computing isotopic fine structure is described in [73].
Direct measurement of proteins is known as top-down mass spectrometry. It has the advan-
tage of being able to better locate chemical modification sites and a simpler sample handling,
as a digestion step can be omitted. Due to their size, proteins can carry many charges and
give rise to a broad isotopic envelope where the monoisotopic peak is hard to observe due to its
low abundance. Furthermore, the higher the charge the closer two isotopic peaks will be; thus,
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Figure 2.3: Isotope gross structure of the averagine model for three different masses. The
monoisotopic peak (i.e., leftmost peak) declines with increasing mass, and the distribution be-
comes wider and more Gaussian-like.
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Figure 2.4: Isotopic envelope of the TRP-Cage protein with only 20 amino acids (NLY-
IQWLKDGGPSSGRPPPS) with monoisotopic mass of 2 168.10145 Da. Displayed is the 2 172
gross isotope peak at ≈2 173.12 Th, consisting of multiple fine structures at different resolutions
(R = M/∆m50%). The masses were convolved with a Lorentzian peak shape to reflect the
limited mass precision of the MS instrument.
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high resolution is required. In contrast, bottom-up mass spectrometry deals with the analysis of
peptides which are cleaved from proteins by enzymatic digestion or created by synthesis. For
digestion, trypsin is the most widely used enzyme due to its high specificity to cleave after lysine
(Lys) and arginine (Arg), which under the optimized experimental conditions leads to two well-
defined charges for a tryptic peptide, i.e., one charge at the N-terminus and one charge at the
C-terminal Lys/Arg residue. Under normal experimental conditions most peptides will carry
two charges when trypsin is used for digestion. Additionally, tryptic peptides are on average
≈14 amino acids long, yielding ions in a desirable mass range [74].
2.5 Identification
Identification of peptides is feasible using two different approaches. The conceptually easier one
is called peptide mass fingerprinting in which a peptide is identified solely based on an accurate
mass measurement, which is compared against a list of known theoretical masses. However,
modifications, insufficient mass accuracy and incomplete databases usually make unambiguous
identification hard or impossible, especially in highly complex samples. A more sophisticated
version uses accurate mass and time (AMT) tags where a normalized retention time is incorpo-
rated in addition to an exact m/z value. See [75] for a good overview on uniqueness of mass
and other peptide parameters for different proteomes.
A more complex approach is identification by tandem mass spectrometry where all ions
within a certain m/z range are selected for fragmentation within a collision cell. The mass range
ideally contains only one peptide species which is also known as the precursor ion or parent ion.
Within the collision cell the precursor fragments along the backbone, yielding peptide fragments
(called product ions or fragment ions) which are re-introduced into a mass analyzer, yielding
typical ion ladders. Depending on the position within the backbone, ions are assigned different
names; see Figure 2.5 for an illustration. The dominant ion types depend on the fragmentation
technique used. The most prominent techniques are collision-induced dissociation (CID), higher-
energy collisional C-trap dissociation (HCD), and electron-transfer dissociation (ETD). CID and
HCD result in strong b and y ion ladders, whereas in ETD c and z ions are produced primarily.
The distance on these ion ladders can be used to infer (sub-)sequences of the parent peptide.
The resulting MS spectrum is also known as tandem MS or MS2 spectrum. When the search
space for the peptide sequence is unrestricted, the inference of the sequence is termed de novo
sequencing as no database with potential peptide sequences is provided or even known. If the
content of the sample can be narrowed down and a database can be used, the search strategy
can be adapted as now each database entry can be used to generate a theoretical spectrum
which is matched against the observed spectrum and scored using some measure of similarity.
As search space is much more restricted, database search is usually faster and more powerful,
yet not applicable if a database is unavailable. The most widely used algorithms for database
search are Mascot [76], Sequest [77], OMSSA [78], and X!Tandem [79]. For de novo, usually
PepNovo [80] is used. OpenMS includes a similarly performing algorithm named ANTILOPE
[81].
It is also possible to combine multiple search engines to improve either sensitivity, or speci-
ficity, or both at the same time. Details can be found in Nahnsen et al. [82].
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Figure 2.5: Example of a CID spectrum with b and y ion annotation. The inset shows the
naming convention for fragment ions, depending on the break point within the peptide. Ion
types a, b, and c denote an N-terminal fragment whereas z, y, and z ions denote C-terminal
fragments. The subscript indicates the number of amino acid residues.
2.6 Quantification
Varying susceptibility to efficient ionization for different peptides/proteins is one of the major
reasons why mass spectrometry is only semi-quantitative. Inferring the sample concentration of
certain peptide/protein species from the measurement is not possible without the use of internal
standards where concentration is known. Usually, these standards are heavy isotope versions
of the molecule of interest to ensure comparable ionization efficiency. If no internal standards
are used, quantitative statements are only valid to a certain extent for comparative purposes to
other samples, and no absolute concentration can be inferred.
For quantification in HPLC-based proteomics, two paradigms are prevalent. In label-free
quantification, each biological sample is measured separately, resulting in multiple maps con-
taining the signals of the eluting peptides. In order to compare the signals across samples,
they first have to be identified in the corresponding maps and then grouped together (applying
suitable data reduction, mapping, and normalization methods).
In labeled quantification, different biological samples are measured in a single map concur-
rently – a procedure also termed multiplexing. In order to distinguish the states, they can be
labeled with a fixed mass label, shifting the peptide along the m/z axis (see, for example, Fig-
ure 4.2a for measured data and Figure 4.2b for the respective features of two peptides in two
different labeling states – indicated by filled or empty symbols). Labeling can be done on either
the MS1 or the MS2 level, and solutions for up to eight channels are available. A channel is the
sample assigned to one labeled state (e.g., light) in a labeling experiment.
Today, there is a clear trend toward multiplexing [83], e.g., for time-resolved experiments or
multiple experimental conditions (see Chapter 5 for our own study).
In both paradigms, the ratio of the assigned pairs of signals can be used for subsequent data
analysis (e.g., for the detection of biomarkers). We will now discuss advantages and disadvan-
tages of the respective methods. See Figure 2.6 for a graphical overview.
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Figure 2.6: General scheme for quantification methods with respect to MS level and labeling
state. If applicable, the most widely known representatives are listed.
2.6.1 Labeled vs. Label-free
If experimental conditions and purification procedures can be properly controlled, label-free
quantification is an attractive strategy because it requires no additional sample preparation
steps.
Two types of labeling are discerned. One is in vitro chemical labeling after sample collection,
which is applicable to any sample, the is other metabolic labeling during cell growth, which can
be used only for cell cultures or small animals. Popular methods for in vitro chemical labeling
are isotope-coded affinity tagging (ICAT) and trypsin-catalyzed 18O labeling. Chemical labeling
techniques like isobaric tags for relative and absolute quantitation (iTRAQ) [27] or tandem mass
tags (TMT) [84] might be cost intensive and have the disadvantage of requiring yet another
biochemical step (the labeling itself). Metabolic labeling is also known as stable isotope labeling
with amino acids in cell culture (SILAC). For MS1 labeling, quantification with one label absent
is hard or even impossible as one can not determine if the light or heavy species is observed when
its partner is missing unless an identification is present or PMF is used. Labeling on the MS1
level will lead to increased signal congestion, which is especially problematic for high complex
samples as the amount of overlapping peptides increases. This complicates quantification as
signal contributions from different channels need to be disentangled.
For all labeling methods it holds that labeling efficiency might not be perfect, labeling might
be biased towards one type of label, or only applicable to certain peptide species. ICAT, for
example, can only be applied to peptides and proteins containing a cystein residue. SILAC
suffers from metabolic conversion of the stable isotope-labeled peptide [85].
Due to multiplexing, each sample can be measured in a fraction of the time (depending on
the number of channels) required for label-free measurements. For a long gradient (e.g., 5 hours
and more), this can be a critical advantage when measurement time is limited.
Some labeling techniques are more suited for certain instrument types; e.g., quadrupoles
and TOF instruments excel at measuring low m/z ions whereas for ion traps, the recovery of
fragment ions below 30% of the precursor ion mass is very poor, which makes them unusable
for iTRAQ or TMT. These two labeling techniques give rise to light reporter ions which are
used for quantification [83].
The advantage of labeling techniques is that they naturally control for instrument vari-
ability from the point of channel mixing onwards (e.g., column condition, instrument settings,
instrument performance) as each channel is affected simultaneously, whereas in label-free exper-
iments, instrument calibration might change in time (as shown in [86]), i.e., the earlier channels
are mixed, the smaller the experimental error component will be. The timepoint will differ be-
tween labeling methods, e.g., for bottom-up approaches, SILAC allows mixing before digestion
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whereas iTRAQ does not.
Noirel et al. [87] provide an insight into the popularity of different methods (label free,
iTRAQ, SILAC, and ICAT) in their recent paper [87] – see Fig. 1 therein. By this measure,
iTRAQ is clearly in the lead, followed by SILAC and label-free.
2.6.2 MS1 Quantification
Quantification in MS1 is achieved by finding peptide or protein signals, and using the signal
intensity to assign a quantitative value to the entity (which is not necessarily identified). It is
important to note that comparing intensities across multiple experiments usually requires some
kind of normalization. Even the intensity of different peptide species within one experiment
cannot be used to directly infer their abundance in the sample as peptides have different ion-
ization efficiency. On the software level quantification can be implemented on the raw data or
stick level, and the derivation of peptide abundance can be based on different schemes, e.g., by
summing all datapoints deemed to belong to the peptide, or by fitting a model and using its
theoretical area or maximum.
If a label-free strategy is adopted, quantification is usually done on the MS1 level (see Sub-
section 2.6.3 for alternatives in MS2).
Popular multiplexing techniques used for quantification on the MS1 level include SILAC and
isotope-coded affinity tagging (ICAT) or labeling with nicotinoyloxy succinimide (nicNHS).
2.6.3 MS2 Quantification
MS2 based methods obviously require MS2 acquisition. In the case of iTRAQ only higher-energy
collisional C-trap dissociation (HCD) and pulsed-Q dissociation (PQD) [83] are feasible. These
are usually marginally inferior to collision-induced dissociation (CID) in terms of identification
performance thus offsetting the multiplex advantage slightly by requiring longer gradients to
achieve the same coverage in terms of MS2 identifications.
Methods for label-free MS2 (pseudo) quantification are controversial in the community and
include Spectral Counting, exponentially modified protein abundance index (emPAI) [88], Ro-
bust Intensity Based Averaged Ratio (RIBAR), and Extended Robust Intensity Based Averaged
Ratio (xRIBAR) [89]. A benchmark can be found in [89].
Robust and sensitive quantification in MS2 can be achieved using multiple reaction moni-
toring (MRM). MRM in particular has the advantage of high dynamic range, combined with
reliable acquisition of the targeted species, for up to 100 proteins. MRM uses selected (and
specific) precursor and fragment ions of a peptide (a so-called transition) as it elutes off the
LC column. Quantification is performed on the chromatogram obtained from the fragment ion.
Transitions are designed to be very specific for certain (unique) peptides, thus allowing iden-
tification as well. MRM works for highly complex samples and is usually performed on triple
quadrupole mass spectrometers where the first quadrupole isolates the precursor, the second
quadrupole acts as collision cell, and the last quadrupole records the fragment ion(s).
Methods allowing multiplexing in MS2 include tandem mass tags (TMT) and isobaric tags
for relative and absolute quantitation (iTRAQ). The latter has become a popular multiplexing
technique, which we will now describe in more detail: iTRAQ is an in vitro chemical labeling
procedure, consisting of either four or eight isobaric (equal nominal mass) tags, each of which
can be used to label a specific peptide sample. Prior to labeling with iTRAQ reagent, protein
samples are digested proteolytically to allow labeling of the peptide’s N-terminus. After labeling,
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Figure 2.7: Structure of the 4-plex iTRAQ tag. Green) Reporter group, Blue) Balancer group,
Red) Reactive NHS ester group.
the samples are mixed and then subjected to (LC-)MS analysis. Identical peptides from each
sample will have identical masses in MS1, and quantification will only be possible in MS2. A tag
consists of a peptide reactive region, a reporter region, and a balance region (see Figure 2.7).
The intensity of the reporter ions reflects the relative amount of peptides in each channel.
The NHS ester of the peptide reactive region is designed to react with the N-terminus and
lysines of peptides after protease digestions, but might also attach to tyrosine. As usual in MS2,
fragmentation takes place along the peptide backbone, allowing for qualitative analysis while
simultaneously affecting the link between the reporter and balance region of the tag, resulting in
intense reporter ions in the tandem mass spectrum. For the 4-plex version, the reporter groups
appear in the MS2 spectrum at m/z 114.1, 115.1, 116.1, and 117.1. The attached balancer
group is designed to create tags of a total mass of 145 Da, requiring balancer group weights
of 31, 30, 29, and 28 Da, respectively. There is also an 8-plex iTRAQ kit where four more
reporter tags with masses at about 113, 118, 119 and 121 Da are available. The 8-plex tags
themselves are heavier though, having 305 Da instead of 145 Da as in the 4-plex case. Due to
the low-mass reporter ions, not all instrument types and fragmentation technique combinations
lend themselves equally well to iTRAQ analysis, e.g., due to the 1/3 rule (i.e., the lowest m/z
value recordable is about 1/3 of the precursor mass), an ion trap in CID mode cannot observe
reporter ions [90].
For some more study specific details, see Chapter 5.
2.7 Software for Analyzing MS Data
2.7.1 Widely-used Software Packages
The role of software for data analysis and processing is becoming more and more important. A
recent study [91] conducted by the Human Proteome Organization (HUPO) showed that, the
raw data quality obtained from the instrument is usually a very good basis to start from, but it
is the choice of the software and algorithms therein that determine the success of the analysis.
Every instrument is shipped with the vendor software which enables users to analyze their
data. Analysis options differ: Most vendors offer built-in support for search engines (like Mascot
or SEQUEST) and a software for visualization. However, the user is usually restricted to certain
scenarios as analysis pipelines are monolithic and not flexible. Also, implementation details of
the algorithms are rarely made public, and comparison against other algorithms is difficult
because of different data formats, e.g., it is not possible to benchmark most vendor software
when only an mzML file is available, as converters to mzML are usually available but not the
other way around.
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In addition to vendor software, a number of free and (usually) open source packages have
been developed, which allow data analysis across different platforms and flexible workflow con-
struction.
Each package has a slightly different focus, and not all operating systems (OS) platforms are
supported. We will briefly describe the most important packages.
One of the most comprehensive packages available for all major platforms is the Trans-
Proteomic Pipeline (TPP) [92], which focuses on the analysis of MS2 data sets. It includes a
web server, thus allowing the user to use the browser as a user interface, but can also be used from
the command line. The TPP includes widely known tools like PeptideProphet, ProteinProphet
and ASAPRatio which can be used to analyze labeled data sets.
MaxQuant [93] is a quantitative proteomics software package specifically aimed at high-
resolution MS data (e.g., Orbitrap). It supports several labeling techniques but is mostly known
for its SILAC pipeline. Recently, the search engine Andromeda was incorporated. MaxQuant is
freeware but closed source and requires a Windows PC.
MZMine [94] and MzMine2 [68] are Java-based, open source packages originally aimed at
analyzing metabolite data but with capabilities for peak picking, advanced visualization, and
map alignment.
VIPER (Visual Inspection of Peak/Elution Relationships) [95] includes a GUI and supports
feature detection, calibration, feature alignment, and identification mapping. Its main focus is
AMT processing. It is written in VB (version 6) and thus runs on Windows OS only. It can
read the outdated mzData and mzXML formats.
ProteoWizard [96] is a C++ open source, cross platform suite primarily known for its ability
to convert most vendor formats into HUPO-PSI mass spectrometry data formats like mzML
or mzXML. It also includes Skyline, an editor for creating and analyzing selected reaction
monitoring (SRM) experiments.
msInspect [97] uses Java and the R language and is thus platform-independent. As input
mzXML and pepXML are accepted, mzML support is available in the development version.
Supported are basic signal processing, feature detection, label-free and labeled quantification,
MRM data analysis (via the MRMer tool), alignment, and identification mapping. It also
includes msInspect/AMT, a suite of tools for Accurate Mass and Time analysis.
OpenMS is an open source library written in C++ for label-free and labeled quantification
and identification, supporting all major platforms. The OpenMS Proteomics Pipeline (TOPP)
[98] is a set of executables, chainable in modular fashion for a wide set of analysis scenarios,
and covers common tasks like peak picking, map alignment, identification (via wrappers for
common identification engines like Mascot, X!Tandem and OMSSA), filtering, and quantification
of labeled and label-free data. It supports the HUPO-PSI standards mzML and mzIdentML
as well as the widely used pepXML and protXML formats, enabling data exchange between
collaborators based on open platform-independent formats.
2.7.2 OpenMS in Detail
As the algorithms presented in this thesis are integrated into OpenMS/TOPP, we devote some
pages to the library itself, its design principles, and to how it can be used by developers and
users. A description focusing on on library design and project management can be found in
Sturm [99].
OpenMS itself currently consists of a core OpenMS library and the OpenMS-GUI library.
The core library implements data structures for data points, spectra, LC-MS maps, features,
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Figure 2.8: OpenMS dependencies (bottom) and OpenMS library structure (center). Executa-
bles for the end user are shown at the top. Numbers in brackets give the number of tools in
each category as of OpenMS release 1.9.
consensus features, and a wide range of algorithms, e.g. for signal processing, file handling,
peptide identification and quantification.
The OpenMS-GUI library contains all graphical user interface (GUI) components, like spec-
trum widgets and dialogs, used by the GUI tools TOPPView [100], TOPPAS [101] and IN-
IFileEditor shipped with OpenMS. The split library reduces compile/link time overhead and
avoids linker restrictions on Windows OS with respect to library size.
OpenMS has dependencies on other libraries which enable parsing of XML files (via Xerces-
C), handling of GUI components (via Qt), numerical processing (via GSL), machine learning (via
libSVM), integer linear programming (ILP) solvers (via GLPK), sequence alignment (SeqAn)
and more. All support libraries except Qt are bundled in a contrib package provided by the
developers of OpenMS, which is essential for Windows platform support. On Linux and MacOS,
the native packages can be used as an alternative. This allows easy installation of OpenMS’
dependencies (on Windows) and contains patches for some packages which might otherwise lead
to fatal errors and incompatibilities. For an overview of the OpenMS dependencies and library
structure itself, see Figure 2.8.
Algorithm prototyping is a key feature of OpenMS as the developer has access to a powerful
toolbox for all kinds of data processing steps.
As the library itself is only of use for developers of C++ or programming languages capable
of wrapping C++ libraries, TOPP tools are provided to enable non-programmers to connect
algorithms in a flexible and comprehensive way. TOPP is meant to provide small building
blocks for a wide range of analysis pipelines, which can be chained together to fit custom needs.
Build System and Installers
The build system of OpenMS relies on CMake [102], an open source cross platform build system
using simple platform-independent and compiler-independent configuration files, e.g., CMake-
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Lists.txt. CMake generates native makefiles and workspaces via so-called generators for many
environments like Visual Studio, nmake, make, XCode, Eclipse and QtCreator. OpenMS also
makes use of CTest, a testing software tightly integrated into CMake, which allows to set up
automated testing. The results can be submitted to CDash, an open source, web-based software
testing server, which aggregates and displays the results of software testing processes submitted
from one more clients, usually running different compilers and/or platforms. Finally, binary
installers for two major platforms (MacOS, Linux) and architectures (32bit and/or 64bit) are
generated by CPack, a package creation tool, to ease installation of TOPP and GUI tools within
minutes. For Windows OS, we use the more powerful Nullsoft Installer System (NSIS)2. The
NSIS-based Windows installer features user account control (UAC) bridging, file extension reg-
istration (e.g., for files formats supported by OpenMS’ GUI tools), and PATH manipulation. It
also includes a release of ProteoWizard, enabling the user to convert many vendor formats into
the mzML format, which is supported by OpenMS.
Porting OpenMS to Windows OS
Supporting multiple platforms and thus giving the user the ability to use their favorite operating
system (OS), is a desirable property. Indeed, most users of OpenMS are most familiar with the
Windows OS, in part because Windows is favored by most vendor software and delivered with the
instrument hardware. Supporting Windows allows users to install OpenMS/TOPP on already
existing systems.
From a software development perspective, advantages of supporting multiple platforms for
a C++ application outweigh the disadvantages in the case of OpenMS and its dependencies.
Disadvantages include the need for more maintenance and testing code on multiple platforms.
Also, support libraries need to be available for all platforms supported by OpenMS or need to
be ported by the OpenMS developers. Platform-specific code is also unavoidable in some cases,
e.g. attributes for specifying storage-class information for Windows dynamic link libraries (dll)
(i.e., declspec(dllimport) and declspec(dllexport)), platform-specific API calls (e.g., locating
executable paths, process ids, time measurements, etc.). However, other cases can be abstracted
by use of other libraries, such as Qt. Compiler-specific extensions not covered by a C++ standard
(such as the round() function) can be used only conditionally or must be avoided, thus making
the code more standard-compliant. Advantages of multiple platforms go beyond using multiple
compilers on one platform. E.g., debugging and memory-leak checking tools differ for each
platform and have different strengths and usability advantages. Usually compilers are not cross-
platform and have complementary warning and error messages. Thus finding a bug is easier
when using multiple platforms. Bugs might go unnoticed entirely if the code is not tested on
multiple platforms. This is especially true for memory access violations. We collected some
of the most malicious cases that were detected during the Windows port and testing of clang
compiler in Table 2.1.
2http://nsis.sourceforge.net
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Own Contribution
We developed major parts of the current build system for OpenMS and OpenMS Contrib using
CMake, CTest and CDash, providing a platform-independent build system, testing, and nightly
regression tests.
Five new TOPP tools were written (MSSimulator, Decharger and ITRAQAnalyzer, EICEx-
tractor, GenericWrapper). MSSimulator, Decharger and ITRAQAnalyzer will be described in
the following chapters.
EICExtractor was developed for targeted metabolite feature finding and quantification (manuscript
in preparation).
The TOPP Pipeline Assistant (TOPPAS) was extended to allow more flexible workflows, error
checking, file list recycling, online download of workflow files, and more (see [101] for details).
The GenericWrapper tool was written to enable external program support via TOPP tool de-
scriptions (TTD) which describe parameter mappings, values and types from external third-party
tools to a TOPP-conformant format. This enables the usage of these tools within TOPPAS or
other workflow engines if the TOPP interface can be parsed (e.g., via KNIME [103]).
We ported OpenMS/TOPP to work on the Windows platform (i.e., Visual Studio 2005 to
2010) and wrote the binary packaging system which enables the creation of a full-grown installer
package.
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Chapter 3
Simulation of LC-MS Data
Synopsis: We introduce the most comprehensive simulation software for LC-MS data, provide
statistics on the realism of the generated data, and finally show its usefulness for algorithm
benchmarking and how parameters of the instrument influence the computational analysis.
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This chapter subsumes and extends the work presented in Bielow et al. [34].
During the development of software for LC-MS data processing the algorithm should be
continuously evaluated against suitable benchmark data sets. This allows to refine the algo-
rithm (and its internal parameters) and to create a robust and sensitive solution. Ideally, the
benchmark data should be diverse in terms of instrument type, sample complexity, instrument
resolution, noise, and other key parameters in order to make the algorithm applicable to a wide
range of data. Obviously, each benchmark data set needs to be annotated according to a gold
standard (so-called ground truth). This annotation then represents the ideal solution, which the
algorithm should be able to reconstruct. Depending on the type of algorithm, different levels of
ground truth (GT) are required: feature detection, for example, requires the position, charge,
and intensity of peptide signals. Peak picking requires peak annotation and map alignment
the positions of corresponding points between two (or more) maps. Furthermore, knowledge of
ground truth allows a developer to find subtle errors in the program (i.e., when not all signals
contained in the data are identified) which are hard to trace otherwise.
One common solution to establish a ground truth is the use of standard protein mixtures,
which are commercially available and can be used to generate data sets with known protein
content. These mixtures, however, often lack the complexity inherent to real biological samples,
and the data quality (e.g., in terms of contaminants from sample handling) strongly depends on
the expertise of the laboratory. Inevitably, such controlled experiments cannot provide the lower
levels of a gold standard, e.g., for peak picking, whereas they are useful for peptide identification
and quantification problems. Of course, manual annotation can be employed for many levels of
ground truth. However, manual annotation is labor-intensive, and the quality of the annotation
strongly depends on the skill of the human expert. Some parts of the data may even be impossible
to annotate due to high levels of noise or other ambiguities. Public data sets with comprehensive
manual annotation are usually not available for many levels of ground truth.
An orthogonal solution to the problem of a benchmark data set is the use of extensive sim-
ulation of mass spectrometry data. The use of simulation in the mass spectrometry community
began more than 30 years ago. A popular software for ion optics simulation is SIMION [104],
which was used to provide the understanding required for the development of new instrument
generations. For software development, Morris et al. [20] used simulation to benchmark their
new approach for feature extraction and quantification. The Cromwell software, as presented by
Coombes et al. [105], was used to create a simulated data set which was then fed to the feature
extraction algorithm. Renard et al. [23] implemented a quite simple simulation approach to
validate the NITPICK feature finding algorithm. Ipsen and Ebbels [106] published a promising
statistical model specific to LC-MS data obtained from TOF instruments. Simulation was used
to validate the results. Unfortunately, no software was made available to the community. In
2009, Yang, He, and Yu [24] used a simulated data set from Morris et al. [20] to benchmark
different peak picking algorithms. However, simulation is usually given only marginal attention
when used to validate an algorithm [20, 23, 24]. The software employed is usually written for
this purpose alone and not extensively described. In 2008, Schulz-Trieglaff et al. [26] presented
a comprehensive approach to simulating LC-MS data and used it to benchmark different feature
detection approaches. Unfortunately, LC-MSsim is not maintained anymore, lacks some desir-
able functionality (e.g., simulation of fragment spectra and simulation of labeled LC-MS data),
and has a few undesirable properties. For example, the retention times of charge variants of
a single peptide (or protein) are determined for each feature separately. Since this calculation
includes an RT variance term, the charge variants have (significantly) different retention times.
This is not the case in real data and should thus be avoided.
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Figure 3.1: Overview of our simulator concept. Peptides/proteins with modification (optional)
serve as input, along with parameter settings and models. Result files cover multiple levels of
ground truth.
We developed MSSimulator, a simulation software for LC-MS and LC-MS2 experiments,
which is based on LC-MSsim [26] and extends it in many respects. The input for the simulator
is a list of proteins (or peptides) and optionally a list of contaminants. For a detailed description
of the contaminants file format, see Appendix 6.5. The simulator performs in silico digestion,
retention time prediction, ionization prediction, and raw signal simulation (including MS2) while
providing many options to change the properties of the resulting data, such as column conditions,
resolution, noise levels, and sampling rate. Protocols for SILAC, ICAT, 18O labeling, iTRAQ
or MSE are available in addition to the usual label-free approach, making MSSimulator the
most comprehensive simulator for LC-MS and LC-MS2 data. As output, the program provides
ground truth on multiple levels, which can be used for easy benchmarking and prototyping of
algorithms. These levels include raw MS data, centroided MS data, feature positions including
peptide sequence, feature relational data for labeled experiments, positions of contaminants, and
charge ladder groups. Compared to experimental data, simulation thus not only gives valuable
ground truth but is also much faster (usually completed within minutes). Simulation is also
unaffected by experimental errors. Since we make heavy use of random number generation, two
simulations using the same input data can be configured to yield slightly different results.
An overview of the simulation workflow is illustrated in 3.1.
In the following sections we will describe the basic steps which can be simulated using
MSSimulator and the underlying theoretical models. Then we give some examples of how
MSSimulator can be used to benchmark algorithms or conduct a large scale simulation on
experimental robustness and optimal setup. Parts of this chapter have been published in Bielow
et al. [34].
46 CHAPTER 3. SIMULATION OF LC-MS DATA
3.1 Methods
MSSimulator is written in C++ as part of the OpenMS [29] framework and is integrated into
The OpenMS Proteomics Pipeline (TOPP) [98]. The simulator is configurable via a parameter
file, which can be edited using a dedicated GUI shipped with OpenMS. As input we use one
or more FASTA files. Optionally, a parameter file containing a (non-default) configuration and
a list of contaminants can be provided. A FASTA file contains protein or peptide sequences
including modifications1 and can also be used to provide protein/peptide-specific information
like the abundance or a specific retention time. For labeled experiments, one FASTA file for each
channel must be present. This allows to specify a different set of proteins and their concentrations
for each channel.
The simulation is divided into several submodules, which account for the different steps
carried out in a classical LC-MS experiment and will be explained in detail in the following
sections.
3.1.1 Digestion
Digestion can be performed in two modes or can be switched off. The first mode does a complete
in silico digest using regular expressions, also modeling missed cleavages2. To add another level
of realism, the second mode uses a model from Siepen et al. [108], which was reimplemented in
OpenMS to predict missed cleavages. The current model is based on trypsin data but can be
easily adapted, simply by substituting a text file containing the model parameters. To extend
the model to other enzymes, the log-likelihood ratio data matrix described in the original paper
needs to be computed.
3.1.2 Peptide Separation
As prefractionation techniques, two widely used approaches are available in MSSimulator: Cap-
illary Electrophoresis (CE) and High Performance Liquid Chromatography (HPLC). Both tech-
niques yield separation of peptides according to different properties therefore complementing
each other. In CE mode, MSSimulator will predict a migration time based on a theoretical
linear model described below whereas for HPLC simulation we use a machine learning approach
based on support vector regression.
3.1.3 A Model for Capillary Electrophoresis
In a strong electric field, molecules are separated based on their physicochemical properties which
determine their migration time (MT). A molecules’ MT is further dependent on the background
electrolyte and its properties, e.g., ionic strength, pH, type of ions.
Our migration time model concentrates on simulating the electrophoretic mobility (µep) of
analytes while electroosmotic flow (µeo), which is mainly governed by the viscosity of the buffer
and the capillary itself, is a parameter provided by the user.
Electrophoretic mobilities and separations are predicted from physicochemical properties of
the peptide species, namely net charge and mass. A common model for electrophoretic mobility
is
µep = q/MW
α, (3.1)
1We support all modifications contained in UniMod [107].
2Note that when missed cleavages are used, the completely cleaved peptides will be contained in the sample
as well.
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Figure 3.2: Raw CE-MS map of 100 proteins using default CE settings.
where q is the net charge of the ion, MW is its molecular weight, and α is some constant. In a
vacuum, an ion’s speed is proportional to its net charge when an electric field is applied. In a
medium, however, we need to correct for frictional drag (MWα term). The choice of α has been
the topic of extensive discussion. The most common values include 13 ,
1
2 ,
2
3 , which all relate to
theoretical models. For details on choices of α and charge determination, see Appendix 6.4.
To determine the migration time we compute
t =
LdLt
(µep + µeo)V
, (3.2)
where Ld is the distance between injection site and detector, Lt is the total capillary length, and
V is the applied voltage (see McLaughlin et al. [109]). Peptides with negative migration times
are discarded (but mentioned in a summary statistic).
In contrast to HPLC where elution profiles remain constant across the RT dimension, in CE
the peak width increases as a function of migration time due to dispersion factors and decreased
mobility. We use a linear model to account for this effect. Figure 3.2 shows an exemplary
CE-MS map using our CE model. The typical charge bands can be observed easily.
Prediction of Retention Times in Liquid Chromatography: Schulz-Trieglaff et al. [26] already
applied the paired oligo-border kernel (POBK) presented by Pfeifer et al. [49] to accurately
predict the retention times for peptides in their simulation. We use the same approach in
MSSimulator. A trained model is provided with our software, but training a custom model
using MS2 identifications is easy using the RTModel tool, which is part of TOPP.
A Model for Elution Profile Shape: Peptides eluting from an HPLC- or CE column will
usually display an elution profile, which has a Gaussian-like shape. Asymmetric shapes due to
fronting or tailing (defined as the widening of the left or right tail of the Gaussian, respectively)
are commonly observed. Tailing is more common and has many possible causes [110]. The expo-
48 CHAPTER 3. SIMULATION OF LC-MS DATA
nential Gaussian hybrid [111] (EGH) function allows to model asymmetric peaks conveniently.
fegh (t) =
H exp
( −(t−tR)2
2σ2g+τ(t−tR)
)
, 2σ2g + τ (t− tR) > 0
0, 2σ2g + τ (t− tR) ≤ 0
, (3.3)
where t is the retention time, tR the center of the chromatographic peak, H the peak height, σg
the standard deviation of the peak, and τ the time constant of the exponential decay.
MSSimulator comes with a set of default values for σg and τ as well as the possibility to vary
them using a Lorentzian distribution. For more details, see Bielow et al. [34].
To reflect poor chromatographic conditions, the user can also customize the quality of the
generated elution profiles by adding uniformly distributed noise.
3.1.4 Peptide Detectability Filter
Although detectability and ionization are closely coupled, we treat them as separate steps during
simulation. To account for the effect that not necessarily all peptides ionize with the same
efficiency, we include the peptide detectability filter presented by Schulz-Trieglaff et al. [26].
It uses a support vector machine combined with a paired oligo-border kernel to compute the
likelihood of each peptide to create a signal in a mass spectrum. The user can define a threshold
value – every peptide below the threshold will be discarded. MSSimulator is shipped with a
trained model. Customized models can be trained using TOPP’s PTModel.
3.1.5 Ionization
We support the two common ionization methods electrospray ionization (ESI) and matrix-
assisted laser desorption/ionization (MALDI). For ESI we sample charge states for each peptide
entity from a binomial distribution B(n, p) where n is equal to the number of basic residues, plus
one for the N-terminal charge, and p is set to 0.8 by default. We also support custom adducts
like Na+ or K+.
For MALDI we have chosen a discrete distribution of the charge states, with default prob-
ability values of P (q = 1) = 0.9 for charge 1 and P (q = 2) = 0.1 for charge 2. The user can
customize the charge probabilities according to their needs, specifying as many charge states as
desired.
3.1.6 Modeling Peptide Signals in the Mass Spectrum
At this point, a list of peptides annotated with charge, retention time and an elution profile
shape was generated. Based on this list, MSSimulator computes the signals for each peptide
ion. Each signal has two components, i.e., the shape in the retention time dimension, which
has been defined during the simulation of the chromatographic column, and the signal in m/z
dimension.
To compute the complete isotopic envelope, MSSimulator uses a fast algorithm [112] im-
plemented in OpenMS. The shape of each individual isotopic peak is a topic of discussion in
the literature [113] and can therefore be modeled during the simulation by either a truncated
Gaussian or Lorentzian distribution (see Figure 3.3).
The width of the peaks can be controlled by the user with regard to resolution. We addi-
tionally provide three models of resolution behavior, which are present in common instruments.
Resolution is usually specified at a fixed m/z position p, which we denote Rp, where p is usually
400 Th. Depending on instrument class, resolution might change for other m/z positions q.
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Figure 3.3: Comparison of Gaussian (blue) and Lorentzian (red) peak shape. Left) Theoretical
model, Right) A peptide signal at equal resolution, the Gaussian as vertical sticks, Lorentzian
as connected lines. Note that due to the broader tails of the Lorentzian, peak height is reduced.
Figure 3.4: Resolution behavior of three common MS instrument types. Left) at the same
resolution, Right) at typical resolutions.
Resolution is constant in time-of-flight (TOF) instruments (i.e., Rq = Rp); in Fourier transform
ion cyclotron resonance (FTICR) instruments it is known to degrade linearly with m/z (i.e.,
Rq = Rp · (p/q)); in Orbitrap mass spectrometers it degrades with the square root of m/z (i.e.,
Rq = Rp · (√p/√q)) [70].
See Figure 3.4 for an illustration. Note that at ≈1 500 Th, a TOF with R = 30 000 will create
peaks of similar FWHM to an FTICR with R = 100 000.
The estimation of peak width from real Orbitrap data confirms that a square root model
fits much better than a linear model (see Figure 3.5). The data was obtained from peak width
estimation of the high-resolution peak picker on an Orbitrap data set.
3.1.7 MS2 Sampling
MSSimulator supports three MS2 modes: The naive mode creates fixed-intensity peaks for
selected ion types (a, b, c, x, y, z), neutral losses, and immonium ions. The second mode uses
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Figure 3.5: Resolution behavior of an Orbitrap. The dashed red line represents the fit of a linear
model (as expected from an FTICR instrument), the green line shows a square root model (as
expected from an Orbitrap).
3.1. METHODS 51
a support vector machine-based classifier to predict if a primary ion type is present or not.
Neutral losses and charge variants are added using a trained Bayesian model. A support vector
regression (SVR) constitutes the third mode and additionally allows to predict the intensity of
primary ion types (within five intensity bins). We provide models (pre-trained on CID data)
for the two support vector machine-based modes which support precursor charges from one to
three. For more details, see [34].
MS2 precursor selection is based on data-dependent acquisition. A user-defined number of
high-intensity precursors are automatically selected from the preceding MS1 scan. Accepted
precursor charges and the width of the isolation window can be changed by the user.
Simulating MSE Data: Concurrent peptide fragmentation (i.e., MSE) is an emerging tech-
nique in proteomics which could revolutionize the way peptides are identified and quantified.
Currently there are very few algorithms capable of analyzing MSE data, e.g., Elution Time Ion
Sequencing (ETISEQ) [18]. This fragmentation technique has been proposed in the metabo-
nomics community several years ago [114], but manual analysis is still prevalent. By providing
simulated data we hope to facilitate algorithm development as the simulator provides an easy
means to benchmark the results. MSE data is generated by alternatively recording data in MS
and MS2 mode. The latter has no restriction on the precursor mass; thus, all ions are fragmented
simultaneously. This has the advantage that suboptimal precursor selection is no longer an issue,
but it also leads to congested MS2 spectra which need to be disentangled for proper peptide
identification. The simulator will create MS2 spectra for each peptide currently eluting from the
HPLC/CE column according to our fragmentation model. Spectra are scaled in intensity such
that MS and MS2 spectra will display proper elution profiles, which can be used to correlate
MS2 peaks with MS features. Subsequently, the single MS2 spectra are merged to form the final
MSE spectrum. An example can be seen in Figure 3.6. The peaks are color-coded by precursor.
3.1.8 Labeled Experiments
The simulator contains a framework which allows an easy and fast incorporation of any labeling
technique used in mass spectrometry. We currently provide four widely used techniques, namely
iTRAQ (isobaric tag for relative and absolute quantitation) [27], SILAC (stable isotope labeling
by amino acids in cell culture) [115], 18O labeling [116], and isotope-coded protein label (ICPL)
[117] in addition to the usual label-free setup. For each labeled channel a FASTA input file
must be given. This allows to model different protein/peptide sets. Optionally retention times,
abundances, and modification states can be provided for each channel.
iTRAQ Labeling: The software can be used to simulate iTRAQ MS2 spectra with arbitrary
channel allocation (using 4-plex or 8-plex) and customizable isotope correction matrices (the
default being the matrix provided by Applied Biosystems). The labeling efficiency of tyrosine
residues can be changed as desired and has a default efficiency of 30%. A peptide containing a
Y residue will be split into two sibling peptides with different masses, each with an abundance
reflecting labeling efficiency. N-terminus and lysine residues are assumed to be fully labeled. The
MS2 spectra generated in iTRAQ mode differ from normal MS2 spectra in that they contain
the reporter ions in the m/z range from 113-121 Th and that the fragment ions are 145 Da
heavier for every iTRAQ-modified amino acid they contain. Fragment ions with partially or
even completely cleaved iTRAQ tags seem to be missing from the iTRAQ spectra we examined.
Stable Isotope Labeling by Amino Acids in Cell Culture:
MSSimulator currently supports two- and three-channel SILAC labeling. In the following,
mass shifts will be shown in brackets. By default, the medium SILAC channel features a modified
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Figure 3.6: Color-coded detail of MSE spectra containing seven precursor species (black). In-
tensities are scaled to 100% for MS and MS2 spectra.
lysine (≈4.02 Da) and arginine (≈6.02 Da), the (optional) heavy SILAC channel an even heavier
modified lysine (≈8.01 Da) and arginine (≈10 Da). Complete incorporation of the label into the
labeled channel is assumed.
Isotope-coded Protein Label Labeling: ICPL labeling is usually performed on the protein level
and yields a mass shift visible on the MS1 level. Up to three channels are supported, in which all
lysine residues and the N-terminal are labeled. The mass shift is therefore sequence-dependent,
but upon tryptic digestion without missed cleavages, only one lysine should be present. The
protein’s N-terminal peptide carries an additional modification. We also allow ICPL labeling
after digestion such that all peptides carry an N-terminal modification.
18O Stable Isotope Labeling:
The 18O labeling protocol uses inexpensive, stable 18O isotopes, which are incorporated into
the C-terminal of a peptide during protein digestion in exchange for 16O. Complete labeling is
achieved when two heavy isotopes are incorporated, introducing a mass shift of 4 Da. Incomplete
labeling or back-exchange can lead to mono- (mass shift of 2 Da) or unlabeled peptides. Given
a labeling efficiency f , the concentration of unlabeled B0, mono- B1, and dilabeled B2 peptides
is computed from the total concentration B of the labeled channel using the kinetic model of
Ramos-Ferna´ndez, Lo´pez-Ferrer, and Va´zquez [118]:
B2 = Bf
2 (3.4)
B0 = B(1− f)2 (3.5)
B1 = B2f(1− f) (3.6)
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Figure 3.7: Comparison of real and simulated data for FT and Q-TOF instruments. For clarity,
data is shown on zoomed regions of an LC-MS map. a) real FT data, b) simulated FT data, c)
real Q-TOF data, d) simulated Q-TOF data.
3.1.9 Output
The user can specify one or multiple output files which provide different layers of ground truth.
One output file contains the raw MS data in mzML [119] format. A corresponding centroided
version of the raw MS data allows to benchmark peak picking algorithms. A feature map (in
featureXML format) containing all simulated peptides annotated with charge, charge adducts,
and sequence can also be generated. The featureXML file can easily be converted into an Excel
sheet or csv (comma-separated values) file. Also, a list of features describing the contaminants
in the data set can be requested by the user. Last but not least, MSSimulator can provide files
containing the correct associations between the different charge variants of a single peptide and
the correct associations between the labeled and label-free versions of the simulated peptides.
3.1.10 Our Contribution
We re-implemented major parts of the predecessor tool LC-MSsim and integrated it into the
OpenMS library. The simulation was extended to support more levels of ground truth (charge
groups, centroided data, contaminant features), a trained digestion model, a CE model, user-
defined retention times and intensities, ionization with adducts, different peak shapes (Gaussian
and Lorentzian), resolution and peak widening model (linear, square root, constant), iTRAQ
labeling, MSE fragmentation, simulation of contaminants, and detector sampling heuristics.
3.2 Results
Since MSSimulator is highly configurable, it can be adapted to mimic certain instrument types
(e.g., Q-TOF or FT instruments). To asses the level of realism of the simulated data we compare
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simulated data to data sets from the Standard Protein Mix Database [21] (Mix 3, low-res Q-
TOF and high-res Fourier Transform (FT) data). The simulation parameters were adapted to
closely resemble the experimental conditions of the real data (in terms of protein mix, instrument
settings, etc.). After applying the same analysis pipeline (centroiding, feature finding) to both
data sets, we find that the number of peptide signals, charge distribution and intensity range
are highly comparable. For a visual comparison, see Figure 3.7.
3.2.1 Algorithm Benchmarking
We display several examples of how simulation can be used to benchmark algorithms. The list of
applications is numerous, and some more scenarios, carried out by the co-authors, are provided
in the accompanying paper [34].
ETISEQ
We used MSSimulator in MSE mode to benchmark the ETISEQ software which to our knowledge
is the only software publicly available for the analysis of MSE data. Since MSE data has the
inherent property of containing a mixture of fragment ions of possibly hundreds of precursor
ions, an interesting criterion for any algorithm trying to reconstruct single-precursor spectra is
the number of precursors that can be successfully extracted, such that a search engine is capable
of identifying the peptide.
A very simple data set consisting of one protein (P02769, bovine serum albumin) was gen-
erated, yielding 114 peptide signals in different charge states (1-3). We disabled simulation of
contaminants to make the spectra as clean as possible. MS and MSE spectra were generated
alternatingly. Additionally, the simulator was configured to create “debug” MS2 spectra, which
can be used as a ground truth when assessing the disentangled ETISEQ spectra. All spectra
(MS1 and MSE) were generated as centroided data with no missing peaks. Elution profile distor-
tion was disabled, which ensures perfect elution profiles for all features in both MS1 and MSE.
The generation of neutral loss ions (water and ammonia), immonium ions, and precursor ions
was enabled during simulation of MS2 spectra in order to increase identification rates during
database search (using X!Tandem).
Initial tests using the ETISEQ web interface3 revealed faulty reconstruction of precursor
positions when the input spectra were not sorted by RT in addition to XML formatting issues of
the ETISEQ output file. Fortunately, the authors of ETISEQ provided a patched version of the
ETISEQ algorithm which fixes the aforementioned issues and allows access to more algorithm
parameters.
In order to assess the ability of ETISEQ to reconstruct MS2 spectra from complex MSE
spectra, the following parameters were modified: We disabled ion exclusion (i.e., x = 0) and
chose a high value of n = 15 (the maximum number of spectra to be reconstructed from a
single MSE spectrum). To allow for reconstruction of low intensity spectra, we set the minimum
relative intensity for parent and fragment ions to zero.
On our dataset ETISEQ successfully reconstructed precursor positions for every simulated
feature. Since ETISEQ has no knowledge about the true peptide sequence, usually multiple
putative monoisotopic peaks are reconstructed. Many of these spectra yield identical sequences
iff a wide precursor tolerance window is selected during spectra identification. It is not clear
if ETISEQ uses an averagine approach to match isotope pattern. The data suggests that the
3http://www.cancerresearch.unsw.edu.au/CRCWeb.nsf/page/Elution+time+ion+sequencing
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Figure 3.8: Location of precursor positions as reconstructed by ETISEQ for a single feature of
charge two and weight of ≈2 434 Da. Projections in both RT and m/z are shown on top and
right side. Not only the true monoisotopic peak (lowest position) is chosen, but also the first,
second, and even third isotope peak. For this rather heavy peptide the deviation of all but the
true isotope pattern to an averagine model are rather large.
acceptance threshold for any isotope pattern is low, since many putative precursors are recon-
structed. See Figure 3.8 for an example of precursor positions.
To reduce the number of putative monoisotopic peaks in MS1 (and thus the number of redun-
dant reconstructed spectra) an improved algorithm could use a heuristic which searches for a
maximal pairing of b-y ions (or any other dominant ion types), or use an averagine model with
appropriate model fitting thresholds.
Even though we have simulated MS2 spectra available as ground truth, not all spectra are
identifiable by a search engine. Therefore, we compute an unbiased set of identifiable spectra
by submitting all debug spectra to the same search engine (X!Tandem) that is later used for the
spectra reconstructed by ETISEQ. For X!Tandem we chose a precursor mass tolerance window of
2.5 Da to allow for small errors in precursor reconstruction. All resulting spectra were searched
against a combined database containing 38 717 proteins, as described in the ETISEQ publication,
and filtered at 1% FDR using a decoy database approach. The overall identification rate of debug
spectra was 75% after 1% FDR filtering. This can serve as the optimal result obtainable by
ETISEQ if reconstruction is perfect. We report recall, defined as
recall =
true positives
true positives + false negatives
, (3.7)
and precision, defined as
precision =
true positives
true positives + false positives
. (3.8)
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(a) (b)
Figure 3.9: Number of concurrently eluting peptides over time. a) shows an overlay of ground
truth (grey), identifiable peptides (green), peptides identfied from spectra reconstructed by
ETISEQ (blue), and unique peptides in terms of sequence and charge of the latter (red). b)
shows the results using x = 1 for ETISEQ.
of the peptide sequences reconstructed by ETISEQ (while requiring charge to be correct as
well in order to be counted as true positive).
Figure 3.9a shows that the density of features in RT is highly heterogeneous, but never
exceeds our selection of n = 15. One can clearly see that some debug spectra cannot be identified
(especially in lower RT regions). Thus, computing an unbiased set of identifiable spectra is
clearly advisable. ETISEQ was not able to successfully reconstruct more than seven unique
peptide sequences from a single MSE spectrum (counting distinct charge states as separate
results). In most cases only three unique peptide sequences were reconstructed. The number of
reconstructed MS2 spectra is higher, though, since redundant spectra were generated which only
differ in the position of the precursor (see Figure 3.8). Overall recall of ETISEQ-reconstructed
spectra compared to ground truth was ≈32% (less than half of the identifiable spectra). Precision
was 100%, i.e., no wrong peptide sequences were reconstructed. As already shown, selecting a
global number n of precursors to reconstruct per MSE spectrum for the whole experiment is
not trivial, because feature density varies significantly with RT. To test if the ion exclusion
parameter x can improve performance, we set x = 1. The results are shown in Figure 3.9b.
Excluding ions in subsequent scans does not improve performance at any RT position. It rather
leads to zigzag patterns due to exclusion of previously successful candidates.
Investigating which spectra could not be reconstructed by ETISEQ, we found no dependency
on RT or peptide length (data not shown). Fragment ion intensity seemed to have a significant
influence iff many high and low abundant precursors were eluting at the same time. However, for
only few precursors with large intensity span ETISEQ is able to reconstruct all charge variants,
e.g., see Figure 3.9a (≈870 Th) for a single peptide (no other peptides in RT range) in multiple
charge states. In more dense regions low abundance features are not reconstructed, despite a
high n and no intensity thresholds. See Figure 3.10 for the intensity distribution of identified
and unidentified spectra. In dense regions most features’ apexes will inherently be close to each
other. For our dataset the fraction of features (disregarding charge variants) whose apex is at
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Figure 3.10: Intensity distribution of spectra whose reconstruction was successful (red) versus
all simulated spectra. A preference for high intensity spectra is clearly visible.
least 1 s from its closest neighbor is 82%, for 0.5 s this number rises to 97%. Thus, most features
should be distinguishable by apex alone. Additionally, the simulator uses random elution profile
shapes, which should enable the Pearson correlation analysis to distinguish features which are
close in RT. Nevertheless, changing the threshold for the Fourier transform lag to 0 and Pearson
correlation to 0.9 did not change the ETISEQ results (defaults are 3 and 0.7, respectively). This
is unfortunate, since the performance of the algorithm is critically dependent on its ability to
distinguish features which are close in RT, possibly with similar elution profile shapes.
To summarize, our data suggests that ETISEQ is currently limited in the number of peptides
that can be reconstructed from a single MSE spectrum. Also, high abundance precursors are
preferred over low abundance precursors in dense regions. Furthermore, the precursor selection
strategy has potential for improvement, since isotope peaks are often selected in addition to the
monoisotopic peak. According to the ETISEQ paradigm for peak assignment, all fragment ions
of a peptide with multiple precursors are copied to all precursors from other peptides. This
could introduce a serious amount of noise, therefore decreasing identification rates.
Map Alignment
In this study we aim to benchmark the ability of a map alignment strategy to correct for a
retention time distortion between two simulated data sets when the overlap of sample content
is varied. We used the simulator to create feature maps of decreasing overlap in terms of
protein content but constant number of features (≈4 000) and applied the TOPP MapAligner
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Figure 3.11: Quality of alignment when altering peptide overlap between the two data sets.
Red triangles indicate the reconstructed offset in comparison to the simulated offset (red dotted
line). Blue squares indicate the reconstructed scale in comparison to the simulated scale (blue
dashed line).
tool to reconstruct the affine retention time shift plus a local Gaussian distributed distortion.
We chose offset = 100, scale = 1.3, and a local Gaussian distortion with sd = 3 for each
feature. This scenario can provide insight on how many corresponding features (i.e., alignment
anchors) are needed to reconstruct the correct alignment. Inefficient feature finding and/or poor
chromatographic conditions may lead to poor overlap of (replicate) experiments, thus a robust
algorithm is required to reconstruct the RT shift. The results show that even a very small
overlap does allow for a reliable estimation of the true transformation (see Figure 3.11).
3.2.2 Experimental Settings Optimization
The exact conditions under which LC-MS experiments are performed, e.g., which gradient
length, column type, resolution, etc. are used, are important for the success of the scientific
endeavor. Simulation cannot only be used for algorithm debugging, optimization and perfor-
mance evaluation but also for predictive purposes, namely for the optimization of experimental
settings. Given a certain sample of known complexity, experimentalists choose LC and MS
settings based on previous experience. In this case simulation can help to determine if any
significant improvement can be gained by increasing resolution, LC time, or by using replicates
with exclusion list.
Starting from a default configuration for an analysis pipeline (see Figure 3.12), we are going
to change prominent parameters and evaluate their influence on precision and recall.
The list of parameters along with all tested values for simulation is shown in Table 3.1.
Values in bold show the default setting used for all dimensions except for the one dimension
that is used for iteration.
To speed up evaluation, one could opt to work on a subset of the map; however, this can
bias the results for two reasons. First, the feature spread in RT and m/z dimension is non-
homogeneous and secondly, evaluation software might depend on a map large enough to estimate
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Figure 3.12: Evaluation workflow allowing to test multiple simulation parameters and evaluate
their effect on precision and recall.
Table 3.1: Iteratable simulation parameters. Values in bold represent the default.
parameter values
protein count 10 50 100 500 1 000 3 000 10 000
dyn. range 0.1 0.2 0.5 1 1.5 3 6 9
resolution 5 000 7 500 10 000 20 000 40 000 60 000 100 000 200 000
RT (min) 5 30 60 90 120 240
shot noise 0 0.01 0.02 0.05 0.1 0.5 1 2 3
signal-to-noise ratios robustly. Thus the location and number of features found might differ (as
is the case for the OpenMS centroided FeatureFinder – data not shown).
We report recall (see Eq. 3.7) and precision (see Eq. 3.8), since only true positives, false
positives, and false negatives are available. The number of true negatives is infinite.
Figure 3.13 summarizes the results.
According to the simulation, dynamic range and noise levels do not negatively influence
precision and recall of the OpenMS FeatureFinder (centroided). The computation of signal
strength from peptide abundances uses a linear model during simulation. The dynamic range
is therefore linear as well. This indicates that the feature finding algorithm can identify weak
features amidst high-intensity features. However, higher spectral density where more overlapping
features occur will drastically decrease performance. One way to avoid overlapping features is to
increase the gradient length of the HPLC. Not surprisingly, the algorithm is then able to recover
more features and suffers less from false positives. Larger gradient lengths can balance higher
sample complexity. Interestingly, increasing resolution does not change precision but increases
recall due to more narrow raw peaks, which, once they are centroided, allow the algorithm to
disentangle interleaved features. If overlapping peaks cannot be resolved, the observed isotope
distribution will deviate strongly from the expected averagine distribution, leading to rejection
of the putative feature as peptide signal. This increases the false negative count; thus, recall is
decreasing.
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Figure 3.13: Recall and precision for multiple parameter sweeps.
3.3 Discussion
MSSimulator is the most extensive collection of algorithms and models for MS simulation and
allows for easy algorithm validation on a broad range of conditions, opening a wide range
of benchmarking scenarios that can easily be automated. The availability of a ground truth
reduces the need for expensive manual validation on real data sets. For each simulation step
the simulator has several models (e.g., CE and HPLC for separation, MALDI and ESI for
ionization, three resolution models for mass measurement), it allows for arbitrary modifications
and contaminants. In addition to the four labeling techniques which are currently supported,
future labeling techniques can be added quickly by implementing a powerful labeling interface.
We have shown that our simulated data is very similar to real data and allows easy validation
of existing algorithms. Compared to experimental data, simulation thus not only provides
valuable ground truth but is also much faster to generate and unaffected by experimental errors.
Simulation of different experimental conditions can be used to predict which parameters have
the largest influence on a subsequent computational analysis (e.g., feature finding). However, in
order to find the optimal experimental parameters a cost function is required (e.g., is increasing
the gradient from four to six hours worth a gain of 20% in feature count). This cost function is
most certainly subject to change for every laboratory or project. Missing support for ionization
efficiency, trapping capacity, etc., during simulation is currently the reason why the parameter
ranges will most likely not be comparable (i.e., under identical conditions a real dataset with
5 000 proteins will have a different amount of feature overlap than the corresponding simulated
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dataset). Another model trained on real data would be required to account for this during
simulation.
Future extensions might include, but are not limited to, automatic estimation of simulation
parameters (e.g., resolution, sampling rate, noise level) from real data allowing to quickly gener-
ate benchmark data for analysis software, quantitative prediction of ionizability, incorporation of
additional noise models and ion statistics and more instrument-specific properties (e.g., shoulder
peaks on FT instruments – see Subsection 2.3.2). Due to the broad support of different levels
of ground truth and a wide variety of models, the simulator could also be used to re-evaluate
published algorithms whose performance was assessed using a feature-limited and special pur-
pose simulation tool. A comparison might reveal significant differences in the performance of
the algorithm, pointing to violated model assumptions (e.g., shape models, data complexity).
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Chapter 4
Decharging of Charge Variants
Synopsis: A new algorithm for charge variant detection based on integer linear programming is
introduced and evaluated. We show that it outperforms existing methods and is robust to missing
data in simulated experiments.
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Figure 4.1: Schematic illustration of (simple) decharging problem. Two peptide species in different,
rather small charge states are shown. One peptide has an additional variant featuring a sodium adduct.
In addition, both peptides exist in a light and heavy state, i.e., peptides are labeled.
This chapter subsumes and extends the work presented in Bielow et al. [35].
In electrospray ionization mass spectrometry (ESI-MS), peptide and protein ions are usu-
ally observed in multiple charge states. Peptides and proteins are measured in positive mode,
making protonation the primary mechanism of charge acquisition. The number of charges de-
pends on experimental conditions and on the length of the amino acid sequence. Therefore,
peptides usually carry a small number of charges in ESI, usually two, whereas proteins can
reach charges above 50. Adduction with other ions such as sodium or potassium leads to further
partitioning and more complex signal patterns for a single species, adding to spectra density
and complicating the derivation of quantitative information from the mass spectra. Labeling
strategies targeting the MS1 level further aggravate this situation since multiple samples must
be represented simultaneously. For an example, see Figure 4.1.
We developed an integer linear programming (ILP) approach which can cluster signals be-
longing to the same peptide or protein. Our widely applicable and general approach models
all possible shifts of signals along the m/z axis, taking into account different charge states of
the compound, the presence of adducts (e.g., potassium or sodium), and/or a fixed mass label
(e.g., from ICAT or SILAC), or any combination of the above. We show that our approach
can be used to infer more features in labeled data sets, correct wrong charge assignments even
for high-resolution MS data, improve mass precision, compute intact protein masses from large
protein charge ladders in complex mixtures, cluster charged species with several adduct types,
and is robust against missing values in simulation studies.
Figure 4.2a shows the raw map of two peptides of similar mass but different retention time.
Usually, the raw data is subjected to algorithms for data reduction, and the measured signal is
reduced to a single data point – a feature (see Section 2.6).
The problem of multiply charged peptide species is usually only present in ESI whereas in
MALDI, peptides mostly receive one charge, rarely two. However, even in MALDI, experimental
conditions can be changed such that higher charges are observed [30]. Obviously, it is crucial to
find all signals originating from a peptide. Unfortunately, this task is more difficult in practice
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Figure 4.2: Schematic illustration of ESI spectral cluttering due to multiple charge states and
adduct formation in experiments involving light and heavy-labeled species. a) Two ideal peptide
signals (top and bottom) eluting from a chromatographic system, each showing a light and
heavy analog. b) Features identified from raw signal on the left with the resulting intensity ratio
between labeled and unlabeled compounds. c) The same peptides as in sub-figure A but spread
across several charge states. Even an adduct can be observed, which is related to the high-
intensity heavy peptide at higher retention time. d) Charge ladders and charge states indicated
at the feature level for sub-figure C.
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than implied in Figure 4.2 since samples are usually highly complex and ambiguities need to be
resolved. Figure 4.2c, for example, shows the (realistic) case of two and three charge variants
of each peptide with the addition of a sodium adduct. Figure 4.2d then shows the respective
feature map in which one feature is missing, which is also quite common in practice due to
noisy data or algorithms not being able to detect all signals correctly. While charge ladders of
peptides are usually rather small (a few charge variants), proteins give rise to a much broader
charge distribution due to their size and can easily reach charges of 30 and even above 50. As
for peptides, proteins can carry adducts such as sodium.
The problem of clustering differently charged species from the same compound in ESI spectra
is often referred to as deconvolution (although this is misleading – mathematically speaking),
decharging (although experimentalists usually interpret this as a reduction of the average charge
state [61, 65]), or simply disentanglement. Deconvolution is also sometimes used synonymously
for deisotoping [120] or resolving overlapping shapes [121]. We thus suggest the name decharging
for a reduction of multiple (deisotoped) species of the same analyte with different charge adducts
to a single zero-charge signal.
In labeling approaches (see Subsection 2.6.2), usually no decharging is applied. Instead,
signals of different labeling states with equal charge are grouped and compared directly, which
results in redundant information if multiple charge states are present. In both label and label-free
approaches, the quantification is further aggravated by the presence of adducts with ubiquitous
ions, such as sodium and potassium, whose occurrence depends on experimental conditions, e.g.,
usage of salts during HPLC or capillary electrophoresis (CE). Peptide signals incorporating such
adducts are usually low in abundance but will nevertheless reduce the ion count of proton-only
signals.
Inferring the correct mass of a peptide or protein from charge states and charge ladders has
been an active research topic from the onset of application of ESI-MS in proteomics. Early
approaches targeting undigested protein samples use “global” information, i.e., multiple signals
of different charge states, to infer the mass and are best suited for mass spectra containing
only a few analytes. With the emergence of high resolution instruments it became possible
to use “local” information, i.e., isotope patterns, to infer charge, which is sometimes the only
option to infer mass if an analyte is only present in a single charge species. For protein spectra,
Mann, Meng, and Fenn [31] proposed an algorithm to fold a spectrum into mass space, thus
eliminating charge ladders. Although this greatly improved mass precision, the algorithm can
only deal with few analytes in one spectrum and gives rise to artifact peaks. This algorithm
was further improved by Reinhold and Reinhold [122], who reduced artifact peaks by using an
entropy-based measure at the cost of requiring a model distribution of charge ladders which is
applied to all masses under investigation and a loss of the peak height-abundance relationship.
For broad-range MALDI spectra, a heuristic approach [30] working on single spectra was devised,
which can cluster multiple charge states considering only H+ but relies on MALDI-specific rules
not applicable to ESI. The widely known ZScore-Algorithm [32] features either local or global
decharging but not both simultaneously. It can deal with complex single (stick) spectra but
might also produce artifact peaks due to spectral noise. A similar algorithm along with a brief
review was published by Zheng et al. [123]. Du and Angeletti [120] infer charge from local isotope
peaks and cluster all species projecting onto the same mass. This approach, however, is prone to
incorrect charge assignment during charge estimation and requires a threshold parameter. One
algorithm that attempts to make use of global and local information was published by Wehofsky
in 2002 [33]. It rewards features with charge q when their sibling of charge q − 1 is also found.
Unfortunately, the algorithm has no notion of retention time, only considers adducts of type
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H+, and relies on identifying gapless charge ladders. Furthermore, if charge and thus mass are
estimated incorrectly, the decharged spectrum is neither likely to contain the wrong signal nor
the correct one, because wrong charges are not fed back into the input spectrum. MaxQuant [93]
creates charge pairs based on retention time correlation and a peptide mass estimate threshold
for SILAC-based experiments. ASAPRatio [124] also uses charge pairs in ICAT-type LC-ESI-
MS data to improve quantification results. In addition to the two algorithms above, another
tool capable of analyzing labeled data is VIPER [95]. It supports arbitrary mass differences
(e.g., from ICAT or 16O/18O labeling) and can deal with pairs in multiple charge states.
None of the algorithms mentioned above is able to model charge ladders with multiple adduct
combinations, e.g., a combination of pure proton adduct species with a proton/sodium species
from the same peptide or protein. And except for the more recent ones, they were all designed
for undigested analytes producing long charge ladders. In tryptic digests, however, one rarely
encounters species with a charge of five or higher. There is a solution to cluster undigested
protein degradation products based on an EM algorithm, which is not publicly available [125].
For metabolites an approach using database search accounting for different adducts was recently
devised [126]. Additionally, there is the CAMERA software package1, which groups metabolite
mass signals based on rules for mass differences and peak shape comparison [127].
In this work we propose a method for identifying groups of signals belonging to the same
compound in labeled or label-free MS data. The algorithm is general in that it models all possi-
ble shifts of signals along the m/z axis. These shifts can be induced by a different charge state
of the compound, the presence of adducts (e.g., potassium or sodium), the presence of a mass
shift due to isotope labeling, or any combination of the above. It allows for an iterative approach
(rerunning feature detection on missing charge states or missing pairs in labeled experiments)
and can deal with missing data (e.g., gapped charge ladders). We show that by applying our al-
gorithm, several types of errors can be corrected in a feature map, e.g., wrong charge assignment
or missing features. Additionally, we can achieve a reduction of data volume, improvements in
mass precision, and prevent manual annotation errors and incomplete annotation.
Parts of this chapter have been published in Bielow et al. [35].
4.1 Mathematical Preliminaries
Our approach uses a widely known optimization technique called integer linear programming
(ILP). To facilitate understanding, we now give a brief introduction to linear programming (LP),
its special form integer linear programming, and some standard notation. This section is mostly
based on Bertsimas and Tsitsiklis [128]. To ease reading we will use bold letters for vectors,
bold capital letters for matrices, and plain letters for scalars.
In linear programming we seek to minimize an objective function c′x =
∑n
i=1 cixi where c
is a given cost vector and x is an unknown vector of decision variables subject to a set of linear
equality and inequality constraints of the form a′x = b, a′x ≤ b or a′x ≥ b where b is a scalar.
We can write a set of constraints as Ax = b where b = (b1, ..., bm) is a vector of m constraint
bounds and A is a m×n matrix whose rows are row vectors a1, ...,am. Every LP can be brought
to standard form, i.e.,
1http://www.bioconductor.org/packages/bioc/html/CAMERA.html
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Figure 4.3: Two conflicting edges inducing a constraint due to inconsistent annotation of feature
f2 (implicit H
+ are shown as well).
minimize c′x
subject to Ax = b
x ≥ 0.
A vector x satisfying all constraints is called a feasible solution. If additionally some x
minimizes the objective function, x is called an optimal feasible solution. Depending on the
problem, there can be no, one or multiple optimal solutions. Maximizing c′x is obviously
equivalent to minimizing −c′x.
The first and most widely used algorithm described by Dantzig [129] to solve an LP is
called the simplex algorithm, which has exponential worst-case complexity but performs well in
practice.
ILP formulations are exactly the same as LP formulations with the additional constraint
that some variables are restricted to take integer values, i.e.,
minimize c′x
subject to Ax = b
x ≥ 0 , x integer.
In general ILP problems are NP-hard and can be solved using a number of algorithms, e.g.,
branch-and-bound or cutting-plane methods.
4.2 Methods
The input data set is a feature map F as generated by a feature finding algorithm, each feature
having at least a retention time and m/z (monoisotopic or average). In addition, it can be
advantageous to have an initial charge estimate and an intensity value.
We model our problem as a graph, which lends itself to an ILP formulation. The nodes
in the graph correspond to features at a certain RT and m/z and hence to a peptide with a
certain charge state, possibly with adducts and/or mass labels. Edges are inserted between pairs
of nodes if a certain combination of adducts and charge assignment of the nodes explain the
mass difference between the nodes. Each edge carries information on the potential charge of its
adjacent nodes and the adducts which are required to explain the resulting mass difference. In
Figure 4.3, for example, the edge between f1 and f2 is inserted because the mass difference can
be explained by the assumption that f1 has charge 6, f2 has charge 5, and f2 has a potassium
adduct. The inserted edge hence induces charge states on f1 and f2.
For building the graph, we only use the most commonly occurring adducts listed in Table 4.1.
Note that this table can be easily modified by the user if required. Simple protonation is the
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Figure 4.4: Histogram of pairwise mass differences showing evidence of presence of sodium and
potassium (obtained from the SPC data set used below).
most common effect (and desirable due to better fragmentation behavior and decreased signal
congestion [130]). Non-proton adducts are usually a result of prior prefractionation via CE or
HPLC.
Adduct frequencies can be estimated by looking at the histogram of pairwise mass differences
of all features (see Figure 4.4). At the masses of Na, K and NH4 (minus a proton mass each),
one can clearly observe clusters which indicate their presence (see Table 4.1 for adduct masses).
Constructing the graph in such a fashion obviously results in conflicting edge descrip-
tions. Each pair of edges adjacent to a node might induce a constraint due to a conflicting
charge/adduct combination. For example, Figure 4.3 shows two edges adjacent to f2 where the
left edge assigns four protons and a positively charged potassium ion to f2 while the right edge
assigns 5 protons to f2. Obviously, only one of these conflicting annotations can be fulfilled at
a time. Hence, our goal is to choose a subset of the edges with an overall maximal weight which
does not contain any pair of conflicting edges. We compute the optimal subset by solving an
ILP. In the following, the method is specified in further detail.
4.2.1 Generating the Adduct Transition Graph
Initially, our algorithm generates a table L of all feasible net adduct transitions, i.e., the subset
“lost” on one side and the subset “gained” on the other. Losing a proton and gaining a sodium
adduct, for example, can serve as an explanation for an edge between [M + 2H]2+ and [M +
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Table 4.1: Adducts commonly observed in ESI-MS. All adducts occur singly charged, i.e., they
are lacking one electron.
name formula monoisotopic mass (Da)
hydrogen H 1.0078250319
ammonium NH4 18.05
sodium Na 22.98976928
potassium K 38.96370668
Table 4.2: Example for adduct transition table L.
loss gain net charge mass
Na+ H+ 0 -21.9819
- H+ +1 1.0078
- Na+ +1 22.9892
H+ 2Na+ +1 44.9712
Na+ 3H+ +2 -19.9674
2Na+ 4H+ +2 -41.9493
- 2H+ +2 2.0146
- HNa+ +2 23.9965
H + Na]2+ ions. The table contains net mass and net charge differences. An example using
proton and sodium adducts can be found in Table 4.2. Note that we do not model redundant
transitions, i.e., elements that occur on both sides and would cancel each other out. Additionally,
each adduct is assigned an a priori probability (e.g., using Figure 4.4), which allows to compute
adduct transitions up to a probability threshold which can be chosen generously but avoids
adduct transitions which are unlikely to occur (e.g., all-sodium adducts in a charge 5 feature).
Furthermore, the list is bound by the charge difference qspan, which is the maximum number of
charge states that can be bridged by edges in the graph. By default, qspan is set to 4, which
allows bridging q3 (charge 3) and q6 (charge 6) but would not allow to join two nodes with q3
and q7. The size of L depends very much on the number of adducts allowed and qspan but rarely
exceeds 400 entries.
We now construct the adduct transition graph G = (V,E) where V is a set of nodes ni
corresponding to features fi from the set F . E is a set of undirected edges ej = {nk, nl}. To
generate edges between nodes, the algorithm enumerates all pairwise features within a small RT
delta deltaRT since charge ladders are a property of ESI and thus have similar RT. However, if
method-specific RT shifts are known (e.g., in ICAT pairs), this can easily be accounted for by
specifying an adduct’s intrinsic RT shift. During enumeration, mass differences are looked up in
L, and for all matches an edge containing the putative charge and adduct of the left and right
node is inserted as well as a score which serves as an edge weight. All charges not explicitly
explained by the adduct transition are implicitly modeled as H+ and stored in the edge as well.
Obviously, edges with adduct transitions that require a feature to take up more charges than
allocated are not realized. Edges are weighted by the product of probabilities of adducts which
are required to explain the mass difference (see Table 4.2). However, a more involved scoring
scheme can be easily implemented, which could, for example, account for mass and RT deltas,
feature quality, and violation of a feature’s local charge prediction.
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Figure 4.5: Example for edge inference. e5 is inferred by using the adducts induced by e2 and
e4. (Note that for clarity only edges important for edge inference are shown, e.g., e = {n1, n4}
is missing.)
To reduce the number of false positives in highly complex maps, an additional filter which
reduces the number of edges in the graph can be used. In case that ch(ek, ni) = ch(ek, nj), we
add an edge ek = {ni, nj} only if sign(int(ni) − int(nj)) = sign(pr(ek, ni) − pr(ek, nj)) where
ni and nj are the nodes connected by edge ek; int(n), pr(e, n) and ch(e, n) are the intensity,
probability, and charge of node n induced by edge e. In other words, we enforce that features
with lower probability also have a lower abundance. We only enable this constraint for equal
charge states since it is very hard to predict ionization behavior across multiple charges.
As table L only contains non-redundant adduct transitions, it is sometimes necessary to infer
sibling edges that contain explicit redundant adducts from already existing edges. An example is
given in Figure 4.5. As edge e3 induces purely protonated nodes n2, n4, it is in conflict with edges
e2 and e4, each inducing a sodium adduct at n2, n4 respectively. To enable the final solution to
contain a fully connected subgraph {n1, n2, n3, n4}, another edge e5 needs to be created. These
inferred edges are created between any two nodes ni, nj for any pair of edges ek, el with either
ek = {ni, nm} or ek = {no, ni} and el = {nj , np} or el = {nq, nj}, using the adducts induced for
ni, nj by ek and el.
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The graph construction algorithm can be summarized in pseudo code as follows, assuming
the input F is sorted by RT:
for fi in F [start : end] do
for fj in F [i+ 1 : index(rt(fi) + deltaRT )] do
for (q1, q2) in Q Q do
adduct candidates = massDeltaLookup(fi · q1, fj · q2,mz tol)
for aci in adduct candidates do
if (not intensityFilter(fi, fj , aci)) then
continue
end if
insertEdge(E, aci, fi, fj)
end for
end for
end for
end for
edgeInference(E)
The for-loop enumerating all feature and charge combinations is optional. It is only used
when the algorithm is in “discovery” mode, i.e., when searching for edges without relying on the
annotated charge of the feature but instead enumerating all possible values.
4.2.2 Constructing the ILP
Having constructed the adduct transition graph for our problem, it is straightforward to define
the corresponding ILP. During this phase, all edges sharing one or more nodes are checked for
consistency, i.e., whether any pair of edges induces an inconsistent adduct annotation for the
shared feature. Consistency requires
1. identical charge,
2. identical adduct composition.
An example for two inconsistent edges can be found in Figure 4.3. Feature f2 is assigned
adducts K+4H+ by the left edge whereas the right edge induces 5H+, both of which cannot
be true simultaneously. We introduce xi to indicate the presence/absence of edge ei from the
solution and ci as the score of edge ei.
The ILP is defined as
max c′x
s.t. xi + xj ≤ 1
xi, xj ∈ {0, 1} for all pairs of inconsistent edges.
(4.1)
A more advanced formulation can be established when we model the configurations (charge,
adducts) of each feature i as a set yi with size mi and force one configuration to be chosen. The
configurations are induced by the adjacent edges of each feature. We thus arrive at the following
formulation:
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max
n∑
k=1
ckxk
s.t.
mi∑
j=1
yij = 1 ,∀i
xk ≤ yij , xk ∈ E(yij), ∀i, j
xk, yi ∈ {0, 1},
(4.2)
where E(yij) is the set of edges inducing configuration j of feature i. In other words, an
edge is chosen if and only if the two feature configurations induced by this edge are active. We
use Equation 4.2 to solve the decharging problem, as in practice it is much faster to solve than
Equation 4.1, especially for larger problem sizes. The reason for this is most likely due to the
large number of pairwise constraints induced by Equation 4.1.
The ILP’s output is a set of active edges. Thus, finding all connected components will
automatically cluster nodes (features) into groups representing charge ladders with adducts
and/or labeled pairs.
Due to the problem structure, the ILP solver employed (COIN-MP) achieves runtime im-
provements of ≈40% just by ordering the pairs as connected components when constructing the
ILP columns even though a clique heuristic is active within the solver. As a further optimization
we split the ILP into child ILPs by determining connected components in the graph and only
feeding the edges for one (or a few) connected components at a time. The overall result is not
affected by the concurrent amount of connected components fed to the ILP solver, but runtime
can improve about five-fold.
Also, the resulting child ILP’s lend themselves to parallelization in a very straightforward
manner. Thus, the algorithm has been parallelized by OpenMP [131] using dynamic thread
allocation. The resulting runtime improvements can vary considerably, depending on the hardest
sub-ILP. Usually improvements of another 40-60% can be observed with four threads.
4.2.3 Post-Processing
During post-processing clusters can be discarded using a filter which reduces spurious hits. The
“backbone” filter will only allow clusters which have at least one feature whose charge can be
explained by protons only, i.e., that is part of the backbone of a charge ladder. Otherwise wrong
or very unlikely clusters might be found, e.g., ([3K]3+, [5Na]5+). Without the backbone filter
(especially in complex maps) these spurious hits are common when all possible feature charges
are enumerated by our algorithm.
4.3 Results
The algorithm was applied to several real data sets. On all data sets analyzed here, the running
times for our algorithm were below five seconds (2.26 GHz Core2Duo), and memory requirements
did not exceed 500 Mb. Time and memory requirements can increase, however, if many adduct
types are allowed and the feature finder charge is not fixed.
We will now show some practical cases where decharging can help increase data quality. We
compare our approach to a commercially available tool (Xtract) and to a pair-finding algorithm
implemented in OpenMS. Comparison with other packages is difficult since they are partially
specialized for certain labeling methods like SILAC or ICAT. If not indicated otherwise, we used
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the OpenMS PeakPicker for centroiding raw data and the OpenMS FeatureFinder for generating
feature maps.
4.3.1 Increasing Mass Precision
We applied our decharging algorithm to one of the SPC data sets (Mix1, LTQ-FT, 20060502data08)
[21]. This data set stems from a tryptic digest of 18 proteins measured in an LTQ-FT mass
spectrometer and is available at http://regis-web.systemsbiology.net/Publicdatasets/. The in-
teresting region of 500-4 000 s and 400-1 400 Th was excised and only every second scan was
retained from the MS1 data, as only they contained the FT scans. The OpenMS PeakPicker
and FeatureFinder were applied to the raw data, resulting in 1 064 features. Subsequent internal
calibration using high-confidence MS2 identifications was applied to enable the calculation of
a standard deviation between monoisotopic feature position in m/z and MS2 identifications.
Decharging was applied to find clusters of corresponding features stemming from the same pep-
tide with different adducts. We found evidence for adducts (see Figure 4.4) and thus allowed
H+, Na+, K+, and NH4
+. With the data set being a high-resolution measurement, the charges
assigned by the FeatureFinder are mostly correct, nevertheless misassignments did occur (espe-
cially when the isotope pattern deviated strongly from the averagine model). Hence, we allowed
the decharging algorithm to alter the FeatureFinder charge. The adduct transition graph had
1 064 nodes, 344 edges, inducing 167 constraints. About 35% of all features (371) were grouped
into 155 clusters during decharging, and their monoisotopic m/z position was corrected using
the average mass predicted by all members of the cluster. For all other features (693), no partner
was identified. For 20 clusters, an MS2 identification was available. This allowed to calculate the
mass deviation between the predicted MS2 mass and the feature mass. The standard deviation
between the features’ monoisotopic m/z and the theoretical m/z position predicted by MS2
identifications prior to decharging was 1.044 ppm. In contrast, it was significantly reduced to
0.527 ppm after decharging due to the fact that feature masses are averaged over all members of
a cluster by our algorithm. The increase in mass precision by clustering obviously only applies
to features which are members of a cluster and can thus benefit from decharging. Furthermore,
we examined those features whose charge (as assigned by the feature finder) was altered in the
ILP solution. In total, the charge of eight features was changed by our algorithm, and, except
for one, these reassignments were found to be correct by manual verification of the raw data.
4.3.2 Finding Pairs in Labeled Data
We applied our algorithm to a centroided data set of MHC peptides [132] which contains 4 117
scans and 3 083 features. Nicotinic acid labeling was used to tag two samples with either a light
or heavy label (in which four hydrogen atoms were replaced by deuterium) prior to mixing and
LC-MS analysis. Our algorithm generally supports any kind of labeling as long as the mass
difference can be expressed as an empirical formula (see below).
As the charge estimation using the OpenMS FeatureFinder was very reliable for this data
set, feature charges were not altered. The set of possible adducts was set to +H and D4-4H, the
former being simply protonation, the latter being an uncharged adduct describing the net mass
gain of 4 Da for the heavy analog due to deuterium exchange. We allowed up to two uncharged
adducts for the computation of L. The adduct transition graph had 3 083 nodes, 653 edges,
inducing 349 constraints.
To compare our results we tested the labeled pair finder of OpenMS. It allows the user to
supply an arbitrary list of allowed masses and RT shifts. We found 293 pairs using this standard
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Figure 4.6: Example of charge ladders spanning two charge states (including light and heavy
partners). Edges connect all features of the cluster as found during graph construction.
approach. Using the decharging algorithm we found 307 pairs, 16 of which have a partner pair
in a different charge state (see Figure 4.6 for an example). These 16 pairs can be condensed into
8, because they represent the same peptide. Moreover, it allows to compute the average of two
intensity ratios (see Figure 4.7).
Sixty-four clusters of size three were also found, 11 of which contained features of the same
charge state, thus indicating a potential conflict in uniquely identifying the light and heavy pair:
when ordered by m/z, it is possible that either feature 1 and 2 or feature 2 and 3 represent the
light and heavy peptide. Other pair-finding algorithms will most likely just pick one greedily.
Even the common precaution in standard pair finding algorithms requiring that any third feature
must lie x Da further away from a pair would not be beneficial here as x would need to be larger
than the pair mass difference in order to avoid ambiguous pairing. Choosing x that way would
result in many pairs remaining undiscovered in the data set. Our approach will detect these
ambiguities and allows to discard/mark those clusters. Another constellation for clusters of
size three occurred 53 times: one light/heavy pair is identified, and additionally, a third feature
(either light or heavy) of a different charge. The missing fourth feature was either not discovered
during feature finding or is simply not detected by the instrument. An example of the former
case is given in Figure 4.8. Without reference to another charge pair or MS2 identification it
is difficult to infer which of the two partners is present or if the identified feature even has a
partner. Manual inspection of the data set suggests that about 60% of the 53 clusters indeed
have a fourth feature, which was simply not detected by feature finding. Reiterating the feature
finding step using the 53 seeded positions suggested by our algorithm yielded 29 new features
(10% increase in pair count).
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Figure 4.7: Intensity ratios (light vs. heavy feature) from nicNHS pairs of different charge
states. Ratios are depicted as squares, averages as circles. Some pairs (e.g., #6) show very
similar intensity ratios in different charge states whereas other charge ladders (e.g., #7) show
a two-fold difference. These differences can aid in determining the confidence in the observed
ratios.
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Figure 4.8: By evidence from a triple (2x q2, 1x q1) we can infer the presence of the heavy
partner of the q1 feature #768. The top section shows the projection of the m/z dimension.
One can clearly see signals at 4 and 5 Da from the monoisotopic mass trace of feature #768. The
missing feature’s mass traces are indicated by dashed boxes in the map view (lower section).
The reason for not identifying this feature is probably the presence of feature #750.
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4.3.3 Calculating Intact Protein Masses
Hemoglobin
We analyzed a hemoglobin HPLC/ESI-MS raw data set consisting of ten scans containing HBA1
and HBB measured on an LTQ Orbitrap XL mass spectrometer with a resolution of 100 000. We
compared the results of our algorithm with the Xtract module of Thermo’s Proteome Discoverer
1.0. This module operates scanwise allows decharging at the raw data level. The maximum
charge was set to 30, and we enabled the reporting of monoisotopic masses only. Xtract finished
after 237 s of CPU time (2.26 GHz Core2Duo). Note that Xtract reports the monoisotopic
protein mass as singly charged.
We used Hardkloer (v1.22) [133] to identify features scanwise and the postprocessing tool
Kroenik (v1.3) to summarize features occurring in multiple scans. Minimum and maximum
charge were set to 4 and 30, union and intersection mode were enabled, and S/N was set to 1.
Decharging was set to consider sodium and potassium adducts and to correct for monoisotopic
shifts of up to one position to the left or right. Alteration of charge values was disabled. The
adduct transition graph had 104 nodes, 315 edges, inducing 2 590 constraints.
CPU time from raw data to features took 15 s, subsequent decharging one second (2.26
GHz Core2Duo). Our algorithm found 68 distinct masses (clusters). The two largest-sized
clusters represent the hemoglobin subunits – cluster A for HBA1 (size 14 ranging from charge
8-18 with 11 proton-only features, 2 potassium and 1 sodium adducted features, average mea-
sured monoisotopic mass was 15 116.92939 Da, molecular mass calculated from the sequence was
15 116.88510 Da), cluster B for HBB (size 14 ranging from charge 9-17 with 10 proton-only fea-
tures, charge 11 occurring split into two proton-only features with different RT, 2 sodium and
potassium adducted features each, average measured monoisotopic mass was 15 857.29186 Da,
molecular mass calculated from the sequence was 15 857.24969 Da).
As Xtract reports several masses (one per scan) for each hemoglobin subunit, we extracted
the relevant regions to obtain an overall of ten molecular mass values for each subunit. By
averaging these ten mass estimates we obtained masses 15 116.95 and 15 857.31 Da for HBA1
and HBB, respectively. Figure 4.9 and 4.10 show the relative mass deviations for both methods,
the horizontal lines indicating the relative mass deviation from the theoretical mass for our
approach and Xtract. Note that our approach is closer to the predicted theoretical mass (at
0 ppm) for both subunits. However, the instrument seems not to be optimally calibrated as
both methods’ standard deviation (0.4987 and 0.3858 ppm for our method with 2 and 1 outliers
removed, 0.3510 and 0.8808 ppm for Xtract with 1 and 0 outliers removed) is lower than the
gap to the theoretical mass of the protein. Outliers were removed using z-scores and a p-value
threshold of 0.95. Hence, our decharging algorithm can also be utilized to recalibrate the mass
spectrometer with signals of multiply charged ion species. Our approach can additionally group
all sodium and potassium peaks into the main cluster (if desired by the user), which further
disentangles the results. Furthermore, our approach also works with single spectra, allowing us
to estimate the mass error from multiple charges – an information not provided by Xtract.
Wheat Extract Protein Mass
Mohr et al. [134] analyzed a wheat extract containing intact protein masses using an LTQ
Orbitrap XL mass spectrometer. In order to obtain protein masses, the data was analyzed using
the Xtract tool supplied with the instrument software and ProMass [134]. In brief, multiple scans
of interesting regions as determined by manual data inspection where summed to increase the
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Figure 4.9: Deviation of observed masses for HBA1 (in ppm). Circles represent charged features
clustered into A, crosses are the mass estimate errors by Xtract from the ten scans. Dashed
(our) and dotted (Xtract) lines are the mean values.
Figure 4.10: Deviation of observed masses for HBB (in ppm). Circles represent charged features
clustered into B, crosses are the mass estimate errors by Xtract from the ten scans. Dashed
(our) and dotted (Xtract) lines are the mean values.
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Figure 4.11: Illustration of decharging workflow for highly charged protein data with unresolv-
able isotope patterns. The resulting protein list was compared to the manually annotated list
by matching protein masses and retention times.
signal-to-noise ratio and submitted to Xtract and ProMass. According to the authors, ProMass
was used for summed spectra where no isotopically resolved signals were available (thus inferring
protein mass by charge ladders only). Xtract uses the distance between isotopically resolved
peaks to infer charge. Subsequently an averagine model is fitted to the isotope pattern to infer
the average mass. Decharged spectra where then manually annotated to obtain protein masses.
The supplemental material if [134] contains a table listing 53 protein masses.
To show the automation and high-throughput capabilities of our approach, we designed a
robust and widely applicable pipeline to automatically extract protein masses from the whole
raw LC-MS map. As the data set contains large proteins which cannot be isotopically resolved,
we replace the feature finding step with data smoothing, peak picking and subsequent mass trace
finding, using the respective TOPP tools (see Figure 4.11). This yields features that represent
the protein in a certain (but unknown) charge state and its average mass.
Processing time for the complete pipeline, starting from raw data (≈4.7 GiB mzML file) to
a list of protein masses, was about 20 min on an Intel Xeon server using 8 GB of RAM at most.
Decharging itself takes only a few seconds.
Our algorithm yields 126 protein masses (after removing spurious hits with less than three
charge variants). We obtain a charge distribution as shown in Figure 4.12 with charges ranging
from 11 to 59.
Figure 4.13 shows the most dense section of the smoothed and peak-picked raw data, super-
imposed with the charge-annotated features. Features in red were assigned to a protein mass
and thus have a charge. Features in blue could not be annotated since no charge ladder was
identified.
To compare the results, we matched the manually created list of 53 protein masses with
associated retention times from Mohr et al. [134] using the FeatureLinkerUnlabeled TOPP tool,
allowing for mass tolerances up to 5 Da and RT shifts of 60 s. We were able to recover 30
proteins (57%) of the manually curated list. 23 protein masses were not found which were
manually annotated. Another 96 proteins were uniquely found by our approach.
In order to explain the missing matches, we manually compared the two protein mass lists.
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Figure 4.12: Charge distribution for all protein charge variants of the gliadin extract sample.
For the protein with manually annotated mass 31 543.54 Da at 38.03-38.63 min, we found a close
match in our list of 31 534.12 Da at 38.45 min. By inspecting the raw data (see Suppl. Mat. of
[134], p.38) we found the true mass to be 31 534.54 Da, which is very close to our result. The
mismatch was caused by a typing error in the manual list of [134].
Two masses in the manually curated list which were apparently computed using ProMass (in-
stead of Xtract) are found at 54 863 Da, 3.88-4.02 min (see p.13, Suppl. Mat.) and 54 977 Da,
4.51-4.68 min (see p.18, Suppl. Mat.). We find close matches at 54 837 Da, 3.96 min and
54 950.55 Da, 4.58 min respectively. In both cases, a mass shift of about 25 Da can be observed,
with the protein annotated by ProMass being heavier. Since we are already computing average
masses, the difference between monoisotopic and average mass cannot serve as an explanation.
When looking at the corresponding spectra computed by Xtract (compare p. 11 versus p. 13 for
the first protein, and p. 15 versus p. 16 for the second), we find the Xtract spectra to agree very
well with our estimated mass. Thus for ProMass spectra, there seems to be a mass calibration
procedure in place, making the protein masses incomparable. This not only prevents us from
finding a match in both cases but also leads to an inconsistent mass list in the Supplemental
Material of [134], since some masses are reported using ProMass and others using Xtract. Since
the sample is of high complexity and the identity of most proteins remains unknown, we cannot
assess if the mass correction of ProMass is meaningful.
To explain the excess of protein masses identified by our algorithm, we tried to find the
masses in the deconvoluted spectra supplied in the Supplemental Material of [134]. Multiple
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Figure 4.13: Dense section of the picked raw data, superimposed with charge-annotated features
(red) and unassigned features (blue).
matches were found, which can be identified from these spectra, but were not mentioned in the
final protein mass table; e.g., on p. 48, a protein of mass 31 112.48 Da was identified, which
our algorithm also found at 31 112.12 Da and RT 2 606.13 s. On the same slide covering 43.18-
44.15 min we found three other masses not mentioned in the table, but matching very well to
entries in our list, namely, mass 30 498.02 Da at 43.27 min (versus 30 499.16 Da), 30 615.08 Da at
43.14 min (versus 30 613.26 Da) and 31 296.43 Da at 43.33 min (versus 31 296.59 Da). Similarly,
this analysis could be done for other retention time windows (data not shown).
4.3.4 Benchmarking Using Simulated Data
In silico data lends itself very well to study algorithm performance under different conditions.
We use a set of proteins with varying complexity, modeling data sets ranging from simple protein
mixtures to complex samples, and apply the decharging algorithm. The feature list which serves
as input for our algorithm depends on a few preprocessing steps, which – if performed carelessly
– will prevent our algorithm from fully reconstructing the complete protein list (false negatives)
or even lead to wrong results (false positives). Thus, we vary the degree of missing data and
study its effect on precision and recall. This data reduction step can be done in multiple ways.
We argue that the most useful approach is random sampling from all features. In real data
sets, some charge ladders are affected more by undersampling than others, especially when peak
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Figure 4.14: Heapmap displaying sample complexity and missing data rate for recall (left) and
precision (right) for simulated protein charge ladders.
intensity is low. Thus, real data is always a mixture of varying degrees of missing data for each
protein. However, this mixture effect strongly depends on the data set and is hard to quantify.
The result is much more interpretable if we create a homogeneous data set.
We model a set of sample complexities, ranging from only a few proteins (10 proteins) to a
complex mixture (640 proteins) randomly sampled from the human proteome for proteins with
a weight up to 100 000 Da.
We report recall (see Equation 3.7) and precision (see Equation 3.8) as we only have true
positives, false positives and false negatives available. The number of true negatives is infinite.
We count true positives as entities which have the correct retention time and mass as well
as internally fully correct charge assignments. The charge ladder is not required to be com-
plete. False positives are proteins not found in the simulated ground truth (by a small RT and
m/z delta) but reported by the decharging algorithm. False negatives are proteins which were
expected but not reported by our algorithm (e.g., due to missing data).
Figure 4.14 summarizes the performance for varying sample complexity and missing data.
The data was averaged over multiple runs to smooth out outliers, especially in low complexity
mixtures. Not surprisingly, increasing complexity and the amount of missing data reduce the
precision and recall of our algorithm. Note that neither recall nor precision dropped below
75%. Recall shows a critical point at a thinning factor of about 0.4 where suddenly many
protein masses cannot be reconstructed. This happens when gaps in the charge ladders become
too big such that the algorithm cannot bridge them any longer. The largest bridgeable gap
in this experiment was two (which is the default), i.e., two intermediate charges are allowed
to be missing. Recall is not significantly affected by the number of proteins. Precision is
dependent on protein count and thinning factor simultaneously as precision improves when
protein count declines and there is less missing data. Intuitively, thinning out data might split
charge ladders into multiple sub ladders which cannot be bridged. As the scoring function
favors easy explanations over more complicated ones, singletons from one charge ladder might
be clustered with singletons from others when the required adduct annotation is simpler, e.g., a
charge difference of one instead of five.
Overall, we find the algorithm to be robust up to and even beyond 50% missing data and
capable of handling very complex protein mixtures.
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4.4 Discussion
We demonstrated that decharging is useful for many applications in quantitative proteomics.
The algorithm is not restricted to a specific instrument or resolution, and although it is intended
for ESI data, it should also be applicable to MALDI data when multiply charged ions are
observed (e.g., for whole protein measurements [30]). The algorithm was optimized by splitting
the ILP into subproblems, which can be solved more efficiently by the solver, but also lend
themselves to parallel processing. Both measures reduce running time significantly such that
for a complex data set with adducts, the runtime is only a few minutes. Without adducts, the
solution is usually obtained within seconds.
Decharging was able to improve mass precision on the SPC data set from 1.044 ppm to
0.527 ppm, as verified using MS2 identifications. On labeled data, the additional information
of charge ladders was used to resolve ambiguous pairs as well as to infer more pairs. In top
down mass spectrometry, decharging was found to be superior to the Xtract software on the
hemoglobin data set. The protein mass estimated by our software was closer to the theoretical
mass for both subunits (HBA1 and HBB). Furthermore, in case of the gliadin data set, we
showed that manual annotation is not only cumbersome and time-consuming, but also prone to
misannotation. Many protein masses which are readily available from the data were not added
to the manual protein list. This is also reflected by the fact that automatic annotation detected
twice as many protein masses. A few protein masses were missed by our automatic annotation,
usually because the mass traces were not detected due to irregular signal of the smoothed data,
and were thus lost for charge estimation. Using in silico data, we showed that decharging is
robust to missing features and can handle very complex samples. Recall was found be sensitive
to missing features, whereas precision is affected by the number of proteins in the sample and
the amount of missing features. Even in the worst case scenario with 70% missing features and
the most complex mixture neither recall nor precision dropped below 75%.
A desirable extension of our approach is the estimation of scoring function parameters from
the data. Also, missing features could be alleviated by a hypothesis-driven feature finding
heuristic which searches for a strong signal (e.g., using signal-to-noise ratio) at putative feature
positions to infer missing features or resolve ambiguous explanations.
Chapter 5
iTRAQ Biomarker Discovery
Synopsis: iTRAQ data from multiple studies within a large project is evaluated. We devise a
new approach to isotope correction, propose an experimental design, introduce new measures of
iTRAQ data quality and confirm known properties of iTRAQ data.
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5.1 Introduction
5.1.1 Predict-IV Project
This chapter describes our biomarker discovery approach using multiple LC-MS iTRAQ experi-
ments in the context of the Predict-IV (Predict-In Vitro) project, which aims at characterizing
the dynamics and kinetics of cellular responses to toxic effects in vitro. The project is titled
Profiling the toxicity of new drugs: a non animal-based approach integrating toxicodynamics
and biokinetics and is funded by the European Union (EU) as part of the Seventh Framework
Programme (FP7) and involves twenty international partners.
Undesired toxic effects of drugs are observed frequently in specific organs, namely liver and
kidney, leading to early termination of compounds and their derivatives during drug develop-
ment. Furthermore, the neuronal system is a frequent target of drug side effects. Thus, model
systems for kidney, liver and the central nervous system (CNS) are used in this project. The
project aims for an integrated test system/test strategy with specific and early markers to pre-
dict toxicity based on in vitro data before entering in vivo testing. The dynamics and kinetics of
cellular responses to toxic effects in vitro, specifically for kidney, liver and CNS were examined.
Improved dynamic and kinetic models for in vitro systems are expected to be delivered. The in
vitro system model is used as a predictor for in vivo systems. This is a common and effective
approach as in vitro systems based on human tissue might hold more predictive power for phar-
maceutical safety evaluation than animal-based models. Also sample collection from animals is
avoided (animal testing, ethic commission approvals). However, the approach has drawbacks
as usually only a single (cancer) cell line is optimized, which might not be representative of a
population of healthy cells. In addition the role of the microenvironment is neglected [51]. The
full list of 29 final compounds for each subgroup of toxicity (hepatotoxic, nephrotoxic and neu-
rotoxic) is currently restricted to project members only. Most compounds induce organ-specific
toxicity. Cyclosporin A was chosen as a control compound, as it affects all three systems.
Our focus is on proteomics experimental design and identification of potential biomarkers
specific for the induced toxic effect, including feature identification and differential display.
A biomarker can either be a single molecule (usually a protein) or a combination of sev-
eral traits. Several classes of biomarkers can be discerned, i.e., diagnostic, prognostic (risk for
a disease, no treatment) and predictive (in response to a treatment) biomarkers. The follow-
ing criteria provide a measure of the performance of a biomarker. (1) high specificity for a
given disease (few false positives); (2) high sensitivity (few false negatives); (3) ease of use; (4)
standardization; and (5) clarity and readability of the results for the clinicians [12].
The aim of this project is the identification of putative biomarkers; thus, exhaustive quanti-
tative protein data needs to be acquired in an untargeted approach. If putative biomarkers are
identified across multiple toxic compounds and cell systems, a targeted follow-up study can be
performed, which, however, is out of the scope of this project.
Multiple studies were conducted within the Predict-IV project. A study is defined as a set of
experiments using exactly one cell system and one toxic compound (in different concentrations).
Multiple biological replicates are usually generated, finally yielding a set of LC-MS data sets.
Parts of this chapter are being prepared for publication [36].
5.1.2 Labeling Preliminaries
In addition to the brief overview in Subsection 2.6.1, we focus on more specific details of iTRAQ
at this point, in order to motivate the analysis procedures described in Section 5.2.
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Figure 5.1: Exemplary iTRAQ signal at MS1 and corresponding MS2 level. a) peptide feature
at the MS1 level with isotopic envelope (blue) and pre-peaks (red) due to isotope impurity of
the iTRAQ 4-plex reagent. b) corresponding MS2 spectrum recorded in HCD mode. The inset
shows the four iTRAQ reporter ions in the 114-117 Th range.
MS1-based labeling techniques (such as SILAC) suffer from signal congestion (the amount of
signal approximately doubles for two-channel labeling) and signal overlap, which lead to biased
quantification results, usually towards higher intensities for heavy labeled peptides. The size of
this effect depends on the mass distance between the labeled channels, peptide mass (as isotope
distributions get wider – see Figure 5.1), and peptide intensity [135].
Isotope widening, i.e., additional isotopic peaks in front of the theoretical monoisotopic peak,
in survey spectra cannot only be observed in MS1 labeling techniques but also in MS2 based
methods like iTRAQ. These additional isotopic peaks are observable in MS1 as isotope impurities
lead to non-isobaric reagents, skewing the isotope distribution and causing isotope peaks below
the theoretical monoisotopic peak of the peptide. Empirically, we observed that about 85% of all
identified features have at least one pre-peak (data not shown). Not surprisingly, the intensity
of a pre-peak is correlated with the intensity of the feature (correlation of ≈0.68 – data not
shown).
In general, labeling techniques – independent of their MS level – tend to underestimate
the true ratio. This effect has been described in the literature and is also true for iTRAQ in
particular [83, 12]. Usually, this effect is attributed to background signal, especially in highly
complex samples. See Subsection 5.3.5 for results on our iTRAQ data. The effect is more
pronounced when the isolation window is widened. Thus, a tradeoff between signal intensity
and signal contamination is required. Karp et al. [136] suggested to globally correct for ratio
underestimation by a linear factor. Bantscheff et al. [83] showed that using wide isolation
windows (2-5 Th) results in increased background signal from coeluting peptides, thus biasing
the iTRAQ reporter ion counts – usually towards a ratio of one in a complex mixture when we
assume that most peptides are not differentially regulated. To minimize this effect, the isolation
window should be narrowed as much as possible, which comes at the cost of sensitivity as the
reporter ion intensity will decrease due to fewer reporter fragments.
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iTRAQ (and other MS2 based techniques) usually require isotope correction of MS2 reporter
ions as the labeling reagents are not 100% isotopically clean. Using a correction matrix, isotope
impurity is removed via inverse matrix multiplication or, in our case, via non-negative least
squares (see Subsection 5.2.4). Isotope impurity also affects the MS1 level; signal congestion is
much less pronounced than in MS1 multiplex techniques, though.
Multi-experiment designs have difficulties with missing values as a missing MS2 scan cannot
be reconstructed from the data; for purely MS1-based methods, however, this is feasible. To
minimize this problem, extensive fragmentation with long gradients or inclusion lists can be
used. The latter require stable column conditions to allow for reproducible retention times.
5.1.3 Experimental Design
The following subsection closely follows and subsumes the work of Oberg and Vitek [137].
An experimental design describes the protocol that selects and allocates individuals to treat-
ment/disease groups and arranges the experimental setup in space and time, e.g., allocation of
iTRAQ channels, number of biological replicates, inference across multiple samples when m > n
(m = |samples|, n = |channels|) and has been researched extensively (e.g., [137]). Limited re-
sources of laboratories for sample preparation, instrument acquisition time and material cost
must be taken into consideration as well.
Three important aspects need to be considered, namely replication, randomization and block-
ing. Replication is the use of (biological) replicates, which allows to assess if an observation is
purely by chance and can help to determine if a difference is significant. See Figure 5.2 for an
example.
Figure 5.2: Importance of replication exemplified by experiments yielding identical mean ex-
pression values for each group. a) Experimental design without replication. It is impossible
to determine if the difference is significant. b) Replication with small intra-group variation,
indicating group difference. c) Replication with large intra-group variation, indicating no group
difference. This figure is inspired by Fig. 2 in Oberg and Vitek [137].
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What fold change is detectable is dependent on multiple factors, such as biological variation,
number of replicates and experimental conditions. Thus, no general answer on the number
of required biological replicates can be given. According to Noirel et al. [87], the fraction of
published studies on iTRAQ suggests that using replicates is becoming more and more popular
since replication is required for sound statistical conclusions.
Randomization helps avoid undesirable artifacts, e.g., instrument drift in time. This bias
occurs if all samples from treatment control are prepared or measured prior to samples from the
treatment group. Additional bias might occur if the instrument was cleaned or the LC column
exchanged after one group was measured. A highly cited article written by Petricoin et al. [138],
where experimental artifacts led to wrong scientific conclusions, prompted scientific concerns
[139]. In general this is known as confounding effect: the observed difference between groups is
(in parts) attributable to experimental conditions or other factors, rather than biological state.
Complete randomization aims to remove this bias. However, especially for a small number
of measurements, random sampling of the order of acquisition can also lead to unbalanced
allocations, e.g., most control samples before treatment samples. In this case a manual allocation
schema can be devised.
Blocking refers to measuring a specific subset of samples concurrently (or at least consecu-
tively in label-free settings). Such a subset constitutes a block. The underlying assumption is
that differences between samples can be assessed more effectively within blocks than between
blocks. As one is usually interested in differences between control and treatment groups, these
samples are blocked rather than blocking replicates of a single group. The size of the block is
determined by the labeling technique, e.g., iTRAQ allows for block sizes up to four for 4-plex
kits and eight for 8-plex kits. In a complete block design, every treatment appears in each block
(i.e., one LC-MS run). If the number of channels is larger than the block size, only a subset
can be allocated, leading to an incomplete block design. Alternatively, a reference design can
be used, i.e., a common (pooled) reference is assigned to one channel in every block, which
can be used as reference for intra-block normalization and comparison between blocks. A loop
design is similar to a reference design, but groups are systematically shuﬄed through each block.
Blocking and randomization can be combined into a block-randomized design where a member
of each treatment group is part of one block and the channels are allocated randomly in labeled
scenarios, or the order of acquisition within the block is randomized for label-free scenarios. A
randomized complete block design is the most robust against run failures and requires the small-
est number of runs, in contrast to a reference design where the reference channel is measured
multiple times, or the loop design where a run failure destroys the link between the preceding
and following block.
Of particular importance is a balanced design, i.e., every treatment should appear equally often,
and within a block, each two treatments should appear about the same number of times [140,
137].
Pooling is an attractive strategy to reduce the number of samples and thus the number of
runs, but has severe drawbacks. If all samples from one group are pooled, biological variability
cannot be assessed, hence determining a statistical difference is impossible. Furthermore, pooling
is particularly vulnerable to contaminated/outlier samples as the pool will be affected too.
However, in a reference design a pool might be useful as it allows to collect enough sample by
mixing and is a stable reference which contains all proteins from all groups, thus circumventing
the problem of infinite ratios, i.e., if a protein is present in a treatment sample but not in the
reference, the log ratio will not be computable and usually be lost in most software solutions.
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5.1.4 Existing Software for iTRAQ Data Analysis
In order to be suitable for our purposes, an analysis tool needs to provide multiple features – most
importantly and integrated analysis of multiple iTRAQ experiments which follow a designated
experimental design. Furthermore, it must be able to deal with centroided high-resolution data
from an LTQ Orbitrap XL instrument. Obtaining raw data from the instrument would be a
major bottleneck for file transfer and storage as data generation and data analysis sites are
located in different countries.
Existing software solutions usually provide methods for the analysis of a single experiment
only. The most common approach for the analysis of iTRAQ data is to force a design that uses
at most four (or in some cases up to eight) conditions and replicates, which avoids the need
for combining multiple iTRAQ experiments [141], but usually limits the answers that can be
given. The experimental design described above (Subsection 5.2.1) necessitates the combination
of technical and, optionally, biological replicates. The most popular tools are described below.
i-Tracker [28] requires raw, i.e., uncentroided data since reporter ion intensity is computed
using the trapezoid method and is limited to peptide level quantification; no protein level anal-
ysis is provided.
iQuantitator [142] is based on a Monte-Carlo-Markov-Chain approach and allows for almost
arbitrary experimental designs. Accordingly, it is theoretically applicable to the Predict-IV
design. The software is freely available for download and runs on Linux OS. Unfortunately,
beyond a few experiments, runtime and memory requirements become unfeasible. For three
experiments, the computation was stopped after 24 hours while using 12 GB of RAM. A minor
problem is that isotope correction is assumed to be already complete.
Multi-Q [143] only supports Mascot search results, or PeptideProphet/ProteinProphet re-
sults, which complicates the use of multiple search engines. During our tests, search results
from Mascot 2.2.4 and Mascot 2.3 yielded a fatal exception, probably because the tools’ latest
version from 2008 does not support the format. Also, the isotope correction matrix described
in the paper (see Eq. 1 therein) seems to promote false diagonal values. Diagonal values should
be computed as 1−∑p∈{−2,−1,+1,+2} kch,p (see Subsection 5.2.4 for details) instead of just set-
ting the diagonal to one. If isotope correction is implemented as described, the results will be
incorrect.
ProteomeDiscoverer, the native solution provided by the instrument vendor for Thermo in-
struments, cannot combine runs and is only commercially available. Furthermore, it suffers from
wrong isotope correction, as explained in Subsection 5.2.4.
An analysis of variance (ANOVA) approach described in [140] is computationally infeasible
for a study of this size, and even the approach described in the paper requires the stage-wise
fitting of parameters, which somewhat offsets the advantage of ANOVA to simultaneously fit
all model parameters. ANOVA models cannot deal with data heteroscedasticity, i.e., noise is
essentially multiplicative and varies with signal intensity. Additionally, the software is based on
the commercial SAS package and not readily available.
The isobar package [144] accepts input as Mascot XML file, mzIdentML, tab-separated
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Figure 5.3: Differentiation and treatment scheme for cells from IMU studies. Treatment is either
low dose, high dose or none (as control).
formats or directly via an R interface, permitting easy integration into an existing pipeline.
isobar also features a flexible R interface, noise models to account for data heteroscedasticity, and
statistically sound significance estimation for protein over- or underexpression, circumventing
ad hoc thresholds for fold changes.
5.2 Methods
The amount of data expected during the course of the project necessitates the deployment of
an efficient, adaptable and fast analysis pipeline. We thus decided to use the capabilities of
OpenMS/TOPP/TOPPAS to build a custom iTRAQ analysis pipeline, covering identification
and quantification, coupled with statistical analysis in R [145], an open source statistical software
package.
Here, we will describe our experimental design and the analysis pipeline. The latter fea-
tures multiple peptide identification engines, isotope correction via non-negative least squares,
exclusion lists, and isobar for the estimation of protein fold changes and p-values to determine
significant protein over- or underexpression.
5.2.1 Experimental Design for Predict-IV
Within the Predict-IV project it was decided that for all cell systems to be analyzed by pro-
teomics, three dosage groups are collected. A control group, not treated with a toxic compound;
a low dose group, receiving a mild dose; and a high dose group. The dose depends on the cell sys-
tem and toxic compound and is determined separately for each. To observe a time effect, three
harvesting points were agreed on, namely days one, three and fourteen after daily treatment
with the respective toxin. See Figure 5.3 for an overview of cell differentiation and harvesting
times for each dose and biological replicate cell sample.
Thus, in combination, this results in 3 × 3 = 9 groups, and therefore, a block size of nine
would be desirable if all conditions were to be compared to every other. Unfortunately, iTRAQ
does not offer blocks beyond four, or eight for the 8-plex kit. The latter is reported to yield
similarly stable results as the 4-plex version with the added advantage of larger block size [146].
However, the probability of an experiment failure due to contaminated sample or experimental
error increases when eight channels are used instead of four.
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The number of biological replicates is bounded by laboratory capacity. For the studies at
hand, three replicates are available. Enough material was delivered to allow for another three
technical replicates.
As the number of groups (nine) exceeds the block size of four, we decided to block by
concentration only, i.e., control, low dose, high dose. This allows to easily track changes in dose
response but makes analysis of time effects hard as time is not blocked. Blocking of time would
have resulted in one third of the experiments only containing control samples (i.e., day one,
three and 14 samples from control in one block), which can at best answer how control samples
evolve in time; this information is of limited interest, though. What is more, cells were grown for
several weeks before being allocated to control or treatment groups, thus the 14 day harvesting
period should not result in a change of protein expression in control samples. Without biological
or technical replicates, this results in three LC-MS experiments, one for each harvest time point.
Since three biological replicates are available per sample, they are distributed randomly across
different blocks, resulting in nine LC-MS experiments. To increase the coverage of the proteome
under investigation, three “technical” replicates were run for each iTRAQ mix. For details, see
Subsection 5.2.3.
As one channel is still unallocated, we decided to add a pooled reference as a fallback option
for later analysis of time series in addition to concentration series. The pool is created from
the 27 real samples (three timepoints, three dosages, three biological replicates) to ensure that
it contains all proteins and infinite ratios can be avoided. The pooled sample will always be
assigned to channel 117 as the iTRAQ labeling procedure is another source of variation, and
using the exact same sample avoids unwanted side effects and decreases laboratory overhead.
For channels 114 to 116, our design incorporates random channel allocation, i.e., random
assignment of samples to iTRAQ channels and thus tags, as a safety measure. However, re-
cent literature indicates that the tag effect is negligible and the direction of the effect is not
reproducible [136, 147, 148]. Thus a tag effect needs not be accounted for during data analysis.
An illustration of the design can be found in Figure 5.4.
5.2.2 Cell Growth and Data Acquisition
All cell cultures (human and mouse) were grown under control (C), low dose (L), and/or high
dose (H) conditions. One study (URO001) additionally used hypoxia (h) conditions (low oxygen)
to simulate complications associated with pre-damaged and compromised tissue. Cell samples
were analyzed by partners in Salzburg using an LTQ Orbitrap XL instrument operated in par-
allel mode. Survey MS scans were acquired in the Orbitrap between 450 and 2 000m/z at a
resolution of 60 000. CID spectra were acquired using the LTQ for identification, and corre-
sponding HCD spectra with the same precursor were acquired in the Orbitrap for identification
and quantification via iTRAQ. Samples were analyzed in triplicates in which peptides identi-
fied in a previous run were excluded from MS2 triggering using the exclusion list option in the
instrument software.
The raw data files were transferred from Salzburg to Berlin via file transfer protocol (FTP)
and fed into our analysis pipeline as described in Section 5.2.3.
5.2.3 Analysis Pipeline
We will now describe the workflow used to convert the raw mzML files from the mass spectrom-
eter to Excel sheets containing protein names, expression values for conditions, and significance
estimates. An identification/quantification workflow was implemented in OpenMS/TOPPAS,
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Figure 5.4: Experimental design for the analysis of 27 samples using iTRAQ. a) For each analyzed
compound, nine conditions comprising three dosages (control, low and high dosage) and three
time points are compared. For each condition, three biological replicates are produced, resulting
in 27 samples per compound. The proteomes of these samples are analyzed in nine 4-plex iTRAQ
experiments as listed in (b). A pool of all 27 samples (P27) is used as reference and ensures
high comparability between ratios across runs.
statistical analysis was done using the isobar package [144] and custom R code. In short, quan-
tification is based on iTRAQ reporter ions extracted from HCD spectra. Reporter intensities
are isotope-corrected using a non-negative least squares procedure. Peptide identification uses
separate searches for CID and HCD spectra on multiple search engines (X!Tandem, OMSSA,
Mascot) and subsequent ConsensusID [82] scoring with FDR filtering at 5%, using a decoy
database approach. HCD and CID spectra are searched in separate runs to allow for optimized
search parameters in terms of mass tolerances, for HCD spectra are acquired in the Orbitrap
with high mass accuracy whereas CID spectra are acquired in the IonTrap at low accuracy. Split
searching reduces false positive hits in HCD spectra due to more restrictive mass tolerances, thus
increasing the number of identifications after FDR filtering (data not shown). However, too nar-
row precursor tolerances will lead to an increased FDR as the reliability of the scoring is reduced
due to fewer candidates [149, 150].
We use UniProtKB [151] as database because it is actively maintained and provides stable
identifiers [152]. Depending on the cell type, the corresponding species-specific database is used
and concatenated with the common Repository of Adventitious Proteins (cRAP)1 to ensure
common contaminant peptides are identified, thereby reducing false positives. To control the
false positive rate, we employ a decoy database which is created by reversing each sequence of
the above database. The search is done with target and decoy database concatenated.
Channel normalization is based on median-of-pairs normalization. Protein ratios are com-
puted from unique peptides after outlier elimination using a weighted average based on peptide
noise level. Using only unique peptides, i.e., peptides matching only a single protein, will avoid
skewed results from (homologous) proteins. Here, uniqueness is defined in the realm of the
database, i.e., the whole known proteome of the respective species (human or mouse), in ad-
1http://www.thegpm.org/crap/index.html
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Figure 5.5: TOPPAS workflow to process raw mzML files as acquired by the instrument, result-
ing in Excel spreadsheets containing lists of identified and quantified proteins with significance
values attached. Entrez gene IDs are queried via BioMart based on protein identifiers.
dition to common contaminants (see above). Significantly over-/underexpressed proteins are
reported using a p-value threshold of 0.05.
Entrez gene IDs are queried via a BioMart R package [153] based on protein identifiers in
order to ease downstream analysis for transcriptomics and proteomics data integration.
The workflow (see Figure 5.5) was modeled in TOPPAS and is executed with all 27 input
files from one study.
Labeling Efficiency
MS2 spectra without iTRAQ reporter ions cannot contribute to the final protein ratio compu-
tation. Those spectra are thus lost for quantification, even if they can be identified. Missing
reporter ions can have multiple causes, e.g., the amount of sample was not sufficient, wrong
precursor selection (e.g., noise peak), failed iTRAQ labeling, etc.
Therefore, labeling efficiency, i.e., the relative fraction of iTRAQ spectra in which a reporter
ion signal is present in any channel, can be used as a criterion for data quality.
If labeling efficiency is to be determined for a specific channel chx, the presence of reporter
ion signals should be evaluated after isotope correction, since isotope impurities can lead to
the presence of noise signals in neighboring channels. When truly no peptide is present in
channel chx, this noise must be accounted for, as chx would be counted as occupied otherwise.
In comparison to a complete identification run (usually with multiple search engines), labeling
efficiency can be computed very quickly because the algorithm solely needs to quantify the
iTRAQ signals.
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Exclusion List
With the current generation of instruments for LC-MS/MS employed in shotgun proteomics,
not all coeluting peptides at a given retention time are selected for MS2 during data-dependent
acquisition (DDA) as spectral acquisition is too slow and not sensitive enough for very low
abundant peptide species [154].
This leads to an undersampling problem that includes a random component as technical
replicates are not completely identical in terms of chromatography conditions, amount of sample,
and other confounding factors.
As shown in multiple publications, pure technical replicates lack reproducibility to varying
degrees, depending on the platform and sample complexity [9] in terms of peptide and protein
coverage as obtained from DDA in MS2. The degree a protein list varies is usually smaller
than the peptide list. Protein list overlap of 70-80% is common [57]. Nevertheless, technical
replicates can be used to increase the protein coverage by relying on semi-random DDA sampling
in high complex samples. However, many peptides, especially the highly abundant ones, are
typically sampled in all replicates, thus wasting acquisition time. Also, FDR on the protein
level will increase since false (random) identifications tend to be unique across runs whereas
true identifications target the same protein in multiple runs [57].
For achieving a wider coverage of the proteome, a common method is to employ exclusion
lists. Peptides identified in previous runs are not considered for acquisition in subsequent runs
under the same technical conditions. As shown by Wang and Li [154], different exclusion strate-
gies are possible. Adding retention time windows, for example, increases the number of identified
proteins.
The Thermo software supports exclusion lists with some restrictions. Precursor positions of
peptides identified in previous runs can be used to generate exclusion windows with a certain
RT range. The m/z position is taken directly from the precursor. We call this single-charge
exclusion.
However, using ESI, one peptide will have multiple charge variants (charge two and three are
the most common), which are likely to be targeted in subsequent runs but will not contribute
to identifying more peptides and proteins. See Figure 5.6 for a distribution of the number of
charges a peptide was observed in, i.e., was identified by MS2. Thus an overhead of up to
≈25% for targeting a charge variant of an already identified peptide can be expected when using
single-charge exclusion. This data was derived from single LC-MS runs without exclusion lists.
Thus, during ESI, no dynamic exclusion of charge variants is performed by the instrument. This
is unfortunate as it leads to overhead, but using multi-charge exclusion (i.e., excluding other
potential charge variants of the observed peptide), it is possible to avoid reacquisition in the
next run. Exclusion of charge variants can unfortunately not be incorporated into the Thermo
solution. We thus devised an OpenMS-based tool called InclusionExclusionListCreator, which
allows to increase coverage by using exclusion lists accounting for charge variants.
For every technical replicate run, exclusion lists derived from all previous runs are computed
and used during acquisition. We use the same identification pipeline that is used for the final
analysis, including multiple search engine identification via ConsensusID [82] and FDR filtering.
This strategy allows for a reacquisition of peptides with marginal scores as well as unidentified
spectra.
The tool was tuned for usage with LTQ Orbitrap devices, which have certain restrictions
on the exclusion data. For example, the exclusion windows are not allowed to overlap in m/z,
and only a certain number of windows are allowed to overlap in RT (over the whole m/z range)
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Figure 5.6: Distributions of the number of charges a peptide was identified in based on MS2
data of IMU006. Multiple empirical distributions are shown, each one from a single LC-MS
experiment where no exclusion list was used.
at any point in time. To resolve this issue, we use a hierachical clustering approach to merge
overlapping windows after generating the exclusion list.
5.2.4 The ITRAQAnalyzer Tool
We implemented a new TOPP tool named ITRAQAnalyzer, which is capable of quantifying
reporter ions in MS2 spectra for 4-plex and 8-plex iTRAQ experiments.
As input, an mzML file must be provided. The output format is the OpenMS format
consensusXML, which can be easily converted into a text file readable by statistics packages
and/or Excel using the TextExporter TOPP tool.
Quantification is achieved by summing ion intensities at the expected reporter positions (e.g.,
114.11123m/z (monoisotopic) for channel 114) while allowing for a user definable mass delta, as
reporter peak position depends on instrument precision and accuracy. Within this m/z interval,
all peak intensities are summed up. Due to the flexible design of TOPP it is also possible to use
a peak picker prior to ITRAQAnalyzer, but it is usually not necessary. Data for Predict-IV is
retrieved from the instrument in centroided format.
ITRAQAnalyzer also supports normalization of each channel by a factor using median of
ratios (see Subsection 5.2.5 for more details).
Isotope Correction via Non-Negative Least Squares
iTRAQ reagents cause the transfer of signal from one channel to neighboring channels on either
side due to reagent impurities affecting the mass of the iTRAQ tag (see Figure 5.1 for an
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Table 5.1: Default isotope correction table for 4-plex iTRAQ. The values at offset 0 were inferred
by computing 1 −∑p∈{−2,−1,+1,+2} kch,p. For simplicity we report values in percent instead of
relative frequencies.
mass offset
channel -2 -1 0 +1 +2
114 0.0 1.0 92.9 5.9 0.2
115 0.0 2.0 92.3 5.6 0.1
116 0.0 3.0 92.4 4.5 0.1
117 0.1 4.0 92.3 3.5 0.1
Table 5.2: Default isotope correction table for 8-plex iTRAQ. The values at offset 0 were inferred
by computing 1 −∑p∈{−2,−1,+1,+2} kch,p. For simplicity we report values in percent instead of
relative frequencies.
mass offset
channel -2 -1 0 +1 +2
113 0.00 0.00 92.89 6.89 0.22
114 0.00 0.94 93.00 5.90 0.16
115 0.00 1.88 93.12 4.90 0.10
116 0.00 2.82 93.21 3.90 0.07
117 0.06 3.77 93.29 2.99 0.00
118 0.09 4.71 93.32 1.88 0.00
119 0.14 5.66 93.33 0.87 0.00
121 0.27 7.44 92.11 0.18 0.00
example). A table can be constructed which lists the relative amount of signal that is lost to
the two immediate neighboring channels.
Default isotope correction tables for 4-plex and 8-plex kits are provided but can be changed
by the user. Table 5.1 and 5.2 give an overview of the defaults in ITRAQAnalyzer. kch,p denotes
the relative loss in channel ch to position p, p ∈ {−2,−1,+1,+2}. The 8-plex table was obtained
directly from AB Sciex2. The 4-plex table is taken from the Certificate of Analysis provided
with all 4-plex iTRAQ kits. Both matrices are stable (personal communication with AB Sciex
support); thus, modifying the defaults should not be required.
Isotope impurity will not lead to excessive loss of signal for the respective channel, i.e.,
loss < 8% (see Tables 5.1 and 5.2) but might cause severe signal gain in neighboring channels,
which should be corrected. Table 5.3 provides an example where failure to correct for isotope
impurity results in a peptide ratio of ≈1:24, whereas the true ratio is 1:100. As this can happen
for high reporter ion intensities, no noise model will be able to correct for this. Thus, isotope
correction should always be applied.
Almost all iTRAQ software packages available are capable of isotope impurity correction.
Some ignore the problem and expect isotopically corrected values, e.g., iQuantitator [142]. There
are two solutions for isotope correction we are aware of, which we will describe in the following.
To ease reading, we will use bold letters for vectors, bold capital letters for matrices, and plain
2http://www.absciex.com/Documents/Support/AB SCIEX Question and Answer.xls
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Table 5.3: Isotope impurity example resulting in skewed ratios.
channel 115/116
condition 114 115 116 117
real 0.00 100 10 000 0.00 1:100
observed 2 392 9 246 450 1:24
Table 5.4: Construction of the matrix A used for isotope impurity correction where f(ch) =∑
p∈{−2,−1,+1,+2} kch,p.
A =
1− f(114) k115,−1 k116,−2 0
k114,+1 1− f(115) k116,−1 k117,−2
k114,+2 k115,+1 1− f(116) k117,−1
0 k115,+2 k116,+1 1− f(117)
letters for scalars. The solution used by the majority of open source software packages is to
simply solve
Ax = b, (5.1)
where A is an n × n isotope correction matrix, b ∈ Rn is the vector of observed reporter
intensities (also called raw intensity values), and x ∈ Rn is the isotope-corrected solution. We
denote this method as the naive approach.
A can be computed from the isotope impurity table given in the Certificate of Analysis as
provided by the supplier AB Sciex. See Table 5.4 for its construction for 4-plex iTRAQ. The
procedure is similar for the 8-plex case.
As a negative peptide abundance is not possible, negative intensities in x are subsequently set
to zero, i.e., reporters are treated as “not observed” or “ignored”. Software packages which use
this strategy include IsobariQ [155]3, isobar [144]4, and Multi-Q [143]. In Mascot [76], negative
ratios are flagged and not used for quantification.
The second method used by Thermo in the ProteomeDiscover software (version 1.2) yields
rather different results. The algorithm employed is unknown, but we could reproduce consistent
underestimation (about 8%) of reporter intensities when compared to the non-negative least
squares (NNLS) and naive approach across all spectra we examined from one experiment. We
only have Thermo isotope correction data available where NNLS (see below) and naive solution
are identical. See Table 5.5 for an example.
The constant overestimation points to the fact that the algorithm used by Thermo is also
a matrix inversion, as described above, but with different matrix values. We implemented a
proper naive approach using diagonal values of 1 −∑p∈{−2,−1,+1,+2} kch,p to reflect the loss of
native ions of channel ch to neighboring channels. If we substitute the diagonal values from the
matrix of the naive approach with entries of 1, the solutions are exactly the same, i.e., the ratio
is one for all channels. Thus we conclude that the Proteome Discoverer software uses a wrong
correction matrix A.
We propose a third method, non-negative least squares (NNLS), to correct for isotope im-
purities. Our approach solves
3Treatment of negative intensities as zero is not explicitly mentioned in the paper [155], but can be found in
the source code (version 1.2) available from http://folk.uio.no/magnusar/isobariq/files/IsobariQ 1.2 source.zip
4Negative intensities are ignored altogether, excluding them from protein ratio computations.
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Table 5.5: Thermo isotope correction result of one arbitrary MS2 spectrum compared to the
NNLS/naive solution. The ratios between the Thermo solution and NNLS are stable for all
examined spectra.
channel
intensity
ratio
Thermo NNLS/naive
114 3 253 3 500 1.076751
115 5 456 5 904 1.080432
116 5 854 6 329 1.082083
117 4 292 4 651 1.084052
min ||Ax− b||2, (5.2)
with the constraint x ≥ 0. A and b are the correction matrix and the raw reporter intensities
as in Equation (5.1). If the solution to Equation (5.1) is positive the NNLS solution is identical;
if it yields negative values, the results will differ.
5.2.5 Protein Ratio Computation
Published papers on iTRAQ dedicate different amounts of effort to describing and carrying out
protein ratio computations and a statistical analyses to determine whether the observed changes
are significant. About 50% of all studies choose arbitrary thresholds like 1.5 as fold-change
cutoffs [87]. However, statistical modeling which provides a p-value is a desirable approach [148].
To properly analyze our data, we use a combination of in-house R code and the isobar
package [144], also implemented in R. Even though isobar cannot combine multiple iTRAQ ex-
periments, it offers the most flexible interface with a sound statistical for protein quantification
and significance estimation approach, allows for a very high degree of automation, and is suffi-
ciently fast, i.e., data from 27 experiments can be analyzed in about 15 min after identification
and quantification results from our TOPPAS pipeline are exported in a comma-separated values
(CSV) format readable by R.
Due to sampling bias of highly abundant peptide species in data-dependent LC-MS experi-
ments, simple global normalization is not advisable for MS1-based methods, as pointed out by
Wang et al. [156]. As abundance in MS is cumulative over all channels when using iTRAQ,
global normalization is feasible here. Normalization using matched pairs, which are available
at no cost in iTRAQ-type experiments, is a viable strategy as well. Both yield similar results
(data not shown), and we use median of ratios for normalization across channels to correct for
different amounts of sample loaded between channels. The rationale behind normalization is
the assumption that most proteins in a sample are not regulated [157], and that thus a global
offset should be corrected. The model is fairly simple, yet avoids overfitting of data as we do
not know the extent of proteomic changes induced by the toxic compounds. The laboratory
will usually ensure that protein concentration in each iTRAQ channel is equal by determining
protein concentration using a Bradford assay, but no mixture can be expected to be a precise
1:1 mix [157]. Hence normalization is advisable, in order to remove the systematic shift. We
use all iTRAQ spectra where reporter ions are present, even if no identification is available, as
this increases the number of pairs and allows for a more robust estimation. After normalization,
three technical replicates acquired using exclusion lists (as described in Subsection 5.2.3) are
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combined.
isobar is then used to compute protein ratios for control versus low dose and control versus
high dose conditions for each harvest time point. In detail, protein ratios are computed based
on all unique peptides (as filtered in TOPPAS pipeline) and weighted by signal strength, which
ensures that ratios from high-abundant peptides receive more weight as they are less influenced
by noise. Weighting is not only applied in iTRAQ workflows but also in other labeling techniques
such as SILAC [93]. The following formulas used by isobar to compute protein ratios and p-
values are taken from the paper by Breitwieser et al. [144] and its Supplemental Material with
minor notational modifications. A protein log ratio is computed as
c(pi) =
∑
j∈S′i
αi,jc(si,j), (5.3)
where c(pi) is the protein log ratio for protein i; S
′
is the set of identified, non-outlier peptide
ratios for protein i; c(si,j) is the log ratio of peptide j belonging to protein i identified from
spectrum s, and αi,j = k ·βi,j with k as scaling factor such that
∑
j αi,j = 1. A peptide log ratio
is computed as
c(si,j) = log(Ich2,i,j/Ich1,i,j). (5.4)
Finally βi,j = 1/V ar(c(si,j)) = 1/(n(log(Ich1,i,j)) + n(log(Ich2,i,j))). ch1 and ch2 represent
the channels, i.e., ch1, ch2 ∈ {114, 115, 116, 117} (for 4-plex iTRAQ). Ich,i,j is the abundance of
a given channel ch, for protein i, with peptide j.
The noise function n() is computed as
n(x) = a+ re−λx, (5.5)
with x as the signal log intensity and a, r, λ as parameters estimated from a dedicated 1:1
experiment (see Subsection 5.2.5). The final noise model is an average over all noise models
from channel pairs deemed of high quality.
Weighting peptide ratios is important since low intensity ratios exhibit more variance due to
noise. High abundance ratios are thus more stable and should receive more weight [136, 144].
Protein ratio variance Var(c(pi)) is determined as
Var(c(pi)) = max(Varestim,i,Varspectrum,i), (5.6)
where
Varestim,i =
1∑
j βi,j
, (5.7)
and
Varspectrum,i =
∑
j βi,j
(
∑
j βi,j)
2 −∑j β2i,j
∑
j
βi,j(ci,j − c(pi))2. (5.8)
The reason for using max() in (5.6) is that Varestim,i can become very small if a pro-
tein has many peptides; thus, the overall sample variance is taken as fallback (see isobar
paper for details). Varspectrum,i is not computable if only one spectrum is available; thus,
Var′spectrum,i = (Varestim,i)0.75 is used as heuristics. Likewise, for two spectra, Var
′
spectrum,i =
max(Varspectrum,i,Varestim,i)
0.75 is used.
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To determine if a protein is differentially expressed, a Cauchy distribution is fitted to the
global protein ratio distribution. Per default, a 5% cutoff is selected where proteins are deemed
significantly over-/underexpressed. This avoids the need for an arbitrary fold change cutoff as
the model adapts to the data naturally.
Additionally, we augment the results with an Entrez Gene ID mapped from the given Swiss-
Prot identifier to ease linking of transcriptomics results later on. We also determine the average
expression ratio from up to three biological replicate measurements and the number of times
a protein was deemed significantly over-/underexpressed by isobar in each dose versus control
scenario.
Noise Model
In isobar it is possible to compute a noise model which determines the weight of a peptide ratio
when computing the protein ratio. Ideally, the model is derived from a dedicated experiment with
1:1:1:1 channel allocation, measured on the same instrument as the real samples. Alternatively it
is possible to derive a model from study data if channel conditions are similar. All data is isotope-
corrected beforehand. We tested three different models, two from dedicated 1:1 experiments
and one derived from study data, and found them all to be very similar. See Figure 5.7 for a
comparison. They all yield almost exactly the same list of significantly expressed proteins (data
not shown). However, care has to be taken as experimental errors can severely alter the model
– see Figure 5.8 for an example.
In the published version of isobar, normalized reporter intensities are used for creating and
evaluating the noise model. As normalization can alter reporter intensities quite significantly, we
suggest to use raw reporter intensities instead of normalized intensities since noise is a property
of the instrument. We obtained and used a version of isobar which supports this strategy.
5.2.6 Our Contribution
In some areas it might not be explicitly clear where our contribution starts and ends. We use
this section to clarify the details. We conceptualized and implemented the ITRAQAnalyzer tool
as well as the custom R scripts (for combining multiple biological and technical replicates and
wrapping isobar), and extended/rewrote TOPPAS to support the workflow required for this
project (in terms of pipeline design restrictions, parallel execution, “dry run” functionality, and
input recycling). We constructed the analysis pipelines for the exclusion list workflow as well as
the iTRAQ identification and quantification workflow, including parameter tuning and fixing of
contributing TOPP tools (e.g., PeptideIndexer to deal with ambiguous amino acids). We helped
write the InclusionExlcusionListCreator and extended it to support restrictions on exclusion lists
of the Thermo instrument software. We had fruitful discussions with the developers of isobar,
who implemented the modified noise model scheme.
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Figure 5.7: Three noise models from 1:1 noise experiments with cells from NUI002 study (red)
and IMU006 (blue), and real data from IMU006 (green). All channels were used, except 117 in
NUI002.
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Figure 5.8: Noise model averaged over all channels from 1:1 experiment in NUI002 study, with
channel 117 only having 10% intensity of the others.
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Table 5.6: Overview of Predict-IV studies analyzed.
study name species (organ) toxic compound conditionsa spectrab qtfy. proteins
IMU002 human (kidney) cyclosporin A C, L, H 238 818 945
IMU006 human (kidney) cyclosporin A C, L, H 389 614 2 642
IMU007 human (kidney) ifosfamide C, L, H 519 822 3 656
NUI002-A human (kidney) adefovir C, L, H ?c 2 160
NUI002-Hyp-A human (kidney) adefovir C, hC, hL 258 222 2 210
NUI002-Hyp-Z human (kidney) zoledronate C, hC, hL 198 098 1 575
URO001 mouse (brain) cyclosporin A C, L, H 330 321 1 674
aC: control, L: low dose, H: high dose, h: hypoxia
btotal number of MS2 spectra of all 27 LC-MS maps, HCD and CID each contributing 50%
craw data not available
5.3 Results
We analyzed multiple studies from the Predict-IV project and demonstrated properties of iTRAQ
data, some of which have already been shown in the literature and some of which are novel. We
also use this data to show the performance of our algorithmic approach in order to maximize
information gain in terms of quantification and identification results.
An overview of the data analyzed can be found in Table 5.6. Identification and quantification
performance varied greatly between studies. Especially initial studies suffered from errors during
iTRAQ labeling. Also, insufficient amount of protein material occurred sporadically. Both
affected the number of identifiable/quantifiable proteins.
5.3.1 Labeling Efficiency
We evaluated labeling efficiency and compared it to the number of identified peptides. Data
from a preliminary study and third-party iTRAQ data (not shown) suggested that a labeling
efficiency of ≈80% is feasible.
IMU002 yielded a rather small result set due to errors during iTRAQ labeling (see Table 5.6).
Therefore, the entire analysis, starting from cell growth, was repeated as IMU006, yielding about
thrice as many quantifiable proteins.
To elucidate if labeling efficiency can serve as a quality control measure, we compare the
number of identified peptides (after FDR filtering) with labeling efficiency, which can be com-
puted very quickly (see Figure 5.9). In most cases, labeling efficiency is good at ≈80%, and
peptide count only slightly declines for subsequent replicate runs with exclusion list. When
labeling efficiency is very poor (< 50%), no peptides can be identified. This is the case for two
samples from IMU006, where protein content was not sufficient for a third technical replicate
run. Labeling efficiency of IMU002 is poor in general as already reflected by the number of
quantifiable proteins (cf. Table 5.6).
Thus, labeling efficiency can be used to exclude low quality data sets from further time-
consuming analysis. We note that the TIC on the MS level is not indicative of labeling efficiency
(data not shown).
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Figure 5.9: Labeling efficiency vs. the number of identified peptides uniquely matching a single
protein after FDR filtering. Each point represents one LC-MS experiment from either IMU002
(inside dashed rectangle) or IMU006 (outside dashed rectangle).
5.3.2 NNLS Isotope Impurity Correction
We now motivate why NNLS isotope impurity correction is superior to naive inverse matrix
multiplication. Theoretically, the absolute difference between Equation (5.1) and (5.2) can
become arbitrarily large, e.g., consider b = {1e5, 0, 1e3, 0} and A as in Table 5.4. Due to the
nature of A, we get
xnaive = {107 792,−6 932, 1 271,−54}
xNNLS = {107 209, 0, 626, 0}
for the naive and NNLS approach respectively. Note that we report the immediate results
of the inverse matrix multiplication directly. We do not set negative intensities to zero to show
the implicit error made by the naive approach.
The difference becomes more pronounced the more diverse we chose the entries for i114 and
i116. When b1 is large enough, x3 will become zero for NNLS, but will increase for the naive
approach. For example, for b = {1e7, 0, 1e3, 0} we get
xnaive = {10 779 110,−689 658, 19 557,−206}
xNNLS = {10 720 973, 0, 0, 0} .
A realistic input might be b = {100, 0, 1, 0}, giving
xnaive = {108,−7, 1.27,−0.05}
xNNLS = {107, 0, 0.63, 0} .
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Figure 5.10: Relative frequency of HCD MS2 spectra from all data sets from two studies which
have one or more intermediate negative reporter intensities during isotope correction.
As can be seen, in relative terms, the difference for i116 is about 2:1. Ratios between i114
and i116 would thus yield very unstable results. Fortunately, most software packages use outlier
filtering and/or take reporter intensity into account by using a noise model where low intensities
receive a low weight for the protein ratio computation.
Also note that any spectra with just one reporter channel present will result in the naive
approach predicting two non-zero channel intensities. One at the initial non-zero position chx,
the other at the next but one reporter position chy (|chx− chy| = 2), which we call a ghost peak.
NNLS will only report the initial position chx as non-zero. For example, take b = {0, 0, 1 000, 0},
giving
xnaive = {1,−35, 1 087,−53}
xNNLS = {0, 0, 1 079, 0} .
In terms of least squares, our solution is more appropriate and not ad hoc as negative values
need not be set to zero, and it does not suffer from ghost peaks.
The reason for obtaining negative intensities is most likely due to noise affecting the reporter
ions. As noise is not accounted for beforehand, the naive solution can yield negative results.
Figure 5.10 shows the relative frequency of all HCD MS2 spectra which have one or more
intermediate negative intensities when using the naive solution. This statistic is provided by
default by our ITRAQAnalyzer tool for each data set. Studies can be grouped very efficiently
by this measure alone (similarly to labeling efficiency – see above). Thus, for high quality data
as in IMU006, we can expect ≈20% of spectra to show this behavior (except for two outlier data
sets where injection volume was insufficient); for low quality spectra with poor iTRAQ labeling
as in IMU002, the values are between 30-68%.
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Figure 5.11: Median raw reporter abundance of spectra where at least one negative intermediate
reporter abundance occurred vs. all spectra, as observed in one IMU006 data set. Negative
intensities are prevalent in spectra where raw abundance is low.
This suggests that mostly low-abundance spectra and/or badly labeled spectra are affected.
We found that the total ion count (TIC) is not indicative of this behavior, as for both studies
of IMU002 and IMU006, the TICs are comparable. However, there is a big difference (approx-
imately ×5) in the median of reporter ion intensities between the studies, which points to an
error during iTRAQ labeling (data not shown).
For spectra with low reporter counts (e.g., due to bad labeling efficiency or simply low
abundance of the fragmented peptide), one can expect that some channels have zero as raw
intensity. This will inevitably lead to different results of the naive versus NNLS solution as
according to the isotope correction matrix for any channel i with abundance bi > 0, every
neighboring channel should have a positive intensity. If the neighboring channel has raw intensity
zero, inverse matrix multiplication will correct this to a negative value. Figure 5.11 confirms
this hypothesis. Data for other data sets are similar (not shown).
The missing peak (with low expected raw abundance) can be explained by the lack of sen-
sitivity of the instrument or too stringent internal noise filtering algorithms. Given that the
isotope correction table is correct, the solution of NNLS is thus more realistic since it implicitly
takes the missing values into account.
We found unusually high ratios in iTRAQ data, which was corrected using the naive method.
For the 1:1 mix used as part of the noise model estimation, we obtain more extreme ratio
distributions using the naive method than with NNLS. In the naive method, ratios go up to
1:8 914, whereas for NNLS, the maximum ratio is 1:312. For an overview of ratios, see Figure 5.12
with dependence on abundance. The outlier ratios for the naive approach are clearly visible. Due
to the nature of the naive approach, certain ratios occur more frequently, visible as horizontal
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Figure 5.12: Zoomed view of reporter abundance (maximum of two values used for ratio) vs.
the resulting ratio after isotope correction. For convenience, if the ratio x:y is below one, we
show the ratio y:x such that only ratios larger than one are plotted. Left) Correction via naive
method. Right) Correction via NNLS method.
traces in Figure 5.12.
NNLS yields a different solution for about 20-68% of the spectra (see Figure 5.10), depending
on data quality. Differing solutions are predominantly observed in low-intensity spectra. Similar
to labeling efficiency, the fraction of conflicting solutions between naive and NNLS approach can
be used as a data quality criterion, i.e., a spectrum with diverse solutions to isotope correction
is most likely suffering from lack of instrument sensitivity. Fortunately, low intensity reporter
ions are usually weighted down when protein abundance ratios are determined, for example, by
using a noise model. However, to our knowledge, all noise models published to date estimate
their parameters after isotope correction has been performed [158, 159, 144]. If the instrument
was truly sensitive in the low-intensity range, however, we would expect small intensity values
(due to isotope impurities) in the raw data instead of zero intensity values. Reasons for the
absence of the peak are unknown, but as the data was acquired on an Orbitrap, limited trap
capacity or acquisition time could play a role.
To summarize, in contrast to the naive method, NNLS does not create ghost peaks and
reduces the need for outlier detection since no extreme ratios are generated; ratios where zero-
intensities are involved are usually handled by all quantification approaches correctly by being
excluded from further computations.
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Figure 5.13: MA plots of three random experiments from the IMU006 study. The upper plots (a,
c, e) show MA plots of intensity values before normalization, the bottom plots (b, d, f) show the
intensity values after normalization. Channel 114 was used as reference channel. Color-coded
ratios of channel 115 (blue) and channel 116 (red) shown.
5.3.3 Normalization
We used median-of-ratios normalization to correct for global bias in protein amount. To check
the result visually, we use an MA plot (minus versus average plot) where M = log2(Ich1)) −
log2(Ich2) and A = (log2(Ich1))+log2(Ich2))×0.5. For normalized data we expect the majority of
points on the y-axis to be located at 0 (= log(1)) with no noticeable dependency on the intensity
(x-axis). Results for three random experiments from IMU006 are shown in Figure 5.13.
The distribution of normalization factors for IMU006 is shown in Figure 5.14. The most
extreme factor was 2.64, which shows that normalization is absolutely critical to avoid wrong
protein quantification values. Reasons for deviation from the expected 1:1 mixture are manifold
and include pipetting errors, lack of sensitivity of Bradford assay and incomplete labeling.
As a consistency check, we compared the normalization factors of all three technical replicates
as the sample mixture is identical for all three data sets. The normalization factors are almost
identical for all data sets we examined (data not shown).
5.3.4 Proteome Coverage
Exclusion List
We compare the number of proteins identified from a list of FDR-filtered, unique peptides for two
data sets, namely IMU002 and IMU006. The former was acquired using the built-in exclusion
functionality of the Thermo software, the latter using our exclusion list approach as described
in Subsection 5.2.3.
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Figure 5.14: Histogram of normalization factors for IMU006. The most extreme factor is 2.64.
Figure 5.15 shows the gain in the number of identified proteins in the second and third repli-
cate measurement with cumulative exclusion list. The first measurement is always performed in
DDA mode without exclusion. For both methods the gain is about 27% for the second replicate
and 44% for the third, when compared to the first initial measurement. Unfortunately, there is
no common data set where both approaches were applied; thus, it is very hard to assess which
performs better.
With the data at hand, it is possible to compute the gain in the number of proteins for bio-
logical replicates without exclusion lists from the first technical replicates, which were acquired
using pure DDA. Note that the exclusion list approach uses technical replicates and thus has no
biological variation. Using biological replicates without exclusion will most likely trigger DDA
acquisition to focus on different proteins as expression values vary between biological replicates.
Using only the first technical replicate from each of the nine iTRAQ samples, we obtain three
groups with three LC-MS experiments each. As the order of evaluation can play a significant
role, we use the mean of all permutations of the group in order to estimate the gain in protein
numbers. Results are superimposed in Figure 5.15 for studies IMU002 and IMU006. Perfor-
mance of this pure-DDA approach is comparable to both exclusion list approaches. Even though
biological replicates should favor a deeper sampling of the proteome compared to technical repli-
cates, the gain (if any) of exclusion lists is much smaller than expected.
We investigated the overlap of identical peptide identifications between subsequent runs using
exclusion lists. The results are shown in Figure 5.16.
Evidently, masses and retentions times which were present on the exclusion list were never-
theless selected for fragmentation. We conclude that the instrument software was either miscon-
figured during acquisition and/or ignored the provided exclusion list. This phenomenon is not
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Figure 5.15: Gain in protein count for Thermo exclusion lists (without charge exclusion) and
OpenMS exclusion lists (with charge exclusion). Performance without usage of exclusion list
(circles) computes the gain in the number of proteins from three pure-DDA experiments of the
same data set.
112 CHAPTER 5. ITRAQ BIOMARKER DISCOVERY
Figure 5.16: Offset in RT of identical peptides between replicate measurements for IMU002
(left) and IMU006 (right) for all replicates. IMU002 uses native Thermo exclusion lists whereas
IMU006 uses our approach. The red boundaries mark the RT window which is (theoretically)
excluded from fragmentation, i.e., in the area between the boundaries no points are expected if
exclusion were perfect. Nevertheless, within the red boundaries multiple traces can be identified
in both studies, each trace representing one replicate experiment.
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Figure 5.17: Euler diagram of the identified protein sets of six Predict-IV studies, each compris-
ing 27 LC-MS experiments. The total number of unique proteins per study is reported in yellow
labels. The size of overlapping regions is proportional to number of proteins common to the
respective studies. The intersection of all studies contains 369 proteins (yellow striped region).
In total, 6 549 unique proteins were identified.
restricted to the exclusion list we generated for IMU006, but is also apparent in IMU002 where
native Thermo exclusion lists were used.
Based on this data we cannot prove our method to be superior as there is no common data
set where precursor exclusion was successfully carried out. However, based on the statistics
shown in Figure 5.6, our approach should reduce redundancy by about 20% compared to the
native approach.
Studywide Overlap
In addition to investigating the gain in protein identifications due to technical/biological repli-
cates, we looked at the overlap of protein lists between studies in order to assess the coverage
of the whole proteome of the respective cell systems. Results from literature indicate a possible
range of approximately 20 300 to approximately 83 800 proteins resembling the human proteome,
but this figure does neither take into account the unknown extent of pseudogenes, nor alternative
splicing or cell type specific expression [160]. The UniProt database has a size of 35 230 proteins
(including predicted).
See Figure 5.17 for an Euler diagram of six human renal proximal tubular cell (RPTEC-
TERT1) studies. The intersection of protein lists from all studies contains 369 proteins, the
union contains 6 549 unique proteins. This number is far below the most modest estimate of
proteome size and illustrates that full proteome coverage is not easily achievable due to various
reasons, such as limited acquisition speed and dynamic range of instruments [161].
The overlap can be expected to further decrease with increasing numbers of studies – a
common property of the stochastic data-dependent acquisition strategy that was used. Once
candidate proteins with expression values indicative of the condition have been identified, tar-
geted proteomics methods, e.g., multiple reaction monitoring (MRM), can be employed for
validation.
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Figure 5.18: Histogram of protein masses from IMU007 study vs. the entire human UniProt
database.
Protein Length Bias
We compared the weight of proteins identified in the IMU007 study to all proteins in the UniProt
database (35 230 proteins). IMU007 was chosen because this study features the highest number
of proteins identified. Results (cf. Figure 5.18) show a small trend towards the identification of
lighter proteins. A preference of heavier proteins cannot be observed (as reported in [148]), but
as our sampling strategy favors highly expressed proteins, the expression pattern is probably
the determining factor for the observed distribution.
5.3.5 Ratio Underestimation
Global ratio underestimation is a known problem in iTRAQ experiments and has been observed
in a number of publications. One possible explanation is contamination of the precursor selection
window [136, 83] due to overlapping MS1 features, which all carry the iTRAQ label [12, 83]. This
assumption is reasonable since a tryptic digest contains a large number of (non-tryptic/partly-
tryptic) peptides, which give rise to a dense proteolytic background [162]. Assuming that most
peptides are not differentially expressed, a tendency towards the null hypothesis (i.e., log ratio
equals zero) will be observed for a differentially expressed peptide in case the MS2 isolation
window includes a non-/adversely-regulated peptide. Thus, the ratio underestimation affects
accuracy since ratios are compressed towards zero (on log scale) [136], even though the overall
trend of over-/underexpression is preserved.
For iTRAQ quantification we acquired HCD spectra using an isolation window of ±1 or
±2 Th (depending on the data set). The Thermo software for Orbitraps will always select the
monoisotopic peak as precursor m/z and extend the isolation window equally to left and right.
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Figure 5.19: Density plot of the fraction of intensity that can be explained by peaks that
belong to the precursor ion, compared to the total intensity observed in the precursor isolation
window. Values for each interval represent data from 27 data sets from the IMU006 study. The
rightmost bar (black) represents the set of precursors with no background signal at all (≈5% of
all precursors).
On the left side, however, nothing is to be gained; only the chances of background inclusion
increase.
Within the precursor isolation window (2-4 Th) we computed (on the MS1 level) the fraction
of signal, that can be attributed to the isotope pattern of the identified peptide compared to
the overall signal. Isotope peaks below the monoisotopic peak resulting from iTRAQ impurities
were also included. All other “rogue” peaks with m/z values between isotope peaks (outside
of mass tolerance of 0.02 Da) were classified as background noise. An example can be seen in
Figure 5.1a: peaks colored in blue or red are counted towards the foreground peptide signal,
peaks colored in black are classified as rogue peaks. To our knowledge, this is the first work
using this approach. See Figure 5.19 for the results from IMU006. Data for other studies look
similar (not shown). Thus, only a small subset of precursors (≈5%) have no other background
signal within the precursor window. Most precursors have background noise, contributing about
20% to the total intensity in the isolation window. Very few precursors are more severely
affected. This could explain the slight underestimation of iTRAQ ratios when assuming that
most overlapping background signals are peptides which are not differentially expressed and
carry an iTRAQ label, thus causing a trend towards ratio underestimation.
We also investigated in what way overlap in MS1 influences the probability of a peptide ratio
as being tagged as an outlier during protein quantification. We found that outliers do not show
a different overlap behavior from non-outliers (see Figure 5.20). It is important to note here
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Figure 5.20: MS signal purity in each abundance bucket for non-outlier ratios (blue) and outlier
ratios (red). No dependency of intensity on overlap is present for outliers.
that we used the reporter ion signal as a reference for abundance. Karp et al. [136] found that
fragmentation efficiency of the iTRAQ tag is peptide-dependent by looking at the 145 Da peak
in MS2 for different peptides and comparing it to the reporter peak intensity. Thus, reporter
ion abundance does not necessarily correlate with feature abundance. This is also backed by
our data (not shown).
Finally, we looked at the distribution of outlier peptides (as tagged by isobar) depending on
their MS2 reporter abundance. Outliers are predominant for low abundance reporters. This is
not surprising as ratios of low reporter ions are less stable (see Figure 5.21).
5.3.6 Detection of Potential Biomarkers
For a powerful biomarker analysis, proteome coverage should be as high as possible while es-
pecially considering the low intensity regions since current results indicate that established
biomarkers are usually in the low abundance domain [15]. Our analysis of proteome coverage
(see Subsection 5.3.4) indicated that only a rather small subset of the proteome was covered,
most likely biased towards more high abundance proteins, as DDA (with exclusion lists) was
used, where preferentially highly abundant precursors are selected for fragmentation. For ex-
ploratory studies where the goal is to find a list of potential biomarkers, the field currently
lacks a more powerful alternative which is feasible for our purposes in terms of time constraints
and proteome coverage [163]. However, the approach could be modified to achieve even higher
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Figure 5.21: Relative fraction of outliers per reporter ion abundance bucket in IMU006. Outliers
appear more often in spectra with low iTRAQ reporter abundance.
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Table 5.7: Number of proteins classified as significantly expressed per study.
study # significant proteins
IMU002 20
IMU006 218
IMU007 112
NUI002-Adefovir 164
NUI002-Hyp-06ADEFVR 156
NUI002-Hyp-09ZOLACD 114
URO001 128
proteome coverage, e.g., by using extensive prefractionation at the cost of acquisition and anal-
ysis time, and/or using the latest instrument generation which allows for acquisition of more
precursor ions.
Biologically interpreted and confirmed results are not readily available for all but one study.
For IMU006, extensive data analysis and interpretation is currently carried out and prepared
for publication in Wilmes et al. [36]. In brief, IMU006 investigates the effect of the immunosup-
pressive compound cyclosporin A (CsA) on the proteome, transcriptome and metabolome level.
CsA at high dosage (15µM) caused significant alterations on all omics platforms. The protein
ubiquitination pathway and Nrf2-mediated oxidative stress response were significantly altered
in proteomics and transcriptomics analysis, thus supporting each other. Results were validated
using western blots. At low dosage (5µM), no major cellular perturbations are observed. A
more detailed evaluation will be reported elsewhere [36].
As one of the main goals of Predict-IV is to find common markers of toxicity across com-
pounds and cell systems, we will now report on the results of an integrated analysis using all
available proteomics data.
Comparative Approach
Table 5.7 provides an overview of the number of proteins classified as significantly expressed per
study. Our goal is to find candidate proteins which are consistently over- or underexpressed in
all studies and can be used as predictive markers for toxicity.
We compared protein expression ratios for control versus high dose samples from day 14 of
IMU002 with the values from IMU006, which is a repetition of IMU002. Results are shown in
Figure 5.22. The Pearson correlation of all common protein log ratios is 0.69 and rises to 0.77 for
proteins which have been deemed significantly expressed in either study. As data from IMU002
was confirmed to be of low quality in terms of proteome coverage and iTRAQ reporter intensity,
results might be overly pessimistic.
Looking at all studies combined, computing a simple intersection of significant proteins across
studies is not advisable since proteome coverage varies greatly between studies; thus, a protein
(whether significant or not) is not likely to be observable in all studies and the probability of
excluding a promising candidate is increasing rapidly with every additional study that is added.
Not surprisingly, the intersection of significant proteins of all six studies with human tissue is
empty.
We thus use an approach on the pathway level which allows for missing values (i.e., pro-
tein quantifications) while still being robust. We submitted the protein lists for each study to
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Figure 5.22: Comparison of protein expression ratios (C vs. H, day 14) between IMU002 and
IMU006 (repetition of IMU002). The Pearson correlation of all common protein log ratios
(black and red circles) is 0.69 and rises to 0.77 for proteins which have been deemed significantly
expressed in either study (red circles only). A dashed regression line is shown for each case.
ConsensusPathDB [164] (release 22), an online tool which allows to identify enriched networks
using a paired Wilcoxon signed-rank test for each pathway based on the provided expression
values. Currently, ConsensusPathDB aggregates pathway information from twelve databases.
We provide expression values for every observed protein in two different phenotypes, i.e., control
versus high-dose samples at day 14. ConsensusPathDB returns a p-value for each functional
set, based on the probability that the combined expression differences of genes in the functional
set between the phenotypes have appeared by chance. Also, q-values (p-values corrected for
multiple testing) are returned.
The q-values of IMU002 and IMU006 give a Pearson correlation of 0.79, whereas q-values of
IMU006 and IMU007 have no correlation (0.03).
There is again a missing values problem since not all studies hit every pathway due to semi-
random protein sampling. Only pathways with quantified proteins are shown in the result list
of ConsensusPathDB for any p-value threshold. We use the median of all available q-values per
pathway to determine a list of pathways with consistently low q-values. Note that the median is
a very conservative statistic here since we allow almost half of the data to be outliers. The top
result (lowest median q-value) is > 0.145 (activation of DNA fragmentation factor; three hits);
thus, according to this method no pathway is consistently enriched across studies.
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5.4 Discussion
We have described an approach to designing and evaluating iTRAQ-based proteomics exper-
iments in the Predict-IV project. We successfully formulated an experimental design which
allowed analysis of dose effects for all studies. The design is flexible enough for analysis in the
time domain by using a pooled channel as reference between experiments. We developed software
as part of OpenMS/TOPP to enable analysis of iTRAQ-labeled LC-MS data sets, and adapted
and integrated the isobar package into a comprehensive TOPPAS-driven analysis pipeline which
allows for highly automated analysis of large data sets.
We devised new measures of data quality for iTRAQ spectra, namely labeling efficiency
and proportion of negative reporter ion counts after naive isotope correction. In general, a
low reporter ion signal strength will decrease the number of confident peptide ratios used for
protein ratio computation or will prevent quantification altogether. For certain data sets based
on iTRAQ reporter strength alone, we can determine that the MS2 search need not be carried
out as we cannot expect to identify (or quantify) any peptides.
Isotope correction via NNLS was shown to be superior to the established naive inverse matrix
multiplication and subsequent elimination of negative reporter ion intensities. NNLS avoids this
ad hoc procedure, does not produce ghost peaks, and avoids extreme ratios as demonstrated for
the naive approach.
We showed that normalization using median of ratios results in MA plots with no visible
intensity bias. The normalization factors were usually between 0.6 and 1.6, but reached up to
2.64 in extreme cases, showing that normalization is absolutely critical.
iTRAQ is known to suffer in terms of accuracy because of ratio underestimation for complex
samples due to precursor overlap, and precision issues due to variance heterogeneity, as low sig-
nal data have higher relative variability. A global correction for lack of accuracy as suggested by
Karp et al. [136] seems only necessary when comparing proteomics results with other technolo-
gies, but is not necessary for biomarker discovery within a sample since the compression affects
all ratios (this picture is somewhat simplistic as ratio compression depends on the actual amount
of overlap for each precursor). For the first time, we have investigated the influence of ions which
will be concurrently fragmented with the selected precursor peptide due to overlapping signals.
We found that about 95% of all precursors are affected by overlapping signals, which contribute
about 20% to the abundance within the isolation window. This again supports the theory of
ratio underestimation by overlapping peptides.
Peptide ratios tagged as outlier are predominantly found in iTRAQ spectra with low reporter
ion counts, which is not surprising since other studies have found variance in low-abundance
spectra to be larger than in high-abundance spectra.
The extended exclusion list approach developed for this project and implemented into OpenMS
can only be theoretically motivated as the data suggests that, while exclusion lists were success-
fully generated, the instrument software nevertheless allowed for precursor acquisition at the
exact same position, indicating an instrument error or false parameter settings on the instru-
ment.
The detection of common potential biomarkers indicative of toxic adverse effects across all
studies was expected to be difficult due to limited and partly diverse proteome coverage of each
study. As there is no significantly over-/underexpressed potential biomarker across all studies,
a network approach was chosen to alleviate the missing values problem. Unfortunately, the
method employed yielded no common enriched network across all studies. If such a panel of
biomarkers is biologically feasible remains an open question.
Chapter 6
Summary and Future Directions
Synopsis: We summarize the results of this thesis and provide an overview of possible future
extensions.
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6.1 Novel Contributions of this Thesis
This thesis has made novel contributions in three areas, namely simulation, decharging, and
iTRAQ-based differential protein expression.
We have presented MSSimulator [34], an extensive collection of algorithms and models for
MS simulation supporting multiple levels of ground truth, which reduces the need for expensive
manual validation on real data sets. Most notably, the simulator supports multiple models of
chromatography (CE and HPLC), enzymatic digestion (regular expression and linear model),
peak shapes (Gaussian and Lorentzian), label-free and labeled experiments (via a modular la-
beling framework), resolution (constant, linear, square root), amongst other features such as
MS2 and MSE simulation. We illustrated that simulation is invaluable to assess algorithm per-
formance (e.g., ETISEQ for MSE data and map alignment using the OpenMS MapAligner).
Furthermore, we used simulation in a pilot study as a means to optimize experimental settings,
e.g., to answer the question of what is the gain in label-free feature identification, if resolution
is doubled when measuring a complex mixture data set.
Our second contribution is the decharging [35] of peptide or protein charge ladders while
allowing for multiplexing and different adduct compositions. The problem is modeled as an
ILP and allows for a fast and robust solution. We demonstrated that decharging is useful for
many applications in quantitative proteomics. The algorithm is not restricted to a specific
instrument or resolution, and although it is intended for ESI data, it should also be applicable
to MALDI data when multiply-charged ions are observed (e.g., for whole protein measurements
[30]). The algorithm was optimized by splitting the ILP into subproblems, which, as a result,
can be solved more efficiently. The split also allows for parallel processing on multiple CPU
cores. Both measures reduce running time significantly such that for a complex data set with
adducts the runtime is only a few minutes. Without adducts, the solution is usually obtained
within seconds.
Decharging was able to improve mass precision on an 18 protein mix data (tryptic digest).
On a whole protein measurement of hemoglobin, our algorithm showed better mass precision
when compared to the Xtract software, which is shipped with the instrument. Decharging is
also applicable to labeled data. Ambiguous pairs can be resolved by the additional information
provided by charge ladders. Also, missing partners of singletons can be inferred, which is
not possible with other pair finders. For the gliadin data set, our reanalysis revealed some
misannotation, introduced by manual analysis. We also found more protein masses which are
readily available in the data but were missed by manual annotation. Using our simulator, we
could show that our decharging algorithm maintains high levels of recall and precision (above
75%) even when the input data is complex or contains many missing values (even beyond 50%).
Our third contribution is a novel, highly automatable analysis workflow in TOPPAS for
iTRAQ-based proteomics experiments. The workflow was adapted to the experimental design
which we proposed for the Predict-IV project. A new isotope correction procedure based on
non-negative least squares was introduced. We showed that NNLS avoids ghost peaks and ex-
treme ratios and is therefore superior to the commonly used inverse matrix multiplication with
subsequent elimination of negative reporter ion intensities. Labeling efficiency was introduced
as a new metric for iTRAQ data quality. The metric can be computed very fast, is easy to im-
plement, and provides a powerful means to assess prospects for high-quality quantification and
identification results. NNLS and the labeling efficiency metric are available in our ITRAQAn-
alyzer tool, which is part of OpenMS/TOPP. Normalization of iTRAQ channels using median
of ratios was shown to be essential to avoid biased quantification results. Normalization factors
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usually ranged between 0.6 and 1.6, but reached up to 2.64 in extreme cases. The extended
exclusion list approach that was developed for this project can only be theoretically motivated.
Despite the fact that exclusion lists were successfully generated, the instrument software never-
theless allowed for precursor acquisition at the exact same position. For the first time, we have
investigated the influence of background ions which will be concurrently fragmented with the
selected precursor peptide. We found that about 95% of all precursors are affected by overlap-
ping signals. The latter contribute about 20% to the abundance within the isolation window.
This supports the theory of ratio underestimation by overlapping peptides as already reported
in the literature [12, 83, 136].
All algorithms presented in this thesis were implemented in OpenMS/TOPP and are part of
the current stable release of OpenMS 1.9.
6.2 Future Extensions
Even though all algorithms presented in this thesis have reached a mature state, have been
published (or are being prepared for publication), and are part of OpenMS/TOPP, there are
extensions to each algorithm, which can be beneficial to extend their applicability.
Our simulation software would benefit from an automatic estimation of simulation param-
eters (e.g., resolution, sampling rate, noise level) from real data, which is currently a manual
process and thus time-consuming. Furthermore, the current model of proteotypicity is not quan-
titative. By using machine learning, it should be possible to create a quantitative model that
could be easily integrated into the current framework. Current approaches (including MSSim-
ulator) only classify peptides as either proteotypic or not proteotypic [165, 166]. Incorporation
of ion statistics, detectors, and instrument specific properties (e.g., “shoulder peaks” on FT
instruments – see Subsection 2.3.2) should also increase the level of realism. Due to the broad
support of different levels of ground truth and a wide variety of models, the simulator could also
be used to re-evaluate published algorithms whose performances were assessed using a feature-
limited and special purpose simulation tool. A comparison might reveal significant differences
in performance of the algorithm, pointing to violated model assumptions (e.g., shape models,
data complexity). Last but not least, to estimate the performance of peak picking or feature
finding algorithms on existing data, one could embed simulated signals into real data and use
the recovered proportion as a proxy for sensitivity.
Decharging has been shown to be robust towards high-complex data sets and missing values
up to 50% and even beyond. If the amount of missing features is higher, missing features
could be attenuated by coupling decharging to a hypothesis-driven feature finding heuristic
(already implemented in OpenMS) which searches for a strong signal (e.g., using signal-to-noise
ratio) at putative feature positions to infer missing features or resolve ambiguous explanations.
Furthermore, automatic estimation of putative adducts from the data would remove the need
for their manual specification. This should be possible by searching for edges with a restricted
set of adducts and selecting those which significantly increase the number of edges.
iTRAQ-based quantification can be re-evaluated on the biological modeling level. Currently,
only proteins with fold changes in the tails of the Cauchy distribution are tagged as significant,
which is the default behavior of the isobar package. This is a conservative measure in the sense
that a lower fold change can be very stable and consistent across conditions but would never
be tagged as significant, which will decrease the number of candidate biomarkers in exploratory
studies. Furthermore, in order to avoid extreme normalization ratios in iTRAQ-based quantifi-
cation it should be possible to measure an aliquot of the sample in the wet lab to determine a
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preliminary normalization ratio. On strong deviation from a ratio of one the mixture can be
adjusted before a full measurement is performed. Also, inclusion lists are a reliable method to
increase protein overlap across studies, but they require additional effort during acquisition. In-
creased overlap would also aid in establishing ratio comparisons across iTRAQ experiments via
a pooled reference (which already exists), thus allowing to track not only changes with dosage
but also with time more reliably.
To sum up, we have introduced a comprehensive simulation framework and have shown its
applicability to algorithm benchmarking and validation. Our decharging algorithm is capable
of handling an arbitrary set of adducts, is suitable for peptide- as well as protein data sets,
and can handle labeled data. It achieves mass precision that is superior to other decharging
algorithms. Its robustness towards missing values and complex data sets was validated using
simulation. Last but not least, our iTRAQ analysis pipeline allows for a fast computation of
lists of differentially expressed proteins. The pipeline incorporates a non-negative least squares
procedure for isotope correction which outperforms inverse matrix multiplication. We have in-
troduced labeling efficiency as a new measure for iTRAQ data quality and also found supporting
evidence for iTRAQ ratio underestimation by overlapping signals.
Appendix
6.3 Availability and Implementation
The TOPP tools and UTILS developed as part of this thesis are available free of charge in
the current release of OpenMS/TOPP, available from http://www.OpenMS.de, running on all
major operating systems (Windows, Linux, MacOSX). The classes on which the TOPP tools
are based are implemented in the OpenMS library and have accompanying regression tests.
6.4 Simulation: Capillary Electrophoresis
6.4.1 Explanations for Choices of α
• α = 13 : Based on Strokes’ law for frictional drag in non-conducting media. The model
predicts the mobility to be proportional to the radius of a sphere (volume of sphere:
4
3 · pi · r3). As volume is proportional to mass (MW ) and a peptide’s shape can arguably
be approximated as a sphere, the radius of the sphere is proportional to the cube root of
the peptide’s mass.
• α = 12 : Classical polymer model. Assuming that frictional drag is proportional to the
average radius of gyration, it has been shown (for synthetic polymers) that mobility is
proportional to the square root of the number of polymers times the length of a unit [167].
This translates to the number of AA, which is approximately the peptide mass.
• α = 23 : Offord model [168], which is similar to Strokes’ law, but assumes the mobility of
an ion in conducting media to be inversely proportional to the surface of of a sphere which
is proportional to the square of the radius (surface = 4 · pi · r2).
However, all these models are only approximations and neglect certain properties of CE and
the analytes (e.g., peptide shapes, electrostatical interactions with separation buffer and other
peptides). See Rickard [169] for a more elaborate discussion. Authors report different empirical
values of α, e.g., 0.52 [44] or 0.46 [170] to produce the best correlation with observed migration
times; others use the theoretical values α = 12 or α =
2
2 [169]. As several different values for α
have been found adequate, depending on the researched peptides, the software allows manual
adjustment for α. The default, however, is set to 12 , which is the exact value for the classical
polymer model and also close to the empirical findings by Williams, Russell, and Russell [44]
and Kim, Zand, and Lubman [170].
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6.4.2 Charge Determination
The net charge value q for a peptide depends on the buffer pH and its amino acid composition.
Depending on the pH and other factors, an amino acid will become positively or negatively
charged (or might even be neutral) if its pI equals the buffer pH. According to Benavente [171],
q can be estimated reliably from average AA pKa values from Rickard [169]. This leads us to
employ the widely used Rickard’s pKa values and the charge equation given by Winzor [172]
and Benavente [171]:
q =
4∑
n=1
Pn
1 + 10pH−pK(Pn)
−
5∑
n=1
Nn
1 + 10pK(Nn)−pH
, (6.1)
where Pn are the number of basic residues (P1 = terminal NH2 = 1; P2 = #His; P3 = #Arg;
P4 = #Lys) and Nn are the number of acidic residues (N1 = terminal COOH = 1; N2 = #Asp;
N3 = #Glu; N4 = #Cys; N5 = #Tyr).
The equation allows the user to provide a pH value (which is typically rather low at about
pH 2-3). The model assumes that each amino acid’s charge is independent of the other groups in
the peptide. However, real pKa values are additionally governed by peptide bonds and ionizing
groups in the neighborhood, and are further shifted due to secondary and tertiary structural
elements [169, 171]. Net-charge-based “trends” in CE-MS data have been observed, seemingly
dependent on the number of lysine [44], arginine, and histidine [173].
6.4.3 Migration Time Computation
For practical purposes we allow an automatic scaling where the 95th MT percentile is projected
to 95% of a given gradient time. The reason for not scaling the whole MT range to the given
gradient is that outliers (with large MT) will otherwise compress the rest of the features into a
small MT range.
6.5 Simulation: Contaminants Input Format
MSSimulator ships with a default text file containing a list of contaminations. The user can
easily modify or extend this list. The file is in comma separated value format with the following
columns:
• Name of the contaminant (this will be included into the generated featureXML file to help
the user identify the simulated contaminant).
• Elemental composition of the contaminant (e.g. CH3OH for Methanol).
• Retention time at which the contaminant starts to elute.
• Retention time at which the contaminant stops to elute.
• The intensity of the contaminant.
• The charge of the contaminant.
• The shape of the elution profile of the contaminant. Valid choices are gauss, which gives a
Gaussian-like elution profile, and rec, which gives a rectangular elution profile (immediate
start and end of elution).
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• The ion source which can ionize the contaminant. Valid choices are ESI, MALDI, and ALL.
The contaminant will be visible if the respective ion source is used during simulation.
Listing 6.1 shows an example of a typical contaminants file.
Listing 6.1: Contaminants example (shortened).
”Methanol” , CH3OH, 1622.67007796 , 1636 .41953782 , 9 .2213957831 , 1 , rec , ESI
”ACN” , CH3CN, 124.649458627 , 214 .635926495 , 2 .16273553493 , 1 , gauss , ESI
”ACN” , CH3CN, 1898.59871684 , 1907.43645208 , 5 .83229369713 , 1 , gauss , ESI
”PEG” , C2H4OH2O, 248.114284788 , 408 .870937779 , 26 .5073181419 , 1 , gauss , ESI
”ACN” , CH3CN, 1315.05880119 , 1323.44605547 , 3 .58052185195 , 1 , gauss , ESI
”Methanol” , CH3OH, 335.244027089 , 363 .211414194 , 13 .7931809344 , 1 , gauss , ESI
”DMSO” , C2H6OS, 1033.09825892 , 1047.95569948 , 7 .10154401272 , 1 , gauss , ESI
”PPG” , C3H6OH2O, 1416.76207731 , 1424.20882302 , 1 .75685771789 , 1 , gauss , ESI
” A c e t o n i t r i l e ” , CH3CN, 1427.9342627 , 1471.10917918 , 3 .03404557045 , 1 , rec , ESI
”PEG” , C2H4OH2O, 841.010029756 , 844 .145059911 , 2 .08297782253 , 1 , rec , ESI
”d6−DMSO” , C2(2)H6OS, 1040.65301474 , 1050 .06202825 , 9 .47611582171 , 1 , gauss , ESI
”Tween” , C22H42O6C2H4O, 1291.34392383 , 1345.04027583 , 5 .6043075182 , 1 , rec , ALL
”Tween” , C24H44O6C2H4O, 1138.92462328 , 1170.23236234 , 11 .4304013533 , 1 , gauss , ALL
”Tween” , C24H46O6C2H4O, 815.201065785 , 906 .178998869 , 7 .02337746262 , 1 , gauss , ALL
”Tween” , C22H42O6C2H4O, 592.070179209 , 615 .839682222 , 8 .38995498978 , 1 , rec , ALL
”Tween” , C24H44O6C2H4O, 420.416093615 , 429 .92926345 , 8 .65663328873 , 1 , gauss , ALL
”Tween” , C24H46O6C2H4O, 506.491681671 , 590 .456315632 , 4 .04299987225 , 1 , gauss , ALL
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Glossary
Accuracy
Accuracy is the difference between the measured mass of an ion and its theoretical mass,
typically given in parts per million (ppm), which can be computed as
Acc =
mmeasured −mtheoretical
mtheoretical
· 106 ppm.
Biomarker
A characteristic allowing to discern normal from pathogenic biological processes, or a
pharmacological response to therapeutic treatment or an in vivo molecule whose altered
abundance is connected to a specific condition of health [12].
Bottom-up Mass Spectrometry
Analysis of digested proteins, i.e., peptides. Requires a smaller m/z range and creates a
narrow charge distribution. Protein quantification and identification values are inferred
from the detected peptides. Not all peptides may be viable for quantification/identification
of proteins if they are shared between multiple proteins (non-unique).
Capillary electrophoresis (CE)
The term CE refers to a family of separation techniques that use narrow-bore fused-silica
capillaries to separate a complex mixture of large and small charged molecules. In a high
electric field, molecules are separated based on their physical-chemical properties which
determine their migration time, which is further dependent on the background electrolyte
and its properties, e.g., ionic strength, pH, or type of ions.
Centroiding
See peak picking.
DDA
Data-dependent acquisition, also known as IDA (intensity-dependent acquisition) is an
operation mode available in MS2-capable mass spectrometers for selecting precursor ions
for MS2 fragmentation. The approach is untargeted (thus no prior knowledge of peptide
content is required) and usually intensity dependent, i.e., the most intense precursor ions
from a preceding survey scan will be selected as precursors.
Exclusion list
In subsequent LC-MS runs of the same (or similar) analytes with reproducible chromatog-
raphy conditions, exclusion lists can be used to exclude certain precursor ions from being
selected for MS2 fragmentation in DDA mode. Usually, the list will be populated based
on previous runs and contains positions in RT and m/z where a peptide has already been
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identified, thus avoiding redundant identification and allowing for a deeper proteome cov-
erage.
FDA
The Food and Drug Administration (FDA) is an agency within the U.S. Department of
Health and Human Services instantiated to protect public health and approve safe and
effective medicines and drugs.
FWHM
Full width at half maximum (FWHM) is a metric used to describe the width of a peak,
which is measured from its left to right flank at half the maximum peak intensity.
Ghost peak
Artefactual peak which is erroneously reconstructed from a zero-intensity peak by the
naive inverse matrix multiplication procedure during isotope correction of raw iTRAQ
reporter ions.
High-performance liquid chromatography (HPLC)
HPLC is a chromatographic technique to separate a (complex) mixture for eased down-
stream analysis. HPLC instrumentation includes a pump, injector, column, detector, and
data system. The analyte mixture is forced through a stationary phase by the flow of a
mobile phase at high pressure, separating the mixture into its components. The stationary
phase is defined as the immobile packing material in the column, whereas the mobile phase
is the solvent added to promote elution and whose composition can be changed in time to
change the interaction of the solute with mobile and stationary phase.
Sacred Birman
Admirable cat breed with blue eyes, native to central Asia and German rental apartments.
Most individuals prefer cozy roosts such as human interface devices (HID), keyboards in
particular, especially when the aforementioned HID is currently in use.
iTRAQ
The isobaric tag for relative and absolute quantitation (iTRAQ) is an MS2-based labeling
technique allowing for multiplexing with up to eight isobaric tags. Reporter ions allowing
to quantify individual sample contributions show in the MS2 spectrum in the 113-121 Th
range for the 8-plex kit, and 114-117 Th for the 4-plex kit.
isobar
The isobar package [144] is a statistical software package written in R [145] for the analysis
of iTRAQ data. It features a flexible R interface, noise models to account for data het-
eroscedasticity, and statistical significance estimation for protein over- or underexpression,
circumventing ad hoc thresholds for fold changes.
Labeling efficiency
Labeling efficiency denotes the relative fraction of iTRAQ spectra where a reporter ion
signal is present in any channel and can be used as a criterion of data quality. Optionally,
when stated explicitly, the term can also refer to the relative fraction of reporter ion
presence in a single iTRAQ channel only.
Multiple reaction monitoring (MRM)
MRM, also called selected reaction monitoring (SRM), is a targeted quantification strategy
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which uses selected (and specific) precursor and product ions of a peptide (a so-called
transition) as it elutes off the LC column. MRM works for highly complex samples and
requires an instrument with MS2 capabilities, usually a Q-TOF or a Triple-Q. MRM has
the advantage of high sensitivity and dynamic range combined with reliable acquisition of
the targeted species, but with a limited amount of peptides/proteins that can be quantified
in one experiment.
Multiplexing
Multiplexing via labeling allows to discern identical peptides (in terms of sequence and
post-translational modifications) from different samples within one LC-MS experiment by
using chemical or metabolic labeling of some kind to introduce a systematic mass shift.
This allows to discern and finally quantify peptides from different samples concurrently.
Non-negative Least Squares (NNLS)
Non-negative Least Squares solves the problem min ||Ax−b||2, subject to x ≥ 0. The NNLS
problem is solved iteratively, and it can be shown that the iteration always converges and
terminates.
OpenMS
OpenMS is a C++-based open-source library for label-free and labeled quantification and
identification, supporting all major platforms. It supports the HUPO-PSI standards mzML
and mzIdentML as well as the widely used pepXML and protXML formats, enabling data
exchange between collaborators based on open platform-independent formats. TOPP is a
set of application based on OpenMS.
TOPP
The OpenMS Proteomics Pipeline (TOPP) [98] is a set of executables, chainable in modu-
lar fashion for a wide set of analysis scenarios and covers common tasks like peak picking,
map alignment, identification (via wrappers for common identification engines like Mascot,
X!Tandem and OMSSA), filtering, and quantification of labeled and label-free data.
Peak
A peak is the signal produced by a single ion species with a fixed number of neutrons and
a fixed charge. The shape of a peak is usually Gaussian- or Lorentzian-like. Its width
depends on the resolution of the mass spectrometer at the designated m/z position. The
width is usually measured as FWHM.
Peak picking
One of the first data reduction steps for processing raw LC-MS data. Peak picking aims
at representing a true peak by single datapoint (the centroid), describing its m/z (usually
somewhere close to the center of the peak or its apex) and cumulative or apex intensity,
while discarding single noise data points.
Precision
Precision is an intrinsic property of the instrument and describes the reproducibility of a
repeated mass measurement as determined by its physical limits.
Precursor ion
In shotgun proteomics, a precursor ion (or parent ion) describes an unfragmented peptide
species which, when selected for fragmentation, will give rise to multiple product ions
which allow peptide identification.
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Predict-IV
Predict-InVitro (Predict-IV) is a project funded by the European Union within its Seventh
Framework Programme. The project aims at characterizing the dynamics and kinetics of
cellular responses to toxic effects in vitro.
Product ion
See Precursor ion.
Reporter ion
An ion observed in MS2 iTRAQ spectra at designated m/z positions (114, 115, 116, 117
Th for 4-plex iTRAQ and 113, 114, 115, 116, 117, 118, 119, 121 Th for 8-plex iTRAQ). We
use the term raw abundance or raw intensity to denote reporter ion intensities as observed
in the data, i.e., prior to isotope correction.
Resolution
Resolution is defined as R = m/∆m50% where m is the mass to be measured and ∆m50%
is the minimal distance to the next theoretical mass which can be resolved. The distance
is defined in terms of the full width at half maximum (FWHM).
Study
In the realm of the Predict-IV project, a study designates a set of experiments involving
exactly one cell type and one toxic compound, but with different dosages and collection
time points. This results in a set of iTRAQ LC-MS data sets according to the experimental
design.
Top-down Mass Spectrometry
Analysis of whole proteins, without prior digestion. Not feasible with all mass spectrome-
ters. Allows easier localization of modification sites but usually creates large charge ladders
and congested mass spectra. Depending on protein size, only high-resolution instruments
are capable of resolving isotopic envelopes.
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